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ABSTRACT 
THE SYNTHESIS OF CHEMOSENSORS FOR TOXIC ANALYTES 
by Johnathan Hugh Broome 
August 2016 
A number of chemosensors have been designed and synthesized to target 
cations (Zn2+ ions), neutral molecules (cathinones), charged molecules 
(aminoindanes), and anions. The Zn2+ ion sensor featured bistriazole designed 
binding unit and ferrocene signaling units. Characterization of Zn2+ ion binding 
was carried out with electrochemical techniques (CV and DPV), 1H-NMR, mass 
spectrometry, and molecular modelling. It exhibited a 1:1 binding stoichiometry 
with Zn2+ and had an affinity for ZnCl2 (Log K1:1 = 4.1 ± 0.02) over other Zn2+ 
salts. 
The cathinone probe was designed to selectively bind mephedrone over 
common street drugs and adulterants, such as methamphetamine and 
acetaminophen, respectively. It featured a bisthiourea design linked by a ridged 
anthracene backbone. The binding occurred via hydrogen bonding and π-π 
interactions and was monitored via NMR, mass spectrometry, fluorescence, and 
molecular modelling. DFT studies found that mephedrone bound inside the 
molecular cleft of the dipodal bisthiourea probe, while flephedrone bound outside 
the binding pocket and interacted with the π system of the rigid anthracene 
backbone. 
The aminoindane chemosensor utilized a bisaza-crown ether design to 
bind the protonated, primary amine functionalities on the aminoindanes through 
 iii 
hydrogen bonds. The hydrogen bonding events were characterized using NMR, 
UV-Vis, and fluorescence. Unfortunately, the bisaza-crown aminoindane probe 
had a higher affinity for aniline-HCl (Ka = 1148 ± 1 M-1) over 2-aminoindane (Ka = 
457 ± 1 M-1). 
Investigation of the anion binding abilities of the bisthiourea designed 
mephedrone probe was carried out using NMR, fluorescence, and mass 
spectrometry. The thiourea moieties are known to hydrogen bond anions, so the 
probe was analyzed with a host of various tetrabutylammonium anion salts. It 
was found that the probe had an affinity for the Cl- anion (Log K2:1 > 10). Using a 
naphthyl moiety, rather than a benzyl one, caused the formation of an excimer 
upon addition of anion to a solution because the naphthyl units were brought into 
close proximity by the hydrogen bond coordination of the anion. 
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CHAPTER I – GENERAL INTRODUCTION 
1.1 Supramolecular Chemistry 
Supramolecular chemistry is a relatively novel discipline of chemistry. The 
pioneering research, conducted in the late 1960s, was recognized with a Nobel 
Prize in 1987.1 The Nobel Prize was shared by Jean-Marie Lehn, Donald J. 
Cram, and Charles J. Pedersen. The three developed different types of 
macrocyclic host molecules simultaneously in the 1960s and 1970s. In his Nobel 
Prize acceptance speech, Lehn defined supramolecular chemistry as ‘chemistry 
of molecular assemblies and of the intermolecular bond;’ in other words, it is the 
chemistry of intermolecular forces.2  
Supramolecular chemistry has two main branches: self-assembly and 
host-guest chemistry. Host-guest chemistry, the more traditional branch of 
supramolecular chemistry, is based on the investigations of intermolecular 
forces, like electrostatic forces, hydrogen bonding, dipole interactions, π-π 
interactions, and van der Waals forces, which occur between host molecules and 
guest ions or molecules.2,3 Self-assembly is the study of complex, spontaneously 
assembled aggregates that arise from these intermolecular interactions between 
molecules and/or ions. 
The host-guest branch of supramolecular chemistry developed first, 
primarily by the 1987 Nobel Laureates: Lehn, Cram, and Pedersen.1 Although, 
there were other contributing scientists: i.e. Simmons and Park, who conducted 
research into anion binding katapinands. The major theme in each of the 
laureates’ research was the use of macrocyclic hosts to bind cationic guests. 
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Many of their initial macrocyclic host molecule designs drew inspiration from 
biological hosts. Pedersen primarily worked on crown ethers (1.1), Lehn on 
cryptands (1.2), and Cram on spherands (1.3) (Figure 1).1,4 Each of these 
macrocyclic molecules represents the initial scope of supramolecular chemistry 
in its infancy. At present, it is a complex field encompassing more than host-
guest chemistry; the self-assembly branch now includes complex systems with 
many hierarchies of structure, such as self-assembled polymers. Other examples 
of complex self-assembled systems include molecular machines, molecular 
knots, and stimuli-responsive, self-assembled structures. The field of 
supramolecular chemistry has expanded well beyond its historical scope and 
affected almost every other field of chemistry. 
 
Figure 1. Macrocyclic molecules investigated by Cram, Lehn, and Pedersen. 
1.2 Chemosensors 
A primary focus of the host-guest branch of supramolecular chemistry is 
the design of chemosensors or molecular probes for specific targets. 
Chemosensors, essentially, are host molecules that can produce a signal when a 
guest is bound to the host. They originally evolved as macrocyclic hosts targeting 
1.1 
1.2 
1.3 
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cationic guests; however, chemosensors have now expanded to include anions 
and small molecule guests. They also include podands, which are acyclic 
molecules, molecular cavities, and a plethora of other types of molecular hosts. 
The primary focus of the research outlined in this dissertation is the use of host-
guest chemistry and chemosensor design to target specific ions (Zn2+ and 
various anions) and small molecules (mephedrone and 2-aminoindane). 
Chemosensor design has been one of the most significant aspects of 
supramolecular research for the past few decades.1 A chemosensor generally 
contains three components: a receptor, a spacer, and a signaling group (Table 
1).5 The receptor is the part of the sensor that binds to the guest.1 Some common 
receptors are crown ethers, calixarenes, thiourea motifs, and many other 
heteroatom moieties that can participate in intermolecular bonding.6–8 From a 
fluorophore, chromophore, to a redox active moiety, the signaling unit can be a 
variety of functional groups that signals the binding of the guest. It aids in 
creating a spectral change that indicates guest binding. The spacer can be a 
simple alkyl chain or a complicated motif that can promote electron transfer 
between the receptor and the signaling group to indicate that the target is bound. 
It is the combination of the three components that defines a chemosensor, which 
is capable of binding and sensing the target. It is the relatively weak 
intermolecular forces that can allow for a reversible interaction between the host 
and guest, which can allow the chemosensor to be reused multiple times. 
Although, reversible covalent interactions is now included in the supramolecular 
chemistry lexicon.9 
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Table 1  
Common chemosensor components and example motifs 
 
Common Chemosensor Components 
 
Nitrobenzene 
chromophore 
 
Alkyl spacer 
 
Crown ether receptor 
 
Naphthalene 
fluorophore 
 
Alkenyl spacer 
 
Triazole binding unit 
 
Ferrocene redox active 
motif 
 
Ether spacer  
Thiourea binding unit 
 
The concept of reusability makes chemosensors an attractive approach to 
detecting chemicals, as opposed to current instrumental detection methods. They 
can be more effective, economical, and reliable detector of targets, such as 
drugs, ions, and biological molecules. Host-guest type molecular sensors are 
much more economical and mobile than most instruments and can be just as 
effective, providing similar detection limits and sensitivities. These attributes 
Receptor 
Signaling 
Group 
Spacer 
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make molecular sensors viable for many applications that require in-the-field 
detection. Many samples cannot be prepared for instrumental analysis without 
affecting their composition, and many instruments are not designed for 
portability, should the scientist need to perform in situ tests.  
1.3 Typical Targets 
Ions and small molecules, such as Zn2+ and pyrophosphate, respectively, 
are some common guests in supramolecular chemistry and have a significant 
effect on the selection and design of a chemosensor.10,11 For example, alkali 
metal cations are relatively simple targets due to the fact that all of them possess 
spherical shapes.1 Anions can have spherical shapes along with many other 
geometries, like trigonal planar and tetrahedral, and are more difficult to detect 
with molecular sensors. Small molecules present even more challenges in their 
detection due to the various functional groups that can alter the geometry and 
electronics of the molecule, which will affect binding in a host. The particular 
guest of choice is an important factor in the consideration of host design. 
1.3.1 Cation Sensors 
As previously mentioned, chemosensors contain three main components: 
a receptor, a spacer, and a signaling group. Varying the choices of the three 
main components gives rise to certain sensing properties.3 It is imperative that a 
chemosensor has the following properties:  
 Selectivity 
 Complementarity   
 Sensitivity. 
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Selectivity and complementarity are related to the structure of the probe. 
Certain motifs can aid the sensor’s selectivity for a specific target. This selectivity 
can be governed by the target size, host’s preorganization, or a specific 
functional group on the chemosensor.12 One traditional example of a 
chemosensor’s selectivity with regards to target size is the pseudo[18]crown-6 
receptor’s (compound 1.4), which has a high affinity for K+ (Figure 2).13 
[18]Crown-6 will bind many spherical cations, but it binds the K+ with the largest 
binding constant, logK = 6.08, versus 4.35, 3.90, and 4.14 for Na+, Ca2+, and 
NH4+, respectively. Complementarity refers to the mutual spatial and electronic 
complementary binding sites on both the guest and host. The size-fit 
complementarity between the crown and metal ion is one reason that [18]crown-
6 has a high affinity for K+. Finally, sensitivity is, typically, related to the signaling 
unit and how well it responds to the presence of the analyte.  
 
Figure 2. Naphthyl-based fluorescent crown ethers for metal complexation. 
Cationic probes typically involve heteroatoms that can coordinate to the 
cation. Traditionally, macrocyclic receptor units, like the azacrown ether (Figure 
2), were utilized to coordinate cations. However, podands can also be effective 
agents in coordinating cations. Podands have higher degrees of freedom than 
macrocycles; this can adversely affect their selectivity because they can bind 
1.4 
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various sizes of cations. This is evident in the probe (1.5) developed by Yagi et 
al., which bound Ca2+, Mg2+, Sr2+, and Ba2+ (Figure 3). 14 However, selective 
binding has been achieved with podands. 
 
Figure 3. Colorimetric bis(spiropyran) podands for the detection of alkaline earth 
metal ions. 
1.3.2 Anion Sensors 
A disadvantage in anion sensing is the various geometries of anions.15 For 
example, carbonate and nitrate are trigonal planar, sulfate and phosphate are 
tetrahedral, while cyanide and thiocyanate are both linear. These examples are 
some of the more common ions, but the geometries can be even more complex; 
carboxylates and dicarboxylates can complicate detection due to their complex 
organic structures. All of these geometries must be considered when designing 
an anion probe. The probe’s structure must be complementary to the geometry of 
the target anion to afford selectivity. 
Another drawback to anion sensing is that anions have high free energies 
of solvation compared to similar sized cations, i.e. the potassium ion and fluoride 
(both have a radius of 1.33 Å).1 They have free energies of hydration of -295 and 
-465 kJ·mol-1, which forces the sensor or host molecule to compete with the 
1.5 
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solvent to bind the anions compared to cations. Another disadvantage with 
sensing anions is maintaining the correct pH. All anions are conjugate bases of 
their respective acids. In their acidic form, they do not hydrogen bond as well. 
The solution to that problem seems simple; just conduct any binding studies at a 
basic pH. However, many of the host molecules designed for sensing anions 
contain hydrogen bond donor moieties, like amines, to bind the anions. At a basic 
pH, these amines can be deprotonated as well; therefore, a narrow pH window 
exists in which the anion is deprotonated or “naked” and the hydrogen bonding 
donor functionalities on the host molecule are still protonated, so that they can 
donate hydrogen atoms.  
Hydrogen bonding is one of the primary intermolecular forces involved in 
the binding of anions. Anions mostly contain heteroatoms that can function as 
hydrogen bond donor and acceptor atoms, like oxygen, nitrogen, and sulfur 
atoms. These intermolecular forces are weaker than the dative covalent bonds 
associated with cation binding. Even with all the disadvantages associated with 
anion sensing (multiple geometries, solvent competition, narrow pH window, and 
relatively weak interactions), it is still a topic of great interest in chemical 
research.  
An anion receptor that uses hydrogen bonding is featured in Figure 4, 
which shows a common “tweezer”-shaped host molecule. Gunnlaugsson et al. 
utilized a bisthiourea derived Tröger’s base molecular ‘tweezer’ for the sensing of 
anions.16 The thiourea moieties functioned as excellent hydrogen bond donors to 
a host of anions. They were able to monitor the binding of these anions by 
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observing changes in the absorption spectra of the probe and changes in the 1H-
NMR signals. The 1H-NMR nuclei involved in the binding underwent deshielding 
in the presence of the anions; this indicated they were involved in hydrogen 
bonding. Gunnlaugsson et al. showed that the bisthiourea probe was selective 
for acetate and dihydrogen phosphate in a 2:1 guest:host stoichiometric ratio 
(Figure 4). They determined a Log K2:1 of 7.40 for acetate and 7.21 for 
dihydrogen phosphate and a Logβ1:1 of 4.22 and 4.21 for acetate and dihydrogen 
phosphate, respectively. Ultimately, Gunnlaugsson et al. were able to 
demonstrate that the geometry Tröger’s base skeleton made a successful 
bidentate anion receptor. 
 
Figure 4. Bisthiourea-derived Tröger’s base molecular tweezer. 
1.3.3 Small Molecule Sensors 
Chemosensors designed to target small molecules present a challenge 
due to their complex geometry.1 This can require the design and synthesis of 
complex molecular probes. Selective binding of the small molecule usually 
requires the use of multiple types of intermolecular forces and a high degree of 
preorganization of the host. This is often required because many small organic 
molecules are neutral, generally, and do not bind as well as cations and anions, 
which benefit from relatively strong electrostatic forces.  
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Many small molecule receptors take advantage of the hydrophobic effect 
and are designed with clefts or cavities (Figure 5).2 Although some small 
molecule receptors do take advantage of electrostatic interactions, many of them 
utilize hydrophobic pockets for the binding of neutral molecules. Receptors that 
feature an intrinsic bowl-shaped cavity and are used for small molecule detection 
are generically known as cavitands. There are several classes of cavitands; 
some of the more common classes include: calixarenes (1.6) and cyclodextrins 
(1.7). 
 
Figure 5. Common cavitands: Calix[6]arene (left) and α-cyclodextrin (right). 
An intricate example of a cavitand used for binding neutral molecules is 
illustrated in Figure 6. Sherburn et al. demonstrated that a penta-cavitand super 
bowl receptor with simple hydrogen bond donor/acceptor groups can function as 
a selective receptor for aspirin.17 However, they noted that only one of the five 
cavitands comprising the super bowl was actually involved in the binding of the 
aspirin. Therefore, Sherburn et al. decided to analyze the aspirin binding ability of 
their shallow cavitands. After analyzing a host of varying spacer lengths and the 
1.6 
1.7 
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number hydrogen bonding acceptor/donor motifs on the upper rims, they found 
that the cavitand in Figure 6 was the optimal structure for selective binding. The 
binding affinities for the various shallow cavitands were determined via 1H-NMR 
and isothermal titration calorimetry (ITC). Sherburn et al. hypothesized that the 
two interactions occurring between the neutral guest and probe were a double 
hydrogen bonding interaction between a –CH2OH motif on the upper rim of the 
cavitand and the –COOH moiety on aspirin and a CH–π interaction between the 
ester’s methyl functionality and the aromatic backbone of the shallow cavitand. 
Ultimately, Sherburn et al. demonstrated that shallow cavitands with hydrogen 
bond donor/acceptor groups can function as a selective sensor for neutral 
molecules. 
 
Figure 6. Shallow cavitand designed to bind neutral aspirin. 
Adapted with permission from reference 17. Copyright 2014, John Wiley and Sons 
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1.4 Summary 
Chemosensors are ubiquitous in supramolecular world; they represent the 
traditional definition of supramolecular chemistry, which involved a host and a 
guest. There are a multitude of sensors designed to target cations, anions, 
neutral molecules, and charged molecules. Guest geometry and intermolecular 
forces play a significant role in the design and development of chemosensors. 
These considerations will be discussed and deliberated in each of the projects 
presented in this work.  
This work presents a structural study of chemosensors designed and 
synthesized for a wide range of targets. The sensors discussed in the 
subsequent chapters utilize known signaling, spacer, and receptor motifs; 
however, the arrangements of these motifs differ in order to investigate the 
spatial effects of these motifs. A common theme throughout this research is 
hydrogen bonding; although other intermolecular forces are employed, hydrogen 
bonding plays a role in each of the subsequently discussed projects. 
Supramolecular chemistry, intermolecular forces, chemosensor design, 
complementarity, selectivity, and sensitivity are all common themes throughout 
this dissertation. The subsequent chapters will focus on the design and synthesis 
of chemosensors for cations, anions, neutral molecules, and charged molecules. 
Chapter II presents a chemosensor designed to selectively bind Zn2+, while 
Chapter III will discuss a probe designed to bind a neutral cathinone, known as 
mephedrone. Chapter IV will present the binding ability of a bisaza-crown probe 
devised to bind the aminoindane class of psychoactive substances. Finally, 
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Chapter V will discuss the anion binding abilities of the probes used to bind 
neutral mephedrone in Chapter III.  
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CHAPTER II – ELECTROCHEMICAL ZINC(II) SENSOR  
2.1 Background 
Zinc(II) is the second most abundant transition metal in organisms after 
iron.18 The human body contains approximately two grams of Zn2+ and 
approximately three grams of iron in the form of ferrous and ferric ions. The 
majority of Zn2+ resides in the central nervous system, muscle, bones, kidney, 
and liver, with an average intracellular concentration of ~150-200 µM in the gray 
matter of the brain.19,20 The Zn2+ ion is also prevalent in the environment; it is the 
24th most abundant element in the Earth’s crust.21 In addition to its natural 
occurrence, Zn2+ is also found in many commercial products; for example, 
sunscreen and anti-dandruff shampoo contain ZnO nanoparticles and zinc 
pyrithione, respectively.22,23 This section will focus on the significance of Zn2+ 
found in the human body, followed by some examples of the environmental and 
commercial impact.  
2.1.1 Biological Aspect of Zinc(II) 
Zinc(II) plays a vital role in the immune system, wound healing, protein 
and DNA synthesis, and cell division.18 It is estimated that greater than ten 
percent of the human genome codes for proteins that contain Zn2+ ions. More 
than 200 enzymes require the d-block metal in their catalytic activity. Zinc(II) also 
plays a significant role in the sense of taste and smell. It is vital for normal growth 
and development of a fetus. Zinc(II) is an essential element for many biochemical 
processes in the human body. However, Zn2+ can function as a neurotoxin; too 
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much can result in nausea, vomiting, epigastric pain, abdominal cramps, bloody 
diarrhea, lethargy, staggered gait, and difficulty in writing.24  
The biological aspect of Zn2+ can be divided into three main roles: 18   
 catalytic  
 regulatory  
 structural.  
The metal ions are typically coordinated to side chain residues, like aspartic acid, 
glutamic acid, cysteine, and histidine. Of the 200 enzymes that utilize Zn2+, 
carbonic anhydrase is one of the most well-known.25 Carbonic anhydrase’s 
function is the conversion of carbon dioxide (CO2) into bicarbonate (HCO3-). It 
also performs the reverse (HCO3- to CO2) during exhalation. Without the catalytic 
activity (by zinc) of carbonic anhydrase, the conversions of CO2 to HCO3- would 
occur about 106 times slower at the normal blood pH of 7.4.25 
The regulation of intracellular and extracellular Zn2+ concentrations in the 
brain is maintained by certain families of  
 Metallothioneins 
 Zn2+ transporter (ZnT) 
 Zn2+ importing proteins (ZIPs). 
The metallothioneins protect cells against Zn2+ deficiency and toxicity, and they 
have a very high affinity for Zn2+ (Kd = 3.2  10-13 M-1 at blood pH, 7.4).20 The 
metallothioneins family also regulate copper; excess zinc can impair cellular 
copper absorption.24 A similar situation occurs with transferrin, a protein that 
transports both Fe3+ and Zn2+ ions.26 So, the homeostasis of Zn2+ in the brain 
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also affects concentration of both Cu2+ and Fe3+ ions. The ZnT protein facilitates 
transport of Zn2+ from the cytosol to the lumen of intracellular organelles; they 
also transport Zn2+ out of the cell.27 The ZIPs’ fundamental role is the regulation 
of the Zn2+ ions at the plasma membrane and in intracellular organelles. The 
regulation of Zn2+ ions is vital in order for the brain and body to properly function. 
Zinc(II) serves as a major structural component of zinc fingers, which form 
parts of transcription factors. Transcription factors recognize DNA base 
sequences during replication and transcription of DNA. A Zn2+ finger contains 
nine or ten Zn2+ ions that maintain the finger’s structural integrity by binding to 
four amino acids in the transcription factor.28 That transcription factor utilizes its 
zinc fingers to precisely bind a DNA sequence.29 
For all the positive aspects of Zn2+’s biological importance, it also is 
believed to be involved in the pathogenesis of Alzheimer’s Disease (AD).20 The 
telltale signs of AD are the extracellular accrual of amyloid-β and the intracellular 
accumulation of the tau protein. The exact role that Zn2+ ions play is still largely 
disputed. Studies show that Zn2+ ions may coordinate to amyloid beta (Aβ) and 
promote the aggregation of Aβ, which ultimately results in neuronal cell death.30 
At concentrations of 300 nM and above of Zn2+ ions, which are common 
concentrations in the synaptic cleft, it is believed that this will induce aggregation 
of Aβ at picomolar concentrations.20,27  
Amyloid-β released into the synaptic cleft can encounter Zn2+ at ~300 nM 
that has been released through glutamatergic neurotransmission.27 This 
promotes the oligomerization of Aβ (Figure 7). Studies indicate that as the 
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oligomers become increasingly insoluble they become resistant to degradation 
by matrix metalloproteinases (MMPs) and insulin degrading enzymes (IDEs), and 
they can bind up to 2.5 moles of Zn2+, which disrupts the Zn2+ homeostasis and 
normal memory events. In contrast to this hypothesis, one study indicated that 
Zn2+ at 5 µM may actually protect neuronal cells against Aβ in a concentration 
dependent manner by preventing the aggregation of Aβ 1-40 in to a β-sheet 
structure.31 Even though the exact role of Zn2+ is still unknown, Zn2+ is still being 
investigated as a potential therapeutic target for AD. In fact, ligands are being 
developed to chelate Zn2+ and prevent the aggregation of Aβ; this approach, 
known as chelation therapy, is commonly utilized to treat heavy metal 
poisoning.20 
 
Figure 7. Zinc(II) and copper(II) induced amyloid-β oligomerization occurring at 
the synaptic cleft  
(ZnT3= Zinc Transporter Protein 3, ZnR = metabotropic Zn2+ sensing receptor. 
Reprinted by permission from Macmillan Publishers Ltd: [Nature Reviews Neuroscience]: Sensi, S. L.; Paoletti, P.; Bush, 
A. I.; Sekler, I. Zinc in the Physiology and Pathology of the CNS. Nat. Rev. Neurosci. 2009, 10 (11), 780–791. Copyright 
2009 
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2.1.2 Environmental Aspect of Zinc(II) 
Zinc(II) is essential, but can be harmful to humans. Our bodies strive to 
find the perfect balance of Zn2+ levels to maintain homeostasis. Nature performs 
the same delicate balancing act as the human body.32 Zinc(II) is essential for 
many natural processes; however, anthropogenic inputs to the water system, i.e. 
mining, urbanization, and agriculture are harmful to the environment. In 2015, 
approximately 850,000 metric tons of zinc was mined in the United States, with 
the global Zn2+ mining production reaching 13.4 million metric tons.33 Most Zn2+ is 
mined from the mineral sphalerite ((Zn,Fe)S). Dumping of toxic wastes and 
industrial effluent from those mining and other industrial operations is 
contaminating ground water and marine ecosystems with Zn2+ ions and other 
heavy metals. Two large urban sources of excess environmental zinc include the 
corrosion of galvanized metals and the degradation of rubber from automobile 
tires.32,34 A study by Yang et al. found that heavy metals (Cd2+, Cu2+, Ni2+, Pb2+, 
and Zn2+) can be immobilized in soil if the conditions are basic (pH > 8.1).35   
2.1.3 Commercial Aspect of Zinc 
Approximately 80% of the domestic zinc produced in the US per year is 
utilized in anti-corrosion, known as galvanization (Figure 8).33 Eleven percent 
was utilized in alloys, such as brass and bronze, while the remaining 9% is 
reported for other usages. Galvanization is a process that adds thin layers of zinc 
to iron or iron alloys to prevent the formation of Fe2O3 (rust). The second most 
significant usage of zinc is the formation of alloys, like brass or bronze. Aluminum 
and zinc are added to magnesium alloys to have a strengthening effect on the 
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hexagonal lattice structure of the alloys, especially on cast and wrought alloys.36 
Zinc oxide (ZnO) is the most important zinc chemical in terms of production 
volume.37 Zinc oxide is used during the manufacturing process of rubber and is 
commonly utilized in sunscreen to prevent sunburn and windburn. Bacitracin zinc 
is employed in antibiotic ointments; pyrithione zinc is used in anti-dandruff 
shampoo. Zinc is widely exploited in commercial products. Zinc is the fourth most 
consumed metal after iron, aluminum, and copper.37 
 
Figure 8. Percentages of domestic zinc utilized in certain industrial applications. 
2.2 Rationale 
From the engines in automobiles to the biological processes in human 
bodies, Zn2+ is prevalent. Earth’s water is becoming increasingly polluted with 
metals, like Zn2+ ions.32 Various methods have been utilized to capture metal 
waste. Chelation therapy is a process commonly used to remove metals in 
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biological processes.24 Bioretention, which is the process of filtering water runoff 
with soil, organic matter, and vegetation, is a common practice in urban 
environments.34 It has been showed that waste material, like activated carbon, 
natural adsorbents (clay and bentonite), biosorbents (citrus peels, algae, and 
black gram husk), and byproduct adsorbents (sawdust, lignin, rice husk, and coal 
fly ash), can recover Zn2+ from wastewater.38 To have an understanding of Zn2+ 
ion accumulation, the potential effects on the human body, and the environment, 
it is important to detect the amount of Zn2+ being removed.  Therefore, efficient, 
economic, and effective methods of sensing Zn2+ are paramount. In addition, a 
chemosensor that chelates metals could couples sensing and remediation into a 
single probe. 
2.3 Literature Examples of Zn2+ Sensors 
One approach for Zn2+ ion sensing is the use of chemosensors, both in 
the environment and medical applications. Chemosensors can provide straight 
forward in situ testing that benefits field studies of Zn2+ levels. All of the following 
examples utilize the chemosensor as a ligand, which coordinates the Zn2+ cation. 
In order to minimize false positives in sensing that arise from competing metals, it 
is imperative that a chemosensor be selective for Zn2+ ions over other metal 
cations. The Structural Motif Examples and Sensing Motifs Examples sections 
will illustrate structural motifs and examples of sensors that are selective and 
complementary to Zn2+, and sometimes not selective for Zn2+ ions. The Sensing 
Motifs Examples section will solely highlight examples of sensors that utilize 
redox signaling units to detect Zn2+. 
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2.3.1 Structural Motif Examples 
One of the problems with designing a chemosensor for Zn2+ ions is the 
competitive binding environment. In the cell, the sensor has to compete with 
proteins that bind Zn2+. In nature, the sensor will have to selectively bind Zn2+ 
over other metals, like Fe3+, Cd2+, and Al3+, that naturally occur.  Nowakowski et 
al. used biology to their advantage; they used Zn2+ ions binding affinity of proteins 
from LLC-PK1 cells to sense Zn2+ ions in biological media (M199).39 Utilizing the 
fluorophores, Zinquin and 6-methoxy-8-p-toluene-sulfonamido-quinoline (TSQ), 
they were able to observe Zn2+ ion distribution and the movement of metal ions in 
cells. This is due to the fact that Zinquin and TSQ form ternary adducts with Zn2+ 
binding proteins. The formation of these ternary adducts caused a Δ10 nm blue 
shift (λmax = 482 nm to 473) in fluorescence emission. This blue shift in 
fluorescence emission was verified by measuring the fluorescence of the adducts 
in an extracellular environment, which yielded no blue shift due to the lack of 
proteins to form the ternary adducts.   
Jiang et al. utilized nitrogen containing motifs, such as amines and 
amides, with conformational aspects to synthesize a quinoline and piperazine 
based dual mode Zn2+ and Cu2+ sensor (compound 2.1).40 Jiang et al. proposed 
that the sensor was able to bind Cu2+ in the amide tautomer form and Zn2+ in the 
imidic acid form (Scheme 1). The binding mode was confirmed via X-ray 
crystallography, molecular modelling, fluorescence spectroscopy, and 1H-NMR 
studies.40 Jiang et al. used pH studies, in conjunction with UV-Vis spectroscopy, 
to determine that over a broad range of pH (4.30-11.0), there was no obvious 
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UV-Vis spectral shift in the Zn2+ complex; this suggested that the sensor was in 
the imidic acid tautomer, with the amide nitrogen coordinated to the Zn2+ ion. The 
receptor was an efficient ratiometric probe with an “OFF-ON” response to Zn2+, 
and an “ON-OFF” response to Cu2+. Dissociation constants (Kd) were determined 
to be 1.4  10-11 M2 for Zn2+ and 8.7  10-12 M2 for Cu2+, meaning the sensor 
possesses a higher binding affinity for Cu2+ ions by an order of magnitude. This 
sensor example (compound 2.1) proves that nitrogen containing moieties are 
necessary in order to coordination zinc, but more preorganization is needed in 
order to be selective for Zn2+ ions. The high number of degrees of freedom of the 
piperazine moiety and the methylene bridge between the piperazine and amide is 
not conducive for preorganization in the probe and can accommodate metals of 
varying sizes. 
 
 Binding Modes of quinoline-piperazine sensor with Cu2+(supported by 
crystal structure) and Zn2+(supported by molecular modelling) 
2.1 
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Tamanini et al. developed a bis-cyclam-based Zn2+ sensor (2.3) based on 
a monopodal receptor (2.2).41 The sensor feature a cyclam binding unit 
connected to a 1,8-naphthalic anhydride, which acts as the fluorescence 
signaling motif (Figure 9). Tamanini et al. used the Hüisgen cycloaddition, also 
known as “click” chemistry, to connect the 1,8-naphthalic anhydride to the 
cyclam. The “click” cycloaddition allowed for the generation of a library of sensors 
with various fluorophores. The nitrogen atoms in the 1,2,3-triazole also played a 
significant role by allowing the triazole motif to function as a binding site for Zn2+ 
ions. This, along with conformational effects from the cyclam, the bulky, sterically 
hindering fluorophores, and the bis design allowed sensor 2.3 to be selective for 
Zn2+ over many transition metal ions, Cd2+, Mn2+, Ni2+, Co2+, and Fe3+. The 
sensor was shown to monitor Zn2+ ions at cellular concentrations without the 
need for the addition of extracellular Zn2+. 
 
Figure 9. Lariat cyclam-based Zn2+ sensors with triazole linkers. 
Another example of the use of a triazole moiety in modular synthesis is the 
work of Huang et al.42 They also utilized the 1,2,3-triazole due to the fact that it is 
a structural mimic to an imidazolyl moiety in histidine. They were able to 
synthesize a library of compounds that feature tetradentate coordination motifs, 
while having various signaling units (Figure 10). Utilizing the chemosensors’ 
ratiometric fluorescence response, Huang et al. were able to detect nanomolar 
2.2 2.3 
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affinity for Zn2+ ions. Dissociation constants for Compound 2.4 and 2.5 were 12 M 
and 7.2 M for Zn2+ ions, respectively. The two different binding pockets were able 
to selectively coordinate Zn2+ ions over other divalent metal cations (Ca2+, Mg2+, 
Cd2+, Mn2+, Co2+, and Pb2+). Compound 2.5 was able to selectively bind Zn2+ over 
Cu2+ ions, but compound 2.4 was not able to distinguish between these two ions.  
However, Cu2+ quenched the fluorescence instead of enhancing it, which was the 
case for the Zn2+ ions. An interesting note is that the compound 2.5 is slightly 
more selective than compound 2.4 and also has greater degrees of freedom 
resulting from the ethyl linker between the tridentate binding unit and the triazole 
moiety. 
 
Figure 10. Zn2+ sensor featuring tetradentate binding units (S = solvent). 
Wallace et al. also utilized a triazole moiety along with a pyrene 
fluorophore as a signaling unit.43 The difference between this example and the 
others is the fluorescence emission change was generated by the self-assembly 
of the probe, which was templated by ZnCl2. They observed a 2:1 stoichiometric 
binding ratio of the sensor to ZnCl2. This was shown via fluorescence studies, 
whereby a broad excimer emission band was seen upon addition of Zn2+, which 
is indicative of the formation of an excimer between the two adjacent pyrene 
signaling units (Figure 11). Binding was confirmed via 1H-NMR titrations, the 
stoichiometry was corroborated utilizing binding constant calculations and DFT 
2.4 
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calculations (Figure 11). It had a K2:1 of 1.8  106 M-1, which is substantial for a 
self-assembled complex. 
 
Figure 11. Density Functional Theory (DFT) optimized structure of ZnCl2 pyrene-
based molecular butterfly. 
2.3.2 Sensing Motif Examples 
All of the examples in the previous section have primarily utilized 
fluorescence spectroscopy as the technique for characterizing the binding of 
Zn2+. Fluorescence spectroscopy is a sensitive, spectrophotometric technique, 
which has sensitivities down to nanomolar concentrations.44 Due to the fact that 
transition metals have no fluorescence emission, fluorescence is a common 
choice for monitoring the binding of chemosensors to metal cations because the 
detected emission belongs solely to the fluorescent signaling unit. One of the 
most common fluorescence mechanism used in detection is “OFF-ON” mode.45 
This approach is easy to implement because the fluorescence emission 
increases in response to the analyte. However, some drawbacks to the “OFF-
ON” mode are the fact that intensity can be affected by collisional quenching, 
turbid samples, scatter, autofluorescence, photobleaching, phototransformations, 
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and diffusive processes.44 These disadvantages make fluorescence intensity-
based sensing ideal for a laboratory environment, but could prove inadequate in 
field testing due to the uncontrollable field conditions. 
Signaling units involving redox active moieties that monitor cationic guests 
utilizing voltammetric techniques have been well studied.46 Some sensitive 
voltammetric techniques, such as square wave voltammetry, can detect analytes 
as low as 1  10-8 M concentrations.47 Although voltammetry is somewhat less 
sensitive than fluorescence, the use of redox active signaling units does have 
advantages over fluorophores, especially in field applications. Electrochemical 
techniques are not handicapped by issues like collisional quenching induced by 
oxygen, scattering of emission from turbid samples, and interference of ambient 
lighting. 
Due to its extensive stability and versatility in functionalization, one of the 
most common redox active motifs is the ferrocene unit.48 Ferrocene’s standard 
reduction potential is in the range of 400 mV vs. SCE.49 The redox potential can 
be sensitive to the nature of substituents on the cyclopentadiene rings.48 
Electron-donating groups facilitate oxidation of ferrocene to ferrocenium ion, 
which is indicated by the increase in redox potential. For example, 
acetylferrocene has a redox potential of 620 mV vs. SCE.50 Electron-withdrawing 
groups have the opposite effect; they decrease the redox potential. 1,1’-
Dimethylferrocene has a redox potential of 250 mV vs. SCE.48,50 Even with a 
substituent’s effect the redox potential of ferrocene is well out of the range of 
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zinc(II)’s -760 mV vs. SHE standard reduction potential; therefore, the ferrocene 
moiety is a viable choice as an electrochemical signaling unit for Zn2+ ions. 
Ghosh et al. developed two ferrocene-quinoline conjugates that 
possessed Zn2+ recognition properties (Figure 12).51 Compound 2.6 provided 
good proton conductivity through one dimensional helical water chains, and both 
compounds exhibit selective detection of Zn2+ ions in water. Ghost et al. 
determined binding constants utlizing UV/Vis data; compound 2.6 exhibited a 
binding constant of 2.6  104 M-1, while compound 2.7 had a binding constant of 
2.9  104 M-1 for Zn2+ ions. The detection limit was calculated to be ~2 ppb using 
optical spectroscopy. The electrochemical techniques (CV and DPV) showed a 
reversible one-electron oxidation process at E1/2 = 0.59 V for 2.6 and E1/2 = 0.63 
V for 2.7. Stepwise addition of Zn2+ ions decreased the original redox signal, 
while a new signal, associated with the Zn2+ complex, appeared during the 
titration at E1/2 = 0.66 V for 2.6 and E1/2 = 0.72 V for 2.7. 
 
Figure 12. Zinc selective ferrocene-quinoline analogues that bind Zn2+ in water. 
Paul Beer has extensively studied many supramolecular systems that 
contained ferrocene moieties as signaling units. The majority of his work involves 
using ferrocenes for anion detection, but he has utilized them for Zn2+ ions 
2.6 2.7 
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sensing as well.52 Beer et al. developed a series of tunable bis(ferrocenyl) 
transition-metal cation receptors.53 Illustrated in Figure 12 are three of the 
tunable receptors that were prepared. Beer et al. carried out voltammetric and 
1H-NMR studies on the three receptors in acetonitrile. However, protonation 
caused a build up of positive charge close to the ferrocene unit, which produced 
a repulsion. As a consequence, this electrostatically repelled the ferrocenium 
units; thereby, thermodynamically hindering the redox reaction and causing a 
~160 mV anodic potential shift. This shift mimicked a shift that also occurred 
upon coordination of transition metals. Beer et al. were able to utilize 1H-NMR 
studies to distinuish between potential shifts related to the protonation of the 
amines and genuine shifts resulting from the coordination of transition metal ions. 
In fact, of the three compounds illustrated in Figure 12, only compound 2.10 
exhibited a genuine coordination potential shift (75 mV) for Zn2+ ions. 
 
Figure 13. Voltametric bis(ferrocenyl) transition metal receptors. 
2.8 
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Another system developed by Beer et al. was a polyaza ferrocene 
macrocyclic probes for transition metal detection in water (Figure 14).54 By 
selecting a pH (10.5-12), where Compound 2.11 was completely deprotonated. 
The binding of compound 2.11 to Cu2+, Zn2+, Ni2+, and Ag+ were investigated with 
the macrocyclic receptors. Compound 2.11, where n = 1, showed selectivity for 
Cu2+, which changed the potential by 190 mV (anodic potential shift (ΔEpa)), while 
Zn2+ ions only caused a 10 mV shift. Unfortunately, Beer et al. were able to 
synthesize and characterize a selective sensor for Cu2+ ions instead of Zn2+ ions, 
but they were successful in utilizing redox techniques to detect transition metals. 
 
Figure 14. Polyaza ferrocene macrocyclic probes that is selective for Cu2+ in H2O 
(n=1 or 2). 
Molina et al. have synthesized a series of electrochemical/optical 
molecular probes that contained triazole moieties and characterized binding of 
Zn2+ and Pb2+ via voltammetric techniques, UV-Vis, and fluorescence 
spectroscopy (Figure 15).55 Incremental addition of Zn2+ both compound 2.12 and 
2.13 induced spectral changes in each technique (electrochemical and optical); 
this summary will focus on changes in the voltammetric technique. Molina et al. 
showed that the one-to-one coordination of Zn2+ ions (for 2.13, Ka = 1.1  104 M-
1) and Pb2+ (for 2.13, Ka = 2.7  104 M-1) occurred in different fashions for 
2.11 
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compound 2.12 than compound 2.13. With compound 2.12, the binding sites 
included the imine nitrogen, triazole, and the quinoline nitrogen; however, 
compound 2.13 only coordinated the metal through the triazole and the imine 
nitrogen. This caused the voltammograms to “look” quite different; addition of 
Zn2+ to compound 2.12 induced a anodic shift of the potential associated with the 
monosubstituted ferrocene and a cathodic shift of the 1,1’-disubstituted ferrocene 
unit. Compound 2.13 had an anodic shift of the 1,1’-disubstituted ferrocene signal 
after the addition of Zn2+, while the peak of the monosubstituted signal appeared 
at the same  potential as those seen of the free receptor. In the end, compound 
2.12 proved to be an excellent colorimetric sensor for Ni2+ and Cd2+, while 
compound 2.13 was considered a valuable receptor for its selective detection 
Pb2+ using electrochemical, colorimetric, and fluorescent techniques. 
 
Figure 15. 1,1’-disubstituted ferrocene derivates that bind Pb2+ and Zn2+. 
Molina et al. also synthesized a library of receptors with ditriazolyl motifs, 
which were studied for their cationic and anionic binding abilities (Figure 16).56 
One of the compounds that exhibited an affinity for Zn2+. Upon addition of Zn2+, a 
2.12 2.13 
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anodic potential shift (ΔE1/2 = +32 mV) was observed for compound 2.14 in 
acetonitrile. The formation of hydrogen-bond complexes induced significant 
cathodic potential shifts for anionic guests:  ΔE1/2 = -245 mV for F-, ΔE1/2 = -100 
mV for AcO-, ΔE1/2 = -345 mV for H2PO4-, ΔE1/2 = -333 mV for HP2O73-. Even if 
the sensor proved to be an excellent anionic receptor, Molina et al. were able to 
successfully observe the binding of Zn2+ utilizing voltametric techniques. 
 
Figure 16. Ditriazolyl ferrocene anionic receptor. 
2.3.3 Summary 
Many of the previous examples were unable to successfully synthesize a 
selective Zn2+ sensor. For example, the polyaza-based macrocycle developed by 
Beer et al. showed selectivity for Cu2+ over Zn2+ ions. Cadmium(II) and copper(II) 
are two d-block elements that compete with Zn2+; whereby, Cd2+ competes due 
to its similar electronic structure with Zn2+, while copper competes due to the 
complementary nature of the nitrogen-containing Lewis base ligands. Even if the 
previous examples could not build a selective, each sensor did exhibit a binding 
affinity for Zn2+, which indicates that the highlighted binding and signaling 
moieties are viable choices when designing a sensor for Zn2+ions. In order to 
successfully bind Zn2+ ions in a selective fashion, we plan to use a molecular 
2.14 
 32 
cleft design that has already been proven to selectively bind Zn2+ ions. Utilizing 
the molecular tweezer moiety employed by Wallace et al., we plan to develop a 
chemosensor that utilizes a redox active ferrocene signaling unit with the 
bistriazole design from Wallace et al. 
2.4 Sensor Design 
Building upon the design principles of the previous examples by Wallace 
et al. (Figure 11), the proposed chemosensor utilized a triazole moiety, an amide 
linker, and a ferrocene signaling unit. A Zn2+ sensor was also designed with a 
dipodal design (2.15) and a pyridine moiety linking the two arms (Figure 17). The 
sensor built upon the previously discussed research that highlighted triazole 
functionalities as viable Zn2+ ion coordinators.57 The ferrocene moiety was 
chosen as an electrochemical motif for reasons previously outlined (Sensing 
Motif Examples section). It was also proposed for its advantage of better 
solubility over the pyrene signaling unit used by Wallace et al.10,43 In fact, the 
linker connecting the binding and signaling units was identical to the amide 
utilized by Wallace et al. 
 
Figure 17. Dipodal and monopodal triazolyl-ferrocene Zn2+ ion sensor. 
2.15 2.16 
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The triazoles should also provide an easy synthetic route to the 
chemosensor. The Hüisgen cycloaddition is extensively used by the Wallace and 
will facilitate quick and facile synthesis of the probes. The dipodal design allows 
the sensor to utilize the entropic factor of the chelate effect to its advantage, 
which is anticipated to increase the binding affinity for Zn2+ ions. The pyridine unit 
was chosen not only to function as a connector between the two “arms” of the 
sensor, but so that its nitrogen atom could function as a Lewis base and aid in 
the coordination of Zn2+ ions. In order to monitor the dipodal sensor’s affinity 
towards Zn2+ ions, a model system, with a monopodal design (2.16), was also 
synthesized (Figure 17). 
It was anticipated that the dipodal system (Figure 18) would provide an 
excellent binding affinity for Zn2+ ions that could be investigated through a wide 
variety of techniques, such as electrochemical, NMR, and mass spectrometry. It 
was predicted that compound 2.15 would provide a 1:1 binding stoichiometry that 
would simplify calculations in quantifying the amount of Zn2+ ions bound, which is 
highly valued in analytical applications (Figure 18). The monopodal system was 
designed as a control, but Wallace et al. observed that Zn2+ ions induced self-
assembly in their pyrene monopodal system. So, it was anticipated that the 
proposed ferrocene monopodal receptor would bind Zn2+ in a 2:1 fashion as 
indicated in Figure 18. Much like the pyrene monopodal system, it was 
anticipated that self-assembly would bring the ferrocene moieties into close 
proximity through syn coordination, which could affect their redox activity. 
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Figure 18. Proposed binding modes illustrating Zn2+ and compounds 2.15 and 
2.16 (S = solvent). 
2.5 Hypothesis 
A molecular ‘tweezer’ featuring triazole and ferrocene moieties can 
function as a redox active chemosensor for Zn2+ ions. The bis design will 
coordinate Zn2+ ions with the triazole nitrogen atoms in a multidentate fashion. 
This coordination has been previously shown by the Wallace group.10,43 We also 
hypothesize that the pyridine moiety’s nitrogen atom will participate in the 
coordination of the Zn2+ ions. The main question that arises from the probe’s 
design is will the ferrocene moieties improve the solubility of the probes? Will the 
probe be selective via spatial-fit for Zn2+ ions above Cd2+ ions, which are known 
to coordinate to triazole motifs? 
2.6 Results and Discussion 
2.6.1 General Synthesis 
Both compound 2.15 and 2.16 were synthesized in Hüisgen cycloaddition 
conditions (3:1 Acetone:H2O). The desired azide and alkyne were refluxed with a 
catalytic amount of CuSO4 in the presence of the oxidant, sodium ascorbate 
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(necessary to generate Cu+). Workup of the reactions involved extraction into 
chloroform, and precipitating the anticipated compounds with diethyl ether. Refer 
to the Synthetic Methods section for a more detailed synthesis. The receptors 
were characterized with multinuclear and multidimensional NMR, ESI-MS, and X-
ray crystallography for compound 2.16. 1H-NMR indicated formation of the 
products by the appearance of the characteristic triazole proton signal in the 
downfield, aromatic region. 
2.6.2 X-ray Crystallography 
Compond (2.16) was characterised by X-ray crystallography; crystals were 
grown from slow evaporation for acetone. The compound crystalized in 
monoclinic centrosymetric C2/c space group, with the unit cell consisiting of eight 
independent molecules. The structural features for compound 2.16 show that the 
bond distances for the nitrogen atoms in the triazole for N(2)-C(8) N(2)-C(8) N(2)-
C(8) N(2)-C(8) N(2)-C(8) show the typical double bond character. The triazole  
systems show one interesting feature of the molecule is the distinct 
intramolecular CH interaction from one of the CH carbons on the 
cyclopentadiene unit and the centroid of the triazole moity (2.783 Å) (Figure 
19A). The oxygen atom in amide functional group from one of the molecules is 
involved in a bifurcated hydrogen bonding interaction with a C-H interaction from 
cyclopentadiene group and the N-H group from an adjacent molecule, Figure 
19B. In fact, this hydrogen bonding array leads to the formation of a one 
dimensional network, Figure 20. Unfortunately, X-ray quality crystals could not be 
obtained for compound 2.15. Its optimized structure shows that the two ferrocene 
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arms are on the same face of the pyridine ring system adopting a “cleft” like 
stucture. The DFT calculations shows that there is a favorable intramolecular 
hydrogen-bonding interaction between the the N-HO=C (Figure 19B). This is 
one explanation for the difficulty in growing crystals for 2.15; the strong 
intramolecular hydrogen-bonding interaction prevented the formation of a 
repeating unit, like the hydrogen bonding polymer in Figure 20. 
 
Figure 19. X-ray crystal structure of compound 2.16 (A) with thermal ellipsoids at 
50% probability. 
(A) is highlighting the intramolecular CH interaction and (B) highlighting the hydrogen-bonding motif in the crystal 
packing 
  
Hydrogen bond distances in the crystal structure of 2.16 
D-H- - -A D-H H- - -A D- - -A 
C-H- - -N 0.950 Å 2.248 Å 3.112 Å 
N-H- - -O=C   2.465 Å 
C-H- - -O=C   2.565 Å 
(A) (B) 
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Figure 20. Crystal packing in 2.16, highlighting the hydrogen bonding polymer. 
2.6.3 Mass Spectrometry Studies 
Mass spectrometry studies allows for the study of complex formation 
without the interference of solvent. Mass spectrometry studies also indicated 
formation of the desired products. Compound 2.15, the probe, has a mass of 723 
amu. This is evident in the isotopic distribution represented in Figure 21, where 
there are two masses present. 724 m/z is representative of the protonated probe, 
[2.15 + H]+, and 723 is representative of the probe, [2.15] +. The [2.15]+ ion is an 
oxidized ferrocene moiety, giving the molecule a 1+ charge. The experimental 
isotopic distribution (black line) matches the two calculated theoretical isotopic 
distributions of the 723 (red, solid bars) and 724 (blue, pattern bars) mass 
signals, Figure 21. 
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Figure 21. Isotopic distribution of 2.15 (CH3CN, no charging agent). 
Figure 22 is the mass spectrum of compound 2.15. There you observe the 
723 mass, which represents the [2.15]+. The 746 mass is a neutral 2.15 that has 
been charged by a sodium ion, while the 1468 mass is a dimer of 2.15 that is 
charged by a sodium atom as well. A MS/MS of the 723 mass signal results in 
the loss of a cyclopentadiene (cp) unit and is assigned to a 658 m/z signal 
(Figure 23). A CID of the 658 signal produces a 566 m/z mass, which is a 
difference of 92 m/z. The loss of 92 m/z is assigned to the loss of another cp unit 
and a N2 from the triazole. Further, dissociation of the 566 m/z signal results in 
the loss of a Fe atom and N2 from the adjacent triazole. Any further CID produces 
signals too weak to confidently assign. 
 39 
 
Figure 22. Mass spectrum of Compound 2.15 (no charging agent) 
 
Figure 23. CID pathway of 2.15 (+ve mode). 
Addition of Zn(ClO4)2 to the probe, indicates new masses associated with 
the complex (Figure 24). The signal at 394 m/z represents the complex, which is 
 40 
charged by Zn2+ ions. The actual mass is 723 (probe) + 65 (Zn2+) = 788 g·mol-1. 
The 2+ charge reduces that by half to 394 m/z, which was confirmed by the 
isotopic spacing being a half a m/z, due to z = 2. The 886 signal is a singly 
charge complex, which is constituted of 723 (2.15) + 65 (Zn2+) + 99 (ClO4-) = 886 
m/z. The mass spectrometry helps support the existence of the complex and a 
1:1 binding stoichiometry, as shown in literature.58 This supports the proposed 
binding hypothesis in the Sensor Design section.  
A MS/MS of the 886 m/z signal results in the loss 100m/z, which can be 
attributed to the loss of HClO4 (Figure 25). CID of the 786 m/z signal is results in 
several fragments. The significant difference between the CID of the 2.15:Zn2+ 
complex and the MS/MS of 2.15 is that none of the same masses appear. The 
Zn2+ coordination affects the fragmentation of 2.15. There is a loss of a Fe atom, 
which results in the 730 m/z signal. There is also a 519 m/z signal, which is 
assigned to the loss of the alkyne precursor to the triazole. The loss of an entire 
arm of the sensor is not observed in the fragmentation of the ligand. It is 
hypothesized that the ligand fragments around the complex. 
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Figure 24. Mass spectrum of Compound 2.15 and 1.0 equiv Zn(ClO4)2. 
 
Figure 25. CID pathway of Compound 2.15 and 1.0 equiv Zn(ClO4)2 (+ve mode). 
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2.6.4 NMR Studies 
1H-NMR studies allow for characterization of binding by determine which 
nuclei are involved in the binding process by tracking the changes in chemical 
shifts of those nuclei. 1H-NMR assignments are represented in Figure 26, so the 
reader can follow certain NMR signals in the subsequent 1H-NMR titrations. The 
next two pages feature a 1H-NMR representative titration between Compound 
2.15 and ZnCl2 (Figure 27 and Figure 28).  The equivalences of Zn2+ to 2.15 are 
on the right side of the figure. Upon the addition of Zn2+ ions, a downfield shift in 
the 1H-NMR signals as the equivalences of Zn2+ increase indicates deshielding, 
due to the formation of coordinate covalent bonds between Zn2+ and 2.15.  
Upon the addition of Zn2+ ions to probe 2.15, broadening of the 1H-NMR 
signals (Signals 5, 7, 8, and 9) in close proximity to the ferrocene moiety occurs 
(Figure 27). Those particular signals (Signals 5, 7, 8, and 9) are broad due to 
their location in the complex; they are near both the large, diamagnetic Fe2+ and 
the Zn2+ nuclei. These large nuclei transfer their magnetization to the small 
proton nuclei in close proximity, causing an increase in line broadening. A higher 
temperature study (Figure 29) decreased the line broadening, but the heat 
energy increased the rotation of the molecule, which narrowed the lines. The 
energy input possibly did not favor the complex in terms of equilibrium. This 
separated the Zn2+ and Fe2+ nuclei and reduced the line broadening. This 
hypothesis is supported by titration TBACl (Figure 30), which does not have a 
large, diamagnetic metal that can complex with the host. The ferrocene signals 
do not broaden during the titration of TBACl. 
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Another hypothesis for the line broadening of the ferrocene signals is the 
oxidation of ferrocene to ferrocenium. This would result in the oxidation of the 
diamagnetic Fe2+ metal center to a paramagnetic Fe3+ ion center. This would 
induce line broadening. In addition, the anions (perchlorate and chloride) that 
were tested are oxidants. Monitoring the 1H-NMR signals over 72 hours in the 
presence of tetrabutylammonium perchlorate (TBAP), indicated that oxidation 
could be occurring. Upon addition of 10 molar equivalences of TBAP, the 
ferrocene signals showed increased line broadening. At 24+ hours, the entire 1H-
NMR spectrum indicated increase line broadening. Ferrocenium is a 
paramagnetic species that would affect the relaxation of the proton nuclei of the 
entire host molecule. 
The increased line broadening could the result of a diamagnetic metal 
effect, the oxidation of ferrocene to ferrocenium, or kinetic in nature, such as a 
slow exchange occurring between the host, guest, and the complex. The line 
broadening could be a consequence of a combination of these hypotheses. It is 
clear that the increased line broadening occurs in the presence of Zn2+, but it 
also occurs in the presence of an oxidant, like perchlorate. It could also be the 
result of a slow exchange that is happening on the NMR time scale. Whatever 
the cause, binding is still observed due to the deshielding of triazole proton and 
the amide proton. 
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Figure 26. 1H-NMR assignments of Compound 2.15. 
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Figure 27. 1H-NMR titration of 5.5 mM 2.15 and ZnCl2 in CD3CN. 
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Figure 28. 1H-NMR titration aromatic expansion of 5.5 mM 2.15 and ZnCl2 in CD3CN. 
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Figure 29. High temperature study of a 10 equivalence ZnCl2:2.15 solution in CD3CN. 
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Figure 30. 1H-NMR titration of 5.5 mM 2.15 and TBACl in CD3CN
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The greater the de-shielding the more directly affected that nucleus is by 
the coordination of the Zn2+ ions. The triazole proton (Signal 4) and the amide 
proton (Signal 6) have the largest shifts. This is explained because of the 
protons’ proximity to the proposed binding site, which suggests that the triazole 
and amide functionalities are involved in the coordination of the Zn2+ metal ion. 
For example, the triazole proton (signal 4) has a 0.37 ppm downfield shift, while 
signal 3, the methylene linker between pyridine and the triazole only has a 0.11 
ppm downfield shift in the ZnCl2 titration. Binding constants were calculated in 
order corroborate whether anions will affect the binding affinity for the Zn2+ ions 
(Table 3).  
  
NMR binding constants for 2.15 and various Zn2+ salts in acetonitrile 
 Log K1:1 
Zn(ClO4)2 2.2 ± 0.01 
ZnCl2 4.1 ± 0.02 
Zn(BF4)2 2.65 ± 0.01 
TBACl 1.7 ± 0.01 
 
Previous research by Wallace et al. on a similar probe proved to be 
selective for Zn2+.43 Compound 2.15 was also tested with other metal 
perchlorates to ensure its selectivity for Zn2+ (Table 2). The perchlorate anion 
was chosen due to its solubility. The two main metals that were compared to Zn2+ 
were Cd2+ and Al3+; they were chosen and tested due to their diamagnetic nature 
that would facilitate NMR titrations. As illustration in Literature Examples section, 
Cd2+ is often very difficult for receptors to distinguish from Zn2+, due to the ions’ 
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similar electronic structure. In fact, one of the only ways to distinguish the Cd2+ 
from Zn2+ is size. Anticipating this issue, the dipodal probe was designed with a 
binding pocket that complemented Zn2+ ion size. Compound 2.15 is somewhat 
selective for Zn2+ over Cd2+; this is evident in the 1:1 binding constants in Table 4 
(2.2 ± 0.01 for Zn2+ and 1.70 ± 0.01 for Cd2+). 
  
NMR binding constants for 2.15 and various metal perchlorates 
 Log K1:1 
Zn(ClO4)2 2.2 ± 0.01 
Cd(ClO4)2 1.7 ± 0.01 
Al(ClO4)3 <1 
 
In order to monitor the effect of the dipodal system’s affinity for Zn2+, the 
monopodal analogue was synthesized. Compound 2.16 was studied under the 
same experimental conditions as compound 2.15 to directly compare the binding 
of Zn2+. The subsequent figures display the 1H-NMR studies involving compound 
2.16.  
The 1H-NMR titrations of 2.16 and Zn2+ also indicate binding; much like 
the dipodal counterpart, de-shielding of nuclei in the immediacy of the 
coordination site occurs (0.25 ppm downfield shift for the triazole proton (signal 
6) and signal 5 has a 0.15 ppm downfield shift). For reference in the titrations, 
compound 2.16’s protons are labelled in Figure 31, below. Figure 32 and Figure 
33 is a representative titration of 2.16 and ZnCl2. Unlike compound 2.15, the 
degree of 1H signal shift seems to be reduced with 2.16 when the probe is 
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exposed to Zn2+ ion 2.15’s triazole has a 0.37 ppm shift, while the triazole proton 
in 2.16 only has a 0.25 ppm shift). This indicates 2.15 has a greater affinity for 
ZnCl2 than compound 2.16. This is not evident in the binding constants in Table 
5; neither probe is selective for Zn2+. The binding constants are almost equal. 
 
Figure 31. 1H-NMR assignments of Compound 2.16 in CD3CN. 
  
1H-NMR binding constant comparison of 2.15 and 2.16 with Zn(ClO4)2 
 Log K1:1 of 2.15 Log K1:1 of 2.16 
Zn(ClO4)2 2.2 ± 0.01 2.80 ± 0.10 
ZnCl2 4.1 ± 0.02 4.3 ± 0.09 
TBACl 1.7 ± 0.01 1.9 ± 0.06 
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Figure 32. 1H-NMR titration of ZnCl2 into 5.5mM 2.16 in CD3CN. 
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Figure 33. 1H-NMR titration aromatic expansion of ZnCl2 into 5.5mM 2.16 in CD3CN. 
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2.6.5 Two Dimensional NMR 
Two dimensional NMR analysis (specifically ROESY) was utilized to give 
an understanding of the coordination environment of the Zn2+ ion. It is anticipated 
that upon coordination, significant conformational changes occur. As a 
consequence, different ROESY signals should be observed, if the protons are 
within the 5 Å distance, typically required for a genuine ROESY signal.59 The 
subsequent 2D spectra (Figure 35 and Figure 36) represent a 2D ROESY on the 
probe and the complex, respectively. Correlations for the two spectra are 
represented by DFT structures in Figure 34. 
 
Figure 34. ROESY correlations for Figure 35(A) and Figure 36(B) from lowest 
energy DFT structures. 
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Figure 35. 2D ROESY of 0 equivalences of Zn2+ and 5.5 mM 2.15 in CD3CN. 
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Figure 36. 2D ROESY of 1.0 equivalent of Zn(ClO4)2 and 5.5 mM 2.15 in CD3CN. 
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The ROESY signals for compound 2.15 show strong cross peaks 
assigned to the protons on one arm of the chemosensor. There was no evidence 
of signals between on side of the molecule and the other. This is reasonable as 
the molecular probe is freely rotating in solution and these signals cannot be 
seen on the NMR time scale. However, upon the addition of 1.0 equivalent of the 
Zn2+ ion, the ROESY spectrum shows new distinct signals; this discussion will 
only highlight two of the novel signals (correlations f and g).  A new cross peak 
(correlation g) is observed between the CH2 (signal 3) on one side of the 
molecule and the cyclopentadiene CH (signal 9) on the other arm. Correlation (f) 
indicates that the triazole proton (signal 4) is now within ~5 Å of the 
cyclopentadiene CH (signal 9) as well. The only way that these signals can be 
generated is if the Zn2+ has “locked” the rotation of the two arms in place with the 
Zn2+ ion coordinated within the molecular cleft. This is supported by the weak, 
unlabeled correlations that occur between signals 3 and 8, 3 and 7, and 6 and 9. 
This multitude of correlations are indicated that one arm of the sensor is being 
locked into place near the other arm during coordination. The relatively weak 
signal strengths are due to the equilibrium occurring between the free probe and 
bound receptor. This hypothesis is supported by the DFT structures discussed in 
Computational Studies section. 
2.6.6 Electrochemical Studies 
Figure 37A is a Differential Pulse Voltammogram (DPV) representing the 
addition of molar equivalences of ZnCl2 to a 110-4 M solution of Compound 
2.15. DPV was utilized because it is a more sensitive voltammetric technique 
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than CV due to its pulse nature. However, it only measures current for one half of 
the reversible redox process, which in this case is oxidation of the neutral 
ferrocene’s Fe2+ metal center to Fe3+. Both CV and DPV were investigated with 
the sensor (2.15), but only DPV will be reported here. Figure 37B is a binding 
isotherm based on the potential shift as the concentration of ZnCl2 increases.  
Higher equivalences of ZnCl2 increased the oxidation potential of the 
ferrocene signaling units. This indicates that as Zn2+ ions coordinates to the 
dipodal sensor, the ferrocene become more difficult to oxidize. This is reasonable 
as the Zn2+ ions binds to the triazole group the electron density is pulled away 
from the Fe2+ center, as a consequence of an induction effect. Consequently, this 
alters the electronic structure, making it harder to oxidize the Fe2+ to Fe3+ center 
in the ferrocene. This potential shift is observed in construction of Zn2+ ferrocenyl-
carboxylate coordination complexes as well.60  
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Figure 37. DPVs and binding isotherm of ZnCl2 with compound 0.1mM 2.15 in 
CH3CN. 
A 
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Figure 38. DPV binding isotherms for various Zn2+ salts of 2.15 at 110-4 M with 
increasing concentration of ZnCl2. (A = Zn(ClO4)2, B = ZnBr2, C = Zn(NO3)2, and 
D = Zn(BF4)2) 
A similar chemosensor was designed and synthesized by Cao et al. and 
investigated for its anion binding ability.61 As anions have a broad range of 
shapes (i.e. spherical, trigonal planar, and tetrahedral) compared to cations, it 
was important to study how the different geometries influenced the binding 
affinity of Zn2+ to the chemosensor. Therefore, a host of Zn2+ anions were 
investigated to determine if anions would have an effect on Zn2+ coordination 
with Compound 2.15. Above (Figure 38) are binding isotherms from four Zn2+ 
salts.  
Each binding isotherm indicates that anions, effectively, have no effect on 
the coordination. Understandably, ZnF2, Zn(C2H3O2)2, and Zn(CN)2 are poorly 
A B 
C D 
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soluble in acetonitrile; they were studied, but are not reported. ZnI2 was tested as 
well, but the oxidation of the I- anion interfered with the resolution of the Zn2+ 
oxidation in the DPV. The anions have little effect on the coordination of Zn2+ in 
CH3CN. The bar chart (Figure 39) indicates this by illustrating no significant 
change in oxidation potential shifts between the 0 and 10 equivalence 
voltammograms for each anion. Save for ZnBr2, each anion induces a similar 
potential shift and binding affinities. ZnBr2 induces a smaller potential shift due to 
its limited solubility, compared to the Zn2+ anions. Binding constants from 
electrochemical potential shift are currently being determined with a collaborator. 
 
Figure 39. DPV anion selectivity chart (0.1 mM 2.15 in CH3CN). 
The binding stoichiometry between compound 2.15 and Zn2+ was 
calculated to be exclusively 1:1. This was confirmed via Job’s Plot analysis 
(Figure 40) with DPV at 110-4 M in CH3CN. Figure 40 is the Job’s Plot of 
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Compound 2.15. The Job’s Plot confirms the hypothesis of a 1:1 binding, 
indicated by the arrow pointing to mole ratio of 0.45. This is close to 0.5 mole 
ratio, which indicates that the greatest change in potential occurs when the probe 
and Zn2+ are in a 1:1 ratio.  
 
Figure 40. Job’s Plot of 0.1 mM 2.15 and Zn(ClO4)2 in CH3CN. 
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Figure 41. DPV (A) and binding isotherm (B) of the compound 0.1 mM 2.16 and 
Zn(ClO4)2 in CH3CN. 
A 
B 
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The electrochemical studies on 2.16 indicate that Zn2+ also coordinates as 
well. This is evident by the oxidation potential shift observed in the DPV titration 
(Figure 41A); the shift in oxidation potential exhibits a sigmoidal response (Figure 
41B). This same potential shift response is also observed with compound 2.15. 
The binding stoichiometry indicated by the Job’s Plot in Figure 42 does not fit the 
2:1 probe:Zn2+ ratio that was hypothesized in Figure 18. The apex of the Job’s 
Plot is at the mole ratio of 0.5, which indicates a 1:1 binding ratio. A 1:1 binding 
ratio is quite possible. Zinc(II), generally, has a coordination number of four; 
therefore, 2.16 could occupy two of the four coordination spots, while solvent 
occupied the other two. 
 
Figure 42. Job’s plot of compound 0.1 mM 2.16 and Zn(ClO4)2 in CH3CN. 
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2.6.7 Computational Studies 
Computational studies were performed by a collaborator, Dr. Peter Cragg. 
Figure 43 represents the lowest energy DFT structures of the chemosensor and 
the Zn2+ with the probe. The DFT of the probe shows intramolecular hydrogen 
bonding (yellow bond) between the carbonyl on one of the two “arms” of the 
sensor and the amide hydrogen atom on the adjacent “arm” (Figure 43A) This 
hydrogen bonding interaction is interrupted in the calculated structure of the 
complex. The DFT of the complex is further supported by the 1H-NMR data. The 
two proton signals that experience the most de-shielding during the titration of 
Zn2+ are the triazole proton and the amide proton. These protons are bound to 
the triazole ring and the carbonyl functionalities that are directly participating in 
the coordination in the DFT structure (Figure 36B). The DFT structure of the 
2.15-Zn2+ complex supported the 1:1 binding stoichiometry determined by the 
Job’s plot in Figure 40. Probe 2.16 forms a tetrahedral complex in which two of 
the Zn2+ ion’s 4 coordination spots (Figure 44) is occupied by 2.16 and the other 
two are filled with solvent (acetonitrile). 
 
Figure 43. Lowest energy DFT structures of Compound 2.15 (A) and the Zn2+ 
complex with 2.15. 
(A) (B) 
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Figure 44. Lowest energy DFT of the Zn2+ complex with 2.16. 
2.7 Summary 
A selective Zn2+ sensor was successfully designed, synthesized, and 
characterized. The probe’s design was based off of proven Zn2+ sensor’s in the 
literature. Utilizing the Hüisgen cycloaddition, allowed for a facile synthesis, 
which was also modular. Installation of a different signaling unit could be readily 
achieved if necessary. An electrochemical ferrocene signaling unit was utilized in 
conjunction with the 1,2,3-triazole, formed by the Hüisgen cycloaddition, as the 
binding unit. Both a dipodal and monopodal version of the probe was synthesized 
to analyze and compare their binding affinities for Zn2+. 
The dipodal probe indicated Zn2+ coordination in electrochemical studies 
by an oxidation potential shift to higher potentials for the ferrocene moiety. The 
shift to a higher potential suggests that the coordination of Zn2+ is shifting 
electron density away from the Fe2+ center of ferrocene; thus, it requires more 
energy to remove an electron to form Fe3+. Job’s plots from the electrochemical 
technique indicated that a 1:1 binding stoichiometry existed for the dipodal 
sensor (2.15) and 1:1 stoichiometry for the “one arm” sensor (2.16), as well.  
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The NMR data also supported the hypothesis that Zn2+ would bind to the 
two probes. This was shown by the 1H-NMR signal shifts indicating the nuclei in 
the immediacy of the coordination sites were being de-shielded as the probe was 
exposed to Zn2+ ions. The triazole proton and the amide proton shifted the most 
due to their proximity to the coordination site, and this fact is supported by DFT 
calculations. The calculations indicate that the two triazoles and the carbonyls in 
the amide were responsible for the coordination of Zn2+. Two dimensional 
ROESY NMR also supports the DFT calculations by proving the ferrocene on 
one arm is brought into the proximity of the triazole on the other arm during 
binding. By tracking the 1H-NMR shifts, a 1:1 binding constant of Log K = 2.2 ± 
0.01 for Zn(ClO4)2 for the dipodal sensor (2.15) and Log K = 2.8 ± 0.10 for the 
“one arm” sensor (2.16) was observed. 
The mass spectrometry data further supports that Zn2+ ions coordination is 
occurring. In the mass spectrum of the probe, a 723 mass is observed for the 
charged sensor. This mass along with the 724 mass, which is the protonated 
probe, matched the theoretical isotopic distributions. Upon addition of Zn(ClO4)2, 
a 394 mass and an 886 mass was observed. The 394 mass was a doubly 
charged mass representing the complex, which was charged by the Zn2+ ion. The 
886 mass is a singly charged mass represented by the 2+ complex with a 
perchlorate ion.  
The use of a molecular cleft design in the previous work by Wallace et al. 
produced a ZnCl2 selective sensor. The molecular cleft redox active design 
discussed in this chapter also shows selectivity for ZnCl2; however, the probe did 
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have an affinity for Cd2+ ions. This is due to the flexible nature of the molecular 
cleft design. A macrocycle could provide more selectivity with its fixed cavity. The 
redox active ferrocene signaling units did allow for detection of Zn2+ ions, but not 
to the level of sensitivity that was afforded by the pyrene moieties in the 
molecular cleft utilized by Wallace et al. 
A sensor has been designed, synthesized, and the coordination of Zn2+ 
has been fully characterized. Now, the sensor needs to be investigated for its 
real world applicability. The facile synthesis would be easy to scale up to an 
industrial scale. The binding is observed in electrochemical, NMR, and mass 
spectrometry techniques, making it an attractive system for many applications of 
Zn2+ detection. The need for efficient, economic, and reliable Zn2+ detection is 
necessary with ubiquitous nature of Zn2+ in humans, the environment, and 
industrial applications. 
2.8 Experimental Methods 
2.8.1 General Experimental Methods 
All chemicals were utilized as purchased from Sigma Aldrich or Alfa 
Aesar. Proton, carbon-13, and 2D NMR spectra were recorded on a Bruker 
Ultrashield Plus 400 MHz or 600 MHz spectrometer in the appropriate deuterated 
solvents. Chemical shifts are reported in parts per million (ppm) downfield from 
tetramethylsilane (0 ppm) as the internal standard and coupling constants (J) are 
recorded in hertz (Hz). The multiplicities in the proton NMR spectra are reported 
as (br) broad, (s) singlet, (d) doublet, (dd) doublet of doublets, (ddd) doublet of 
doublet of doublets, (t) triplet, and (m) multiplet. All spectra are recorded at 
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ambient temperature, unless otherwise specified. Mass spectrometry studies 
were conducted on a Thermo Fisher LXQ quadrupole mass spectrometer. 
Electrochemical data was recorded on a CH 660A potentiostat with a glassy 
carbon working electrode, Ag/Ag+ reference electrode, and Pt mesh counter 
electrode in acetonitrile and 0.1 M tetrabutylammonium perchlorate as the 
supporting electrolyte. IR spectra were recorded on a Nicolet Nexus 470 FT-IR 
paired with a Smart Orbit ATR attachment. The characteristic functional groups 
are reported in wavenumbers (cm-1),  and are described as weak (w), medium 
(m), strong (s), and very strong (vs). Elemental Analysis data was collected at 
Atlantic Microlabs in Norcross, Georgia. 
2.8.2 Mass Spectrometry Methods 
Mass spectrometry experiments were performed on a Thermo LXQ ESI-
MS with an ion trap mass separator. A solution of compound 2.15 was made at 1 
mg·mL-1 in LC/MS grade CH3CN. After a blank was recorded, the compound(s) 
was injected into the instrument and the mass spectrums were recorded. Mass 
spectrums of the chemosensor and the complex are reported in positive ion 
mode. 
2.8.3 NMR Methods 
1H-NMR titrations of Zn2+ ions and compound 2.15 were performed by 
preparing a 5.5 mM solution of compound 2.15 in acetonitrile-d3 (2.0 mL). A stock 
solution of the Zn2+ (0.276 M) salts was prepared in CD3CN (2.0 mL). Aliquots of 
1 µL (1 µL = 0.1 equivalence of Zn2+ to compound 2.15) of Zn2+ were added, 
resulting in increases in equivalences of Zn2+ to 2.15, and the 1H-NMR spectra 
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was recorded after each addition. Binding constants were determined by 
HypNMR software.62 2D ROESY spectra were recorded and were processed 
utilizing COSY-symmetrization. 
2.8.4 Electrochemical Methods 
Cyclic Voltammetry (CV) and Differential Pulse Voltammetry (DPV) were 
investigated on compounds 2.15 and 2.16 to monitor the potential shifts with 
increasing equivalences of Zn2+. Stock solutions of 110-3 M of compounds 2.15, 
2.16, and various Zn2+ salts (110-2 M) were prepared in CH3CN with 1.0M 
tetrabutylammonium perchlorate (TBAP) as a supporting electrolyte for all 
prepared solutions. 200 µL of the stock solution of compounds 2.15 and 2.16 was 
added to the sample vial and diluted to two mL to a final concentration of 110-4 
M for Compound 2.15 and 0.1 M for TBAP. Aliquots of the Zn2+ salt solutions 
were also added to sample, resulting in increasing equivalences of Zn2+ ions to 
probe. After addition of each aliquot, the voltammogram was recorded. Each 
titration was completed in triplicate. Dilution of compounds 2.15 and 2.16 was 
compensated for to maintain the diffusion coefficient, which was necessary in 
order to compare the voltammograms recorded during the titration experiment.  
2.8.5 Computational Studies Methods 
Computer simulations were carried out using Spartan ’10, which was 
installed on a desktop computer equipped with an Intel Core i7-2600 processor 
running at 3.40 GHz. Equilibrium geometries for the ligand and its zinc complex 
were determined by full searches of the 961 possible ligand conformers and 900 
conformers available to the complex. Conformers were generated through 
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consideration of all rotatable bonds. The equilibrium conformers of free ligand 
and its Zn2+ complex were further refined using molecular mechanics (Merck 
Molecular Force Field) with the resulting structures used as input coordinates for 
density functional calculations (B3LYP/6-31G*). No formal bonds between Zn2+ 
and ligand were introduced; the metal’s position and closest contacts were 
generated by the molecular mechanics simulation but did not change significantly 
during DFT geometry optimization. 
2.8.6 Synthetic Methods 
 
 Synthesis of 2,6-bis(azidomethyl)pyridine 
2,6-Pyridinedimethanol (2.17) (500 mg, 3.58 mmol)  was refluxed with 
48% HBr (5.00 mL) for 24 hours.63 The solution was cooled in an ice bath to 0°C 
and a solution of saturated NaOH was added to the reaction. The desired white 
solid (2,6-bis(bromomethyl)pyridine, 2.18) was filtered off and dried in air (484 
mg, 1.83 mmol, 51% yield). 2.18 was dissolved in a 3:1 acetone:water solution 
(15.0 mL) and sodium azide (238 mg, 3.66 mmol) was added, and the reaction 
was stirred at room temperature for 24 hours. The product (2.19) was extracted 
into chloroform, dried with magnesium sulfate, and the solvent was removed 
under vacuum to yield a pure yellow oil (166 mg, 0.88 mmol, 48% yield). 1H NMR 
(400 MHz, CDCl3) δ 7.74 (t, J = 7.70 Hz, 1H), 7.29 (m, 2H), 4.47 (s, 4H). 13C 
NMR (100 MHz, CDCl3) δ 155.9 (s), 138.1 (s), 121.1 (s), 55.4 (s). 
2.17 2.18 2.19 
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 Synthesis of 2-azidomethylpyridine 
Picolyl bromide hydrochloride (2.20, 505 mg, 2 mmol), 18-crown-6 
(catalytic amount, 0.5 mol %), and TBAI (catalytic amount, 0.5 mol %) were 
dissolved in DMF (10 mL).63 Then, sodium azide (130 mg, 2 mmol) was added, 
and the reaction was stirred overnight at room temperature. Ethyl acetate (100 
mL) was added, and the solution was washed with basic brine (pH>10). Then, 
the organic layer was washed with NH4Cl (2  50 mL), dried with MgSO4, and the 
solvent was removed under vacuum to yield the pure product (2.21), a yellow oil 
(214 mg, 1.6 mmol, 80% yield). 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J = 4.30 
Hz, 1H), 7.73 (t, J = 1.8 Hz, 1H), 7.35 (d, J = 7.8 Hz, 1H), 7.26 (m, 1H), 4.5 (s, 
2H). 
 
 Synthesis of propargyl functionalized ferrocene 
Compound 2.23 was prepared similarly to the literature.64 Ferrocene 
carboxylic acid (2.22, 500 mg, 2.20 mmol),1-hydroxybenzotrizole hydrate (HOBT, 
564 mg, 4.20 mmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 
738.8 mg, 4.76 mmol) were stirred in ethanol (100 mL) under argon for 30 
2.20 2.21 
2.22 2.23 
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minutes.1 Then, propargyl amine (140 µL, 2.20 mmol) was added to the reaction 
and stirred at room temperature for five days. The solvent was removed under 
reduced pressure to form a crude brown solid, which was recrystallized with 
diethyl ether. The pure solid was filtered off and found to be compound 2.23 (241 
mg, 0.90 mmol, 42% yield). 1H NMR (400 MHz, CDCl3) δ 5.78 (s, 1H), 4.68 (t, 
2H), 4.36 (t, 2H), 4.23 (s, 5H), 4.18 (dd, J = 5.4, 2.5 Hz, 2H), 2.28 (t, J = 2.5 Hz, 
1H). 13C NMR (100 MHz, CDCl3) δ 170.2 (s), 80.2 (s), 75.0 (s), 71.5 (s), 70.7 (s), 
69.8 (s), 68.2 (s), 29.2 (s). 
 
 Synthesis of compound 2.15 
Compound 2.15 was prepared based upon the literature.10 Mixed 
compound 2.23 (152.2 mg, 0.570 mmol), compound 2.19 (53.9 mg, 0.285 mmol), 
sodium ascorbate (112.8 mg, 0.570 mmol), copper (II) sulfate pentahydrate (71.1 
mg, 0.285 mmol), and 3:1 acetone:water (20.0 mL) in a round bottom flask. 
Refluxed the reaction overnight, and the product was extracted from the solution 
with chloroform. The organic layer was removed under reduced pressure until the 
volume was ~3 mL. Diethyl ether (~25 mL) was added to the extract until a 
yellow solid was observed. The solid (compound 2.15) was collected via gravity 
2.23 
2.19 
2.15 
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filtration and dried in air for 24 hours (169.0 mg, 0.234 mmol, 41% yield). 1H NMR 
(400 MHz, CD3CN) δ 7.71 (m, 3H), 7.36 (s, 2H), 7.22 (d, J = 7.7 Hz, 2H), 5.58 (2, 
4H), 4.76 (m, J = 1.7 Hz, 4H), 4.56 (d, J = 6.0 Hz, 4H), 4.34 (m, J = 1.7 Hz, 4H), 
4.09 (s, 10H). 13C NMR (100 MHz, DMSO) δ 169.0 (s), 155.1 (s), 138.4 (s), 123.5 
(s), 121.3 (s), 76.4 (s), 69.9 (s), 69.2 (s), 68.2 (s), 54.3 (s), 34.4 (s). Elemental 
analysis (%) Calculated for C35H33Fe2N9O2: C, 58.11; H, 4.60; N, 17.43.  Recalc. 
C35H33Fe2N9O2·3(C3H6O): C, 46.83; H, 3.71; N, 14.04. Found: C, 46.31, H, 4.13; 
N, 14.74. 
 
 Synthesis of compound 2.16 
Compound 2.16 was prepared based upon the literature.43 Added 
compound 2.23 (76.1 mg, 0.285 mmol), compound 2.21 (38.2 mg, 0.285 mmol), 
sodium ascorbate (56.4 mg, 0.285 mmol), copper (II) sulfate pentahydrate (71.1 
mg, 0.285 mmol), and 3:1 acetone:water (15.0 mL) to a round bottom flask and 
refluxed overnight. The work up was the same as compound 2.15. The solid 
(compound 2.16) was collected via gravity filtration (84.3 mg, 0.210 mmol, 74% 
yield). 1H NMR (400 MHz, CD3CN) δ 8.52 (s, 1H), 7.82 (s, 1H), 7.73 (t, J = 7.3 
Hz, 1H), 7.27 (s, 2H), 6.98 (s, 1H), 5.62 (s, 2H), 4.67 (s, 2H), 4.50 (d, J = 6.0 Hz, 
2H), 4.33 (s, 2H), 4.10 (s, 5H). 13C NMR (100 MHz, DMSO) δ 168.9 (s), 136.1 
(s), 128.7 (s), 128.0 (d, J = 12.0 Hz), 76.2 (s), 69.9 (s), 69.2 (s), 68.2 (s), 52.7 (s), 
2.21 
2.23 2.16 
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34.3 (s). Elemental analysis (%) Calculated for C20H19N5OFe: C, 59.87; H, 4.77; 
N, 17.45.  Recalc. C20H19N5OFe·0.5(H2O): C, 58.55; H, 4.67; N, 17.07. Found: C, 
58.80, H, 4.65; N, 17.25. 
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CHAPTER III – MEPHEDRONE SENSOR 
3.1 Background 
Synthetic derivatives of cathinone, a psychostimulant found in khat shrub 
(Catha edulis) leaves, have surged in popularity as ‘legal highs’ over the past few 
years.65 ‘Legal Highs’ are compounds that are commonly purchased at a low 
cost, typically over the internet, and have a similar structure to existing, illegal 
drugs.66 The organic scaffold of cathinone contains a β-ketoamine motif with an α 
chiral carbon. Altering the functionality of just one of the R groups in any of the 
positions will give rise to new psychoactive substances (NPS) (Figure 45); 
therefore, a plethora of molecules can be prepared. In a 2011 study, there were 
30 known cathinones; the common cathinones relevant to this study are shown in 
Table 6. 65,67 These particular cathinones were chosen due to their popularity or 
their structural similarities to common illicit substances. 
 
Figure 45. The structure of generic cathinone derivatives. 
  
Common cathinone derivatives relative to this study 
Name R1 R2 R3 R4 R5 
Cathinone H H H H H 
Mephedrone Methyl H 4-methyl H H 
Flephedrone Methyl H 4-fluoro H H 
Ephedrone Methyl H H H H 
Methylone Methyl H 3,4-methylenedioxy H H 
Bupropion tert-butyl H 2-chloro H H 
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Cathinone, the namesake for the class of synthetic derivatives, features 
hydrogens on all the five sites of functionalization, Table 6.65 Mephedrone and 
flephedrone (R1 = methyl, R3 = 4-methyl for mephedrone, and R3 = 4-fluoro for 
flephedrone) are two of the more popular cathinones; mephedrone will be the 
focus of this study. Ephedrone is the β-keto derivative of methamphetamine, 
while methylone is the β-keto analogue of MDMA (3,4-methylenedioxy-
methamphetamine or ecstasy).65 These motifs will be key points during the 
discussion of the structural relationships of cathinones to known psychoactive 
substances and for a clear understanding of cathinone pharmacology. 
Bupropion, Table 6, is a cathinone that is a popular anti-depressant marketed 
under the name Wellbutrin.  
The surge in popularity of cathinones has resulted in broad restrictive 
legislation from the US and EU governments seeking to ban as many derivatives 
as possible. On April 16, 2010, many cathinone derivatives were classified as 
Class B, Schedule I substances through generic wording in legislation in the 
UK.68 The European Council followed suit in December of 2010.69 The DEA 
(Drug Enforcement Agency) and many US States introduced similar measures in 
2011.67 At the state level, an example of the broad legislation necessary to cover 
as many cathinones as possible is House Bill 1205SG here in Mississippi that 
sought to add cathinones to the list of Schedule I narcotics. The following quote 
is directly lifted from Section1.d.7 of that bill: 
“Cathinone, methcathinone, 4-methylmethcathinone (mephedrone), 
methylenedioxypyrovalerone (MDPV), and, unless listed in another 
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schedule, any compound other than bupropion that is structurally derived 
from 2-Amino-1-phenyl-1-propanone by modification in any of the 
following ways:   
i. By substitution in the phenyl ring to any extent with alkyl, alkoxy, 
alkylenedioxy, haloalkyl or halide substituents, whether or not 
further substituted in the phenyl  ring by one or more other 
univalent substituents;   
ii. By substitution at the 3-position with an alkyl substituent;  
iii. By substitution at the nitrogen atom with alkyl or dialkyl groups, or 
by inclusion of the nitrogen atom in a cyclic structure.” 70 
Since the banning of many cathinone derivatives, more have been developed.65 
This study will focus on the development of an in-field sensor for a popular 
cathinone of abuse, mephedrone. 
3.1.1 Mephedrone Availability and Usage 
Mephedrone’s synthesis was first reported by Saem de Burnaga Sanchez 
in 1929.71 Mephedrone is found in the chloride or bromide salt form, which is a 
white, crystalline powder with a light yellow hue.69 Mephedrone’s availability for 
online purchase made it a popular ‘legal high’. Internet sales have been a 
cornerstone for legal highs; the first internet sales were in 2007, and it is 
commonly distributed via online sites in powder, capsule, or tablet (96-115 mg) 
form. It is often sold in sealed plastic bags with labeling, like ‘not for human 
consumption’, ‘research chemical’, ‘plant feeder’, or ‘bath salts.71 These 
nondescript labels were designed to avoid suspicion during shipping to 
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customers. A March 2010 study found 77 websites that sold mephedrone with 
97% of those websites based in the United Kingdom. Fifty-nine percent of users 
purchased their mephedrone online prior to the April 2010 ban of mephedrone in 
the UK. 
Since the April 2010 classification of mephedrone, a study has suggested 
that many users are sourcing mephedrone from street dealers.72 The 
classification has had little effect in slowing down mephedrone usage.69 A June 
2010 survey showed that 55% of mephedrone users, who used mephedrone 
before the ban, would continue to use the drug. Also, 57% of survey participants 
had purchased from a dealer. The remaining 43% bought mephedrone online. 
Only 41% of the users had purchased from a dealer prior to the ban. While 
internet transactions have dropped, they still account for a large portion of 
mephedrone sales; many online suppliers have circumvented the ban by labeling 
the shipping containers as other chemicals. Another way of avoiding the ban is to 
sell other ‘legal highs’, like naphthylpyrovalerone (NRG-1); however, 
compositional studies of street samples have found that drugs labelled NRG-1 is 
sometimes purely mephedrone or laced with mephedrone and other substances, 
like caffeine, benzocaine, lidocaine, and acetaminophen.73   
Mephedrone seizures have occurred in 28 European countries and the 
US.69 The main settings for its usage are nightclubs, parties, and private homes. 
A research project by the National Addiction Centre in London indicated that 42% 
of readers of the dance magazines were users of mephedrone, while 33% had 
used in the last month. A study carried out in the general population of Tayside, 
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Scotland reported 20% of individuals had previously used mephedrone, with 23% 
of those indicating use on one previous occasion and 4% were daily users. There 
is much speculation about mephedrone’s widespread use. Many experts indicate 
that prior to classification, an aggressive e-commerce advertising aided its 
spread, while others suggest that mephedrone was a cheaper alternative to 
‘traditional’ stimulants, like cocaine, ecstasy, or methamphetamine. Either way, 
mephedrone is a serious issue in the Western world.66  
3.1.2 Mephedrone Effects and Toxicity 
Common routes of delivery to the body include snorting, oral ingestion, 
and  intramuscular and intravenous injections.74 A typical dosage from snorting is 
between 25-75 milligrams. Users frequently compare the drug’s effects to those 
of cocaine, amphetamine, and 3,4-methylenedioxy-methamphetamine (MDMA or 
ecstasy). Users report intense stimulation, increased energy, motivation, 
euphoria, empathogenic effects, sociability, intensification of sensory 
experiences, moderate sexual arousal, and perceptual distortions (reported with 
high dosages).71,75  
Dargan et al. reported that 56% of mephedrone users complained of at 
least one adverse or untoward effect.71 As of 2011, there were no formal human 
or animal studies to determine the prevalence of adverse effects. The only 
available information is user reported.69 These effects are present in almost 
every system of the human body. They include: 
 Gastrointestinal: nausea/vomiting, loss of appetite, anorexia, and 
abdominal pain; 
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 Cardiovascular: sinus tachycardia, hypertension, palpitations, chest 
pain, myocarditis, peripheral vasoconstriction, thrombocytopenia 
anemia, disseminated intravascular coagulation (DIC), and even 
cardiac arrest; 
 Urinary/Excretory:  difficulties in urination, nephrotoxicity, and 
anorgasmia; 
 Central Nervous System/psychiatric: anxiety, agitation, aggression, 
anhedonia, depression, panic attacks, confusion, paranoia, 
insomnia, hallucinations, short-term psychosis, impaired short-term 
memory, mental fatigue, poor concentration, and suicidal thoughts; 
 Central Nervous System/Neurological: seizures, hyperthermia, 
mydriasis, paresthesia, bruxism, motor automatisms, trismus, 
tinnitus, dizziness, blurred vision, and nystagmus.71,75 
Most of the adverse effects are similar to those of MDMA, amphetamine, and 
methamphetamine according to Schifano et al.76 
High doses (overdosing dosages, > 250 mg) of mephedrone typically 
exaggerate the adverse effects, particularly the symptoms in CNS and 
cardiovascular systems.65 The toxic effects usually wear off on their own accord, 
but some patients required the administration of benzodiazepines to counter the 
excessive agitation and anxiety. Most of the reported fatalities were due to the 
concomitant usage of other substances, like alcohol and heroin, with 
mephedrone. The first reported fatality occurred in 2008 in Sweden. By 2012, 
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mephedrone was linked to another 128 fatalities; however, only in 90 of those 
cases was mephedrone identified postmortem.71 
3.1.3 Mephedrone Sample Composition 
After the ban that classified mephedrone, it has still seen usage, and 
sometimes unbeknownst to the users.73 Brandt et al. purchased 24 products 
online after the April 2010 ban.68 The products were labelled NRG-1 
(naphthylpyrovalerone), NRG-2 (no specific chemical), MDAI (5,6-
methylenedioxy-2-aminoindane), DMC (dimethocaine), and granules. Only one of 
the 13 samples that was labelled NRG-1 actually contained 
naphthylpyrovalerone or naphyrone. Seven of the 13 consisted of four different 
cathinones: mephedrone, flephedrone, butylone, and 4-Methyl-N-ethylcathinone, 
with four of the seven NRG-1 samples containing mephedrone. Of the seven 
products labelled NRG-2, two of the products contained mephedrone. One of 
them was only mephedrone, while the other product was a 
mephedrone/benzocaine mixture. The products labeled MDAI and granules 
actually both were composed of mephedrone, solely. Brandt et al. were able to 
conclude that 70% of products labelled NRG-1 and NRG-2 contained cathinones 
or mixtures of cathinones that were banned in the April 2010 classification. The 
mixtures cathinones contained chemicals, such as caffeine, benzocaine, 
procaine, lidocaine, and acetaminophen.77 
3.1.4 Structural Relationships 
All cathinones and amphetamines are considered derivatives of 
phenylethylamine (3.1) and therefore part of the phenylethylamine 
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pharmacophore (structure of the molecule that has psychological activity).65,67 
Cathinones only differ from the amphetamine class by the addition of a carbonyl 
group on the β-carbon. Much like the amphetamine class, cathinones exist in two 
enantiomeric forms; those synthesized in the street are typically racemic 
mixtures, with the psychoactive enantiomer being the S-(-) form.65 The structural 
similarities of some common phenylethylamine analogues are illustrated in Table 
7; the cathinone is in the left column and its corresponding amphetamine in the 
right column. 
  
Cathinone (left column) and amphetamine class structural relationships(right) 
 
Phenylethylamine 
 
Cathinone 
 
Amphetamine 
 
Ephedrone 
 
Methamphetamine 
 
Methylone 
 
MDMA (ecstasy) 
 
Mephedrone 
 
4-methylmethamphetamine 
3.1a 
3.1b 
3.1 
β 
α 
3.1d 3.1c 
3.1e 3.1f 
3.1g 
3.1h 
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Compound 3.1a is cathinone and 3.1b is amphetamine, the namesakes of 
each class. The 3.1c and 3.1d pair is ephedrone and methamphetamine, 
respectively. The β-keto moiety makes cathinones less lipophilic than 
amphetamines. This makes cathinones less likely to cross the blood brain 
barrier, and thus requires a higher dosage to have the same effects as 
amphetamines.65,71 The addition of the methyl group to the amine, known as N-
alkylation, increases the lipophilicity and, in some cases, protects the drug 
against enzyme degradation.67 Addition of functionalities to the aromatic can also 
affect the lipophilicity. Addition of electron donating methylenedioxy moieties, as 
in the case of 3.1e and 3.1f (methylone and ecstasy, respectively), decreases the 
lipophilicity. Addition of electron withdrawing groups to the aromatic ring, as in 
the case of 4-fluoromethcathinone (flephedrone), increases the lipophilicity. The 
last pair, 3.1g and 3.1h, represents mephedrone and its matching amphetamine, 
4-methylmethamphetamine. 
3.1.5 Mephedrone Pharmacology 
There is limited literature evidence regarding the pharmacology of 
mephedrone, and what has been reported deals with the drug’s metabolism. Due 
to structural similarities with amphetamines, a lot of the available 
pharmacological information of cathinones is based upon studies of the 
amphetamine class.69  In fact, users report highs and side effects of cathinones 
by comparing them to methamphetamine or MDMA, the two most popular 
amphetamines.67,71 Mephedrone is anticipated to acts as a CNS stimulant, 
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promoting the release of monoamine neurotransmitters, such as epinephrine, 
norepinephrine, and dopamine, and potentially inhibiting their uptake.71  
Studies of similar cathinones, ephedrone and methylone, do confirm a 
similar pharmacological mechanism for cathinones and amphetamines, which is 
characterized by them acting upon α2 adrenergic receptors and presynaptic 
monoamine transporters, specifically dopamine transporter (DAT), 
norepinephrine transporter (NET), and serotonin transporter (SERT).67,78 An 
investigation into the substituent effects on the phenethylamine pharmacophore 
reveals that small changes in the chemical structure of the drugs have profound 
effects on each drug’s selectivity as a substrate for the transporters. For 
example, amphetamine is three times more selective for NET versus DAT, while 
it is about 70 fold more selective for DAT versus SERT. Methamphetamine, on 
the other hand, is only two times more selective for NET versus DAT and only 30 
fold selective for DAT versus SERT. The N-methylation of amphetamine to 
methamphetamine results in a small decrease in selectivity of NET over DAT and 
a significant decrease in the selectivity of DAT over SERT. Addition of the β-
ketone to methamphetamine forms ephedrone and results in a loss of selectivity 
for NET over DAT; in fact, the selectivity ratio is 1:1. However, the selectivity of 
DAT versus SERT increases to 120 fold. Substituents on the aromatic ring, such 
as the methyl group in the 4 position on the aromatic ring, alter the pharmacology 
of mephedrone to mimic MDMA, which has a methylenedioxy bridge. Overall, the 
N-methyl group on mephedrone should decrease the selectivity for NET versus 
DAT and DAT over SERT. The β-ketone further rendered the ephedrone unable 
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to discriminate between NET and DAT, but increases the DAT vs. SERT 
selectivity by 120 times. Cathinones target all three monoamine transporters, 
with varying degrees of affinity. 
  
Monoamine neurotransporter selectivity comparison 
 NET vs. DAT DAT vs. SERT 
Amphetamine 3x 70x 
Methamphetamine 2x 30x 
Ephedrone 1x 120x 
 
The inhibition of the monoamine amine transporters affects 
neurotransmitter concentrations.67 The increase in dopamine levels gives rise to 
the euphoric effects of cathinones. Norepinephrine concentration increases play 
significant role in activating the central and peripheral systems of the sympathetic 
nervous system. The concentration of serotonin appeared to have two main 
effects. The first is “serotonin syndrome” which has symptoms of tachycardia, 
hypertension, diaphoresis, and hyperthermia. The second effect may deal with 
the abuse liability of these drugs; the selectivity of these compounds to increase 
dopamine over serotonin levels, thereby impacting the stimulation. For example, 
drugs, like amphetamine, which is a dopamine-selective compound, have higher 
addictive properties than serotonin-selective compounds such as mephedrone. 
Maurer et al. utilized GC-MS to analyze urine samples  to study 
mephedrone metabolism in rats and humans to show that urinalysis of lab rats is 
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viable as a predictable model for detectability of metabolites in human urine.79 
Male rodents were administered a 20 mg·kg-1 body mass dose and urine was 
collected over a 24 hour period after dosage. Based upon the metabolites that 
were identified from the urine analysis, they were able to formulate three 
overlapping, metabolic pathways for mephedrone-HCl (Scheme 7). N-
demethylation resulting in 3.2 and 3.4 may occur, along with reduction of the keto 
moiety (3.3 and 3.6 as products) and oxidation of the tolyl moiety, forming 
compound 3.5. Further oxidation would result in 3.6. All five of these metabolites 
were detected in human urine, but only four were detected in rodent urine (3.2, 
3.3, 3.4, and 3.5). 
 
 Mephedrone metabolites detected in human and rodent urine 
3.2 Rationale 
Maurer et al. were able to investigate the detection of mephedrone 
metabolites in human urine using GC-MS and LC-MS/MS.79,80 Bell et al has 
utilized Raman spectroscopy for the detection of mephedrone and other 
cathinones.81,82 However, there are no known techniques for detecting 
mephedrone in-the-field. Chemosensors offer an efficient, economic, and mobile 
3.1 3.2 3.3 
3.4 3.5 3.6 
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detection of analytes. Chemical instrumentation typically requires a controlled 
atmosphere and is often immobile; these conditions are unsuitable for in-the-field 
tests performed by drug enforcement personnel. Development of a molecular 
probe for field testing of mephedrone is essential, given that mephedrone 
seizures have occurred in 28 European countries and the US; more than half 
(57%) of users purchase their drugs on the street from a dealer instead of online, 
and the number of fatalities is increasing.69 
3.3 Hypothesis 
A bisthiourea derived probe can hydrogen bond to mephedrone. The 
thiourea moiety will function as a bifurcated hydrogen bond donor to the carbonyl 
functionality of mephedrone. This intermolecular interaction will allow for the 
selective binding of mephedrone above methamphetamine, which does not have 
a β-carbonyl. The concern for this probe is that thiourea moieties are known to 
bind anions, and mephedrone street samples are in the chloride or bromide salt 
form. What measures will we need to take to ensure that the probe is binding 
mephedrone and not the counter ion? 
3.4 Literature Review 
3.4.1 Literature Examples of Drug Sensors 
To date, there are no mephedrone chemosensors in the literature. 
Sutcliffe et al. were the first to detect cathinone substances utilizing the 
electrochemical reduction of mephedrone.77 Utilizing low-cost, disposable 
graphite screen-printed electrodes, Sutcliffe et al. were able to observe the direct 
reduction of mephedrone and 4’-methyl-N-ethylcathinone (4-MEC), showing that 
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an electrochemical technique could be a viable protocol for the detection of 
mephedrone, with a limit of detection at 11.80 µg·mL-1 for mephedrone and 11.60 
µg·mL-1 for 4-MEC. These limits of detection were improvements over previous 
work by Sutcliffe in 2014, which was the first electrochemical method for sensing 
cathinones.83 The drawback to Sutcliffe et al.’s work is that there is no way to 
distinguish mephedrone over 4-MEC or other similarly functionalized cathinones 
because it involves the redox reaction of the amine functionality. All cathinones 
and amphetamines contain amine functionalities, so there is no way to 
distinguish between the amine redox reaction of a mephedrone or 
methamphetamine. In addition, adulterants, which are common to all cathinone 
samples, greatly affected the redox signal.  
Chemosensors can provide the selectivity while matching the sensitivity of 
Sutcliffe et al.’s work.77,83 Molecular probes have been developed for other 
psychoactive substances. These probes can be categorized into four different 
types:  
 Aptameric based84–86  
 Molecular imprinting based87  
 Macrocyclic, cavity architectures88–90 
 Fluorescent podands. 91 
The subsequent paragraphs will highlight some recent examples of each of the 
four categories of molecular probes for small molecular psychoactive 
substances. 
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Aptameric sensing of cocaine has been a subject of interest over the past 
decade.84–86 Landry et al. utilized a colorimetric, indicator displacement assay to 
sense cocaine in a hydrophobic pocket formed by a noncanonical three-way 
DNA junction (Figure 46).86 They were able to use diethylthiotricarbocyanine as 
the displacement dye; its absorbance exhibited substantial inverse dependence 
on cocaine concentration at micromolar concentrations. Yu et al. managed to 
amplify the detection of cocaine with an intercalating fluorescence dye, SYBR 
Green I.85 Yu et al. utilized a hairpin DNA probe that would bind cocaine at a 
three-way junction. Upon the addition of a primer and KF polymerase, they were 
able to initiate replication and convert the hairpin-probe into fully double-stranded 
form. The cocaine acted as a “catalyst” that induced a conformational change on 
the otherwise inactive hairpin probe into a polymerization active structure. After 
full replication and intercalation of SG, a fluorescence enhancement of as much 
as 93% was observed, allowing for the detection of cocaine down to 
concentrations as low as 2.00 nM. The drawback to Yu et al.’s work is that it 
requires 60 minutes of incubation to replicate the hairpin DNA probe and amplify 
the fluorescence signal; this sensor would not be conducive for field tests 
conducted by drug enforcement personnel. 
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Figure 46. Cocaine selective indicator displacement aptamer. 
Reprinted with permission from Stojanovic, M. N.; Landry, D. W. Aptamer-Based Colorimetric Probe for Cocaine. J. Am. 
Chem. Soc. 2002, 124 (33), 9678–9679. Copyright (2002) American Chemical Society. 
Thompson et al. did not utilize photophysical methods to detect cocaine; 
instead, they utilized a gravimetric analysis technique, an electromagnetic 
piezoelectric acoustic sensor (EMPAS).84 Much like a QCM, EMPAS utilizes a 
quartz piezoelectric substrate, but functions at much higher frequencies (> 1 
GHz), allowing for sensitivity up to three orders of magnitude greater than a 
QCM. Thompson et al. utilized a three-way DNA junction as the hydrophobic 
binding site for cocaine (Figure 47). Instead of relying on a photophysical 
technique like the previous aptameric examples, they tethered the aptamer to the 
quartz substrate of the EMPAS platform. The EMPAS ultrasensitive piezoelectric 
technique allowed for a detection limit of 0.3 µM; it is more sensitive than QCM. 
However, when compared to other instrumental techniques, piezoelectric 
techniques are not sensitive and must be kept in isolated environments away 
from external vibrations. 
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Figure 47. Cocaine binding proposal for EMPAS aptamer-based probe. 
Reprinted with permission from Neves, M. A. D.; Blaszykowski, C.; Thompson, M. Utilizing a Key Aptamer Structure-
Switching Mechanism for the Ultrahigh Frequency Detection of Cocaine. Anal. Chem. 2016, 88 (6), 3098–3106. Copyright 
(2016) American Chemical Society. 
Molecularly imprinted polymers (MIPs) are highly selective receptors.87 
Moreda-Piňeiro et al. were able to utilize Mn-doped ZnS quantum dots coated 
with MIPs to detect cocaine and its metabolites in urine.  A quenching of 
fluorescence emission from the quantum dots was observed in the presence of 
cocaine and two of its metabolites, benzoylecgonine and ecgonine methyl ester. 
Limits of detection were observed at 0.076 mg L-1 for direct measurement in a 
diluted urine solution and 0.0042 mg L-1 for the solid phase extraction method 
that extracted the analytes and dissolved them in a buffer solution prior to 
analysis. 
Macrocyclic-based receptors with cavities have seen use as small 
molecule receptors for psychoactive substances.88–90 Yao et al. utilized 
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cucurbit[7]urils as receptors for clenbuterol (3.8), a livestock feed additive and β-
adrenergic agonists that enhances the meant to fat ratio in livestock by inhibiting 
fat synthesis, improving muscle mass, and decreasing adipose tissue 
deposition.89 They used palmatine (3.9), a natural isoquinoline alkaloid 
fluorophore, in an indicator displacement assay, in order to monitor the amount of 
clenbuterol bound inside the hydrophobic pocket of cucurbit[7]uril, represented 
by compound 3.7. Through molecular modelling, Yao et al. were able to 
determine that clenbuterol bound in to different fashions (Figure 48). A quenching 
of the fluorescence emission of palmatine (3.9) was observed in aqueous 
solutions in the presence of clenbuterol (3.8). At concentrations of 0.05 µg·mL-1, 
they were able to recover an average of 97% of clenbuterol in spiked porcine 
muscle and 98% from swine urine. The cucurbit[7]uril probe was selective for 
clenbuterol over ractopamine, another swine feed additive, but Yao et al. 
observed quenches in fluorescence when the cucurbituril-palmatine complex was 
in the presence of cysteine, cystine, alanine, phenylalanine, and valine. 
Therefore, they were required to separate amino acids from the samples before 
analysis with the probe. Fu et al. developed a similar protocol for the detection of 
carbachol, a lethal, choline ester, by utilizing cucurbit[7]uril and berberine, a 
natural isoquinoline alkaloid fluorophore. 
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Figure 48. Clenbuterol selective cucurbit[7]uril showing displacement of 
palmatine for two proposed binding structures of clenbuterol. 
Dalcanale et al. utilized silicon microcantilevers grated with cavitands as a 
universal probe for illicit drugs (Figure 49).90 Their phosphonate cavitands were 
able to bind common psychoactive amine salts, like methamphetamine, MDMA, 
and cocaine, over adulterants like caffeine. By measuring the structural changes 
of the cantilevers, Dalcanale et al. were able to determine that binding had 
occurred between their probe and methamphetamine salt derivatives. They were 
able to establish exactly which intermolecular interactions were responsible for 
the binding via crystal structures and 31P-NMR. The crystal structures indicated 
that there were one or two hydrogen bonds between R3N+-H and the P=O 
groups. This was shown via 31P-NMR, which indicated deshielding of the P 
nucleus when a drug was introduced to the probe. Dalcanale also observed 
CH—π interactions between the aromatic cavity of the cavitand and the R3N+-
CH3 on the drugs that further stabilized the complex and promoting the selectivity 
of for derivatives containing the R3NH2+-CH3 moiety in water. It was the synergy 
3.7 
3.8 
3.9 
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of these two intermolecular interactions, the hydrogen bonds and the CH-π 
interactions made this probe selective for methamphetamine salt derivatives. 
 
Figure 49. Energy minimized structures of amphetamine, cocaine, MDMA, and 
FMA hydrochloride salts. 
Adapted with permission from ref. 26. Copyright 2014 John Wiley and Sons 
Orti et al. developed a macrocyclic 1H-pyrazole diazatetraester crown 
receptor with fluorenyl (3.10) and naphthyl (3.11) signaling units for the detection 
of dopamine, ecstasy, methamphetamine, and amphetamine (Figure 50).92 
Association constants were determined via spectrofluorometric titrations, and 
were compared to calculated energy values from molecular modelling. At pH = 
7.4 in 7:3 H2O:EtOH, both compounds (fluorenyl and naphthyl) had the highest 
association constants for dopamine (5.60  105 M-1 for compound 3.10, 1:1 
binding stoichiometry, and 3.80  107 M-2 for compound 3.11, 2:1 drug:receptor 
stoichiometry). In comparison, compound 3.10 had a 1.80  105 M-1 association 
constant for methamphetamine. These constants were confirmed by theoretical 
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energy values (-13.71 kcal mol-1 for compound 3.10 and dopamine, -17.28 kcal 
mol-1 for compound 3.11 and dopamine, and -6.97 kcal mol-1for compound 3.10 
and methamphetamine). Orti et al. determined that the varied stability constants 
resulted from various interactions with the macrocyclic receptors. For example, 
dopamine formed hydrogen bonds with the pyrazole nitrogen atoms in compound 
3.11, but with the ester groups of compound 3.10. 
 
Figure 50. Dopamine selective 1H-pyrazole diazatetraester fluorescent 
chemosensor. 
Fluorescent podand-based probes, such as the one developed by Torroba 
et al., can offer more flexibility than macrocyclic based systems due to their 
higher degrees of freedom (Figure 51).91 Torroba et al. utilized bisdiarylurea 
moieties for their hydrogen bonding abilities to function as binding units for 
ecstasy and similar substances (Compound 3.12). They were able to fit their 
classic turn-on fluorescence titration curves via a 1:1 binding stoichiometry and 
obtain binding constants at 1  10-4 M in DMSO of Log Keq = 4.12 for ecstasy, 
4.36, and 4.50 for pseudoephedrine and ephedrine, respectively. A detection limit 
for ecstasy in water was 1.25  10-6 M. They state that their probe is able to 
selectively bind MDMA over tertiary amines. However, the data clearly suggests 
3.10 
3.11 
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that the probe is not selective for MDMA over other secondary amines, like 
ephedrine and pseudoephedrine. 
 
Figure 51. Urea-based turn-on fluorescent probe for ecstasy. 
3.4.2 Summary 
The previously discussed literature utilizes a host of varied chemosensors 
for drug detection. From cavitands to podands, each probe relies on its design to 
bind the drug; intermolecular interactions, such as hydrogen bonding, CH-π, and 
hydrophobic forces aid in binding the drugs. The chemosensor contain 
heteroatom moieties that are complementary to hydrogen bonding or π 
interactions. Many of the previously discussed examples have hydrophobic 
cavities that attract the aromatic moieties of common drugs. Building on these 
principles, we want to design a molecular probe that is selective mephedrone 
over other common street drugs.  
3.5 Sensor Design 
Before designing a probe for mephedrone, an analysis of mephedrone’s 
structure was indispensable to determine which intermolecular forces were 
necessary for selective binding. A pharmacophore was developed by a 
collaborator based on a number of protein, crystallographic experimental data 
3.12 
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sets in the Protein Data Bank (PDB) for multiple structurally similar compounds 
because there is no experimental data within the PDB for compounds that 
contain the β-carbonyl group. The carbonyl group within the cathinone class is a 
structural difference that distinguishes the class from amphetamines. Data was 
collected from the PDB for a total of 27 protein-ligand binding sites; this included 
illicit substances (methamphetamine and ecstasy), adulterants (caffeine and 
acetaminophen), and neurotransmitters (dopamine and serotonin). Once each 
set of data was investigated based on the above validation criteria, each of the 
13 binding sites was converted into a three point pharmacophore based on the 
binding information within the PDB data. One example of a three point 
pharmacophore, developed using data on methamphetamine, is Figure 52. The 
pharmacophore illustrated that hydrogen bonding with the amine motif and edge-
to-face π stacking are the two intermolecular forces that proteins use to bind 
methamphetamine as a substrate. This was developed using the points 
calculated in the Maestro software.93  
 
Figure 52. Methamphetamine three-point pharmacophore developed by 
analyzing interactions from proteins on the PDB. 
From the pharmacophore of methamphetamine, it was determined that 
mephedrone could interact in a similar fashion, such as the hydrogen bonding 
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with the amine and π-π stacking. In addition, mephedrone’s β-carbonyl and tolyl 
methyl group could function as a hydrogen bond donor and be attracted to a 
hydrophobic pocket, respectively (Figure 53). Due to the structural similarities of 
many cathinones and amphetamines, selectively binding mephedrone will be 
challenging. Designing the sensor to take advantage of the two additional 
intermolecular interactions (the β-carbonyl and tolyl methyl group) should boost 
the selectivity of mephedrone over the structurally similar methamphetamine. If 
the sensor is designed to target the specific locations of the additional 
interactions on the mephedrone structure, selectivity over adulterants, like 
caffeine, benzocaine, lidocaine, and acetaminophen, should be much easier to 
achieve because the adulterants are not based on the phenylethylamine 
backbone, like methamphetamine. 
 
Figure 53. Applying the methamphetamine pharmacophore to mephedrone 
indicates two new (red text) interactions. 
Torroba et al. employed a bisurea design in a probe designed to detect 
MDMA, a structurally similar amphetamine.91 However, their bisurea design was 
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not preorganized; the ether linker provided additional degrees of freedom (Figure 
51). This allowed for selectivity of primary and secondary amines over tertiary 
amines, but did not allow for selectivity of MDMA over other amphetamine and 
cathinone derivatives, which had primary or secondary amine motifs. One way of 
eliminating that would be to incorporate an aromatic linker. An example of that is 
a bisthiourea system designed to bind malate (3.13, Figure 54).94 It has a rigid 
anthracene linker, where the arms of the probe are functionalized in the 9,10-
position of the anthracene linker. When compared to alkyl spacers or linkers, the 
planar, rigid structure of the anthracene contributes to the preorganization of 
probe. 
 
Figure 54. Bisthiourea malate sensor featuring a rigid anthracene linker (R= NO2 
or CH3). 
Building upon the bisthiourea designs of the molecular sensors presented 
in the Literature Review section and targeting the intermolecular interactions 
delineated by the methamphetamine pharmacophore, a dipodal system featuring 
thiourea motifs, which function as bifurcated hydrogen bonding donors for the β-
carbonyl, was designed and synthesized (Compound 3.14). A π system 
(naphthyl moieties) was integral to sensor design to promote π-π interactions for 
3.13 
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binding the aromatic system of mephedrone. A dipodal design was also highly 
desirable; the hydrophobic binding pocket could aid in selectivity and increase 
the probe’s affinity for mephedrone over methamphetamine. Figure 55 illustrates 
the proposed sensor. It was anticipated that the bisthiourea design would 
function as a bifurcated hydrogen bond donor for the β-carbonyl on mephedrone, 
while the rigid anthraquinone would help preorganize the probe and function as a 
hydrogen bond acceptor for the secondary amine. The two naphthyl units can 
interact with the π system in the tolyl moiety on mephedrone. The synergistic 
effect of all these interactions should make the sensor selective for mephedrone. 
 
Figure 55. Proposed bisthiourea mephedrone sensor with rigid anthraquinone 
linker. 
After several attempts to prepare compound 3.14 using various 
experimental conditions, it proved to be difficult to achieve the desired molecular 
receptor, Scheme 8. It was believed that the carbonyl on the anthraquinone 
(3.16) was forming intramolecular hydrogen bonds with the 1,8-amines on the 
anthraquinone moiety. It was hypothesized that resonance assisted hydrogen 
bonding (RAHB) interactions were forming pseudo six-membered rings (Scheme 
8), which were further stabilizing the 1,8-diaminoanthraquinone and preventing 
3.14 
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its nucleophilic attack on the isothiocyanate (3.15); in turn, this prevented the 
formation of the thiourea moiety and the sensor. Therefore, another synthetic 
strategy was needed; it was decided that the C=O needed reducing. The 
intramolecular hydrogen bonding hypothesis was further supported when the 
reduction of the ketone on the anthraquinone, allowed for the formation of 
thiourea motifs. A similar molecular probe was produced with an anthracene 
linker in the place of the anthraquinone (Figure 56 and Scheme 9). 
 
 Proposed synthetic route to anthraquinone-based mephedrone 
sensor illustrating RAHB 
Two probes were synthesized, a dipodal probe (3.17), featuring a rigid 
anthracene linker, and its monopodal counterpart (3.18), designed to act as a 
“control” chemosensor. The monopodal version was not expected exhibit much, if 
any, binding ability towards mephedrone. The decision to utilize a benzyl moiety 
in place of a naphthyl moiety was due to concerns over the solubility of the 
probe. The replacement of the anthraquinone with a more hydrophobic 
anthracene reduced the chemosensor’s solubility in polar solvents, which are 
commonly utilized in cathinone analysis, but anthracene analogues have a planar 
3.14 
3.15 3.16
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structure complemented by a conjugated  network, making them excellent 
fluorophores, due to their photoluminescence properties.44 These unique 
photophysical and structural properties allows the anthracene moiety to double 
as a signaling unit, while being an integral part of the chemosensors rigid 
scaffold. The replacement of the naphthyl pendants with benzyl motifs can still 
provide the key π-π interactions necessary to promote the selective binding of 
mephedrone, while decreasing the hydrophobic nature of the probe, which would 
improve solubility. For this study, the focus will be on the two probes in Figure 56. 
The naphthyl version of the probe was synthesized and will be discussed in 
Chapter 4, in regards for their anion binding abilities. 
 
Figure 56. Anthracene-based dipodal and monopodal mephedrone probes. 
3.6 Results and Discussion 
3.6.1 General Synthesis 
Both compound 3.17 and 3.18 were by reacting an isothiocyanate and the 
appropriate amine. Benzyl isothiocyanate and the corresponding amine (1,8-
diaminoanthracene or aniline) were refluxed for two hours in ethanol. A dark 
purple precipitate was filtered after cooling the reaction in ice. The receptors 
were characterized with multinuclear and multidimensional NMR, ESI-MS, UV-
3.17
3.18
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vis, and fluorescence. 1H-NMR showed the formation of the products by the 
appearance of the two distinct thiourea proton signals in the downfield, aromatic 
region at 9.87 and 8.29 ppm. 
 
 Synthetic route to anthracene-based mephedrone sensor 
3.6.2 Mass Spectrometry Studies 
Characterization of probe 3.17 was conducted via mass spectrometry. A 1 
mg·mL-1 solution of 3.17 in acetone with no charging was analyzed by ESI-MS (-
ve mode). There was sufficient residual chloride in the instrument’s capillaries to 
charge probe 3.17. [3.17 + Cl]- was the parent ion peak in the spectrum for 3.17 
(Figure 57). A MS/MS of this signal results in the loss of HCl to form the 505 m/z 
ion, which is represented by [3.17]-. Upon CID of that mass (505 m/z), a loss of 
107 mass units is observed; this represents the loss of a benzylmethylamine 
moiety. The resulting mass is 398 m/z and is assigned to an isothiocyanate 
adduct of probe 3.17 (Figure 57). A MS/MS of the 398 m/z signal produces a 248 
m/z signal. This is the result of the loss of a benzyl isothiocyanate motif and 
produces an anthracene isocyanate adduct. 
3.17
3.19 3.20
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Figure 57. CID fragmentation pattern of compound 3.17 (-ve mode). 
For mass spectrometry studies of the probe:drug complexes, samples 
were prepared in HPLC grade acetone at 0.5 mgmL-1 with 1% formic acid as a 
charging agent. For analysis of the complexes, 10 equivalences of free-based 
drugs were added. The mass spectra of probe 2 was analyzed in the presence of 
free-amine mephedrone, flephedrone, methamphetamine, and prepared drug 
precursor. Data was acquired in the positive ion mode.  
Figure 58 represents the mass spectrum of probe 3.17 (507 m/z) and 
mephedrone (178 m/z). The 1:1 stoichiometric complex (685 m/z) is 30% 
abundant. In Figure 59 and Figure 60, the flephedrone-probe 3.17 adduct (689 
m/z) and a methamphetamine-probe 3.17 adduct (657 m/z) both have lower 
abundances than the mephedrone-probe adduct, 12% and 22% , respectively. A 
lower abundance indicates less of the probe-drug adduct, which means the 
probe has a weaker binding affinity for methamphetamine and flephedrone. This 
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hypothesis is further supported by 1H-NMR titrations in subsequent NMR Studies 
section. 
 
Figure 58. ESI-MS of Probe 3.17 and 10 eq. free-based mephedrone. 
 
Figure 59. ESI-MS of Probe 3.17 and 10 eq. free-based flephedrone. 
178 
507 
685 
182 
507 689 
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Figure 60. ESI-MS of Probe 3.17 and 10 eq. free-based methamphetamine. 
3.6.3 NMR Studies 
Proton and Carbon-13 NMR assignments for both molecular probes are 
illustrated in Figure 61, Table 9 for 3.18, and Table 10 for 3.18. A number of 1H-
NMR titration was conducted with the probe to test the binding affinities with 
mephedrone and other illicit substances (flephedrone and methamphetamine) 
and adulterants (benzocaine, lidocaine, acetaminophen, and caffeine). This 
section will discuss the results and hypotheses concerning the 1H-NMR 
characterization of compounds 3.17 and 3.18 and their binding abilities. 
507 
150 
657 
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Figure 61. Numbering systems used for the NMR assignments for molecular 
compound 3.17 and 3.18 
  
1H NMR and 13C NMR chemical shifts from compound 3.17 (* = disappears 
during a D2O shake) 
Probe (3.17) 
1H-NMR 
(DMSO-d6, ppm, J Hz) 
13C-NMR 
(DMSO-d6, ppm) 
1 N/A 139.0 
2 8.02 (d, J = 8.1 Hz) 125.5 
3 7.55 (m) 127.4 
4 7.55 (m) 126.5 
4a N/A 132.1 
5 7.55 (m) 126.5 
6 7.55 (m) 127.4 
7 8.02 (d, J = 8.1 Hz) 125.5 
8 N/A 139.0 
8a N/A 126.7 
9 8.78 (s) 116.8 
9a N/A 126.7 
10 8.67 (s) 127.0 
10a N/A 132.1 
11/11a N/A 182.4 
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Table 9 (continued) 
12/12a 4.78 (d, J = 5.5 Hz) 47.7 
13/13a N/A 134.9 
14/14’ 7.34 (m) 127.4 
15/15’ 7.34 (m) 128.2 
16 7.34 (m) 127.0 
N(1)H* 9.87 (br, s)  
N(2)H* 8.29 (br, s)  
 
  
1H and 13C shifts for model compound 3.18 (* = disappears during a D2O shake) 
Probe (3.18) 
1H-NMR 
(DMSO-d6, ppm, J = Hz) 
13C-NMR 
(DMSO-d6, ppm) 
1 N/A 139.1 
2 7.43 (d, J = 7.8 Hz) 128.2 
3 7.38 – 7.30 (m) 128.6 
4 7.29 – 7.23 (m) 124.3 
5 7.38 – 7.30 (m) 128.6 
6 7.43 (d, J = 7.8 Hz) 128.2 
7 N/A 180.8 
8 4.74 (d, J = 5.5 Hz) 47.2 
9 N/A 139.0 
10/10’ 7.38 – 7.30 (m) 126.8 
11/11’ 7.38 – 7.30 (m) 127.4 
12 7.12 (t, J = 7.3 Hz) 123.3 
N(1)H 9.61 (s)  
N(2)H 8.16 (s)  
 
Figures 63 and 64 are titrations of free-based mephedrone into compound 
3.17. Upon addition of mephedrone in the free-base form, deshielding of the N(1) 
and N(2) signals occur, along with the signal C(9)H. Signal C(10)H on the 
anthracene ring moves upfield, indicating more shielding of the nucleus. As the 
electron density is withdrawn from the thiourea side of anthracene, the molecule 
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becomes more polarized, which is why C(10)H becomes more shielded, due to 
the increased amount of electron density on that side of anthracene unit. Similar 
shifts occurred upon the addition of methamphetamine (Figure 66 and Figure 67) 
and flephedrone (Figure 68 and Figure 69). Several attempts were made to 
calculate a binding constant between probe 3.17 and the drugs.  However, it 
proved to be very difficult to obtain reasonable thermodynamic values by least-
square regression; the reason for this difficulty is hypothesized in the subsequent 
paragraphs. 
Upon closer inspection of the NMR spectra on the addition of either 
mephedrone, flephedrone, or methamphetamine, new 1H-NMR signals were 
observed (denoted by asterisks). A non-classical, 4π + 4π pericyclic 
cycloaddition reaction could be occurring in the C(9)H and C(10)H position on the 
anthracene ring, resulting in covalent dimerization (Figure 62). This has been 
seen before in the literature.95–97 The binding event of mephedrone, flephedrone, 
or methamphetamine induces the pericyclic cycloaddition reaction in probe 3.17. 
This would explain the difficulties in calculating thermodynamic binding 
constants. 
In addition, heterogeneous pericyclic cycloadditions are common with 
anthracene containing species.98 Many studies have observed Diels-Alder 
cycloaddition reactions in the C(9)H and C(10)H positions on anthracene 
moieties.99,100 Given that mephedrone, flephedrone, and methamphetamine all 
have aromatic motifs, which can facilitate pericyclic reactions, another hypothesis 
is that the new 1H-NMR signals are the result of a host-guest reaction. This could 
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explain why the new 1H-NMR signals appear in NMR titrations with the drugs, but 
are not observed in the NMR titrations of anionic guests, like chloride, bromide, 
iodide, nitrate, phosphate, acetate, or tetrafluoroborate. 
 
Figure 62. Pericyclic cycloaddition dimerization of probe 3.17. 
An advantage of the detection of neutral species over cations or anions is 
that the guest molecules often have an organic framework and proton chemical 
shifts of the drugs can also be used to aid in the understanding of the binding 
event. The NMR signal shifts experienced by mephedrone during the 1H-NMR 
titration are indicated in Figure 65. The majority of the mephedrone proton 
signals experienced deshielding, with only tolyl protons (Figure 65B, signal 1) 
becoming more shielded. The protons assigned to mephedrone signals 4, 5, and 
6 (A, C, and D in Figure 65) are close (within one to two carbons) to the amine 
group, which could be hydrogen bonding to probe 3.17. A hydrogen bonding 
interaction would reduce the electron density around the nuclear environments of 
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signals 4, 5, and 6, which would deshield the protons and cause a downfield 
shift. Signal 1 (B in Figure 65), the tolyl CH3, is located near the aromatic portion 
of mephedrone, which is possibly experiencing π-π interactions with the probe. 
This would cause an increase in electron density at signal 1, which would result 
in the upfield shift that was observed.  
Figures 70-73 feature the probe’s 1H-NMR response to four common 
mephedrone adulterants: benzocaine (Figure 70), caffeine (Figure 71), 
acetaminophen (Figure 72), and lidocaine (Figure 73). There are no significant 
shifts in the probe 1H-NMR signals, which means that the probe has little or no 
affinity for the common adulterants found in street mephedrone samples. 
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Figure 63. 1H-NMR titration of compound 3.17 (19.7 mM) upon the addition of mephedrone in acetone-d6. 
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Figure 64. 1H-NMR titration expansion of mephedrone in 19.7 mM of 3.17 in acetone-d6. 
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Figure 65. Mephedrone 1H-NMR signals during titrations with compound 3.17 (A is Signal #5, B is #1, C is #6, and 
D is #4). 
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Figure 66. 1H-NMR titration of methamphetamine in 19.7 mM of compound 3.17 in acetone-d6. 
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Figure 67. Expansion of methamphetamine titration in 19.7 mM of compound 3.17 in acetone-d6. 
  
1
1
8
 
 
Figure 68. 1H-NMR titration of flephedrone in 19.7 mM of compound 3.17 in acetone-d6. 
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Figure 69. Expansion of flephedrone titration in 19.7 mM of compound 3.17 in acetone-d6. 
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Figure 70. 1H-NMR test of benzocaine and 19.7 mM compound 3.17 in acetone-
d6. 
 
Figure 71. 1H-NMR test of caffeine and 19.7 mM compound 3.17 in acetone-d6. 
 
N(1) 9 10 N(2) 2,7 12 
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Figure 72. 1H-NMR test of acetaminophen and 19.7 mM compound 3.17 in 
acetone-d6. 
 
Figure 73. 1H-NMR test of lidocaine and 19.7 mM compound 3.17 in acetone-d6. 
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Figure 74 is the binding isotherms of various psychoactive analytes with 
Probes 3.17 and 3.18. Each isotherm is the shift of the N(1)H proton signal as 
the concentration of the analyte increases. The mephedrone isotherm displays a 
sigmoidal isotherm, which is indicative of a binding event occurring between the 
probe and mephedrone.  
 
Figure 74. 1H-NMR binding isotherms of 3.17 following the N(1)H NMR signal. 
Probe 3.18 was evaluated for its binding abilities toward mephedrone 
(Figure 76) and flephedrone (Figure 77). Neither flephedrone nor mephedrone 
induce significant shifts in the thiourea amine signals N(1)H and N(2)H. This 
indicates that the dipodal pocket is essential to the binding of mephedrone and 
flephedrone (Figure 75). It is the concerted effort of the hydrogen bonding, π-π 
interactions, and the pocket formed by the host molecule that makes probe 3.17 
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bind the drugs with a higher affinity than its model system counterpart, probe 
3.18.  
 
Figure 75. Binding hypothesis for 3.17 and mephedrone. 
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Figure 76. 1H-NMR titration of mephedrone in 19.7 mM of compound 3.18 in acetone-d6. 
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Figure 77. 1H-NMR titration of flephedrone in 19.7 mM of compound 3.18 in acetone-d6. 
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3.6.4 Computational Studies 
To gain insight into the structure of the probe-drug complexes, 
computational studies were carried out by collaborators, Kathryn Kellett and Dr. 
Mire Zloh. Minimal energy structures of probe 3.17 (Figure 78A), mephedrone, 
flephedrone, and each probe-drug complex were generated (Figure 78B). To 
better understand the locations of the intermolecular interactions, electrostatic 
potential maps of each of drug and probe 3.17 were also calculated. One of the 
optimized structures (Figure 78B), which shows mephedrone bound within the 
cleft of probe 3.17 via an array of hydrogen bonding interactions, CH-π 
interactions, and a π-π interaction, is consistent with the observed NMR 
chemical shifts. 
 
Figure 78. Minimized structures of probe 3.17 (A) and probe 3.17-mephedrone 
complex (B). 
Each of the electrostatic surfaces were calculated using VegaZZ using the 
minimized conformation previously calculated from the DFT studies.101 Solid 
gradient surfaces were applied based on a four color gradient, where red 
indicates low electrostatic potential and blue high electrostatic potential. The 
(A) (B) 
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marching cubes method was implemented for surface calculations, which is 
based on surface facet approximation. 
 
Figure 79. Electrostatic surfaces potential for the free drugs (A) mephedrone and  
 
Figure 80. Electrostatic surfaces potential for compound 3.17 (lowest energy) 
highlighting different orientations (A) side on (B) front view and (C) top view. 
 
Figure 81. Electrostatic surfaces potential for molecular compound 3.17 (second 
lowest energy), different views. 
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Figure 82. Electrostatic surfaces potential for molecular compound 3.17 (A) 
mephedrone (B) flephedrone. 
 
Figure 83. Electrostatic surfaces potential for hydrogen bond complexes between 
compound 3.17, flephedrone (A), and mephedrone (B). 
Figures 79A and B are the electrostatic potential for mephedrone and 
flephedrone, respectively. The difference between the two is the higher 
electrostatic potential near the para position on the aromatic ring of flephedrone 
as a result of the fluorine atom versus the methyl group. Figures 80 A, B, and C 
show various views of the electrostatic potential map for the lowest energy 
conformation of probe 3.17. Figure 81 displays three views of the electrostatic 
potential map of the second lowest energy conformation of probe 3.17. Figures 
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82 and 83 represent the minimum energy of mephedrone and flephedrone 
hydrogen bond complexes.  
The minimum energies of interaction were calculated for probe 3.17 with 
both mephedrone and flephedrone based on the minimum conformation of the 
complexes. Probe 3.17 bound to mephedrone within the binding pocket to allow 
for the formation of two hydrogen bonds with a minimum interaction energy of  
-2.88 kcal·mol-1 (Figure 82A). Flephedrone was found to bind to probe 3.17 
outside of the binding pocket, leading to just one hydrogen bond forming and an 
interaction energy of -7.82 kcal·mol-1 (Figure 82B). Interaction energies indicate 
that there is a clear preference for the lowest energy conformations for each 
complex. To ensure that the minimum conformation of both drugs was in fact 
achieved, the mephedrone and flephedrone were studied in their respective 
binding positions, i.e. mephedrone was positioned to bind to probe 3.17 outside 
of the binding pocket and vice versa.  The interaction of mephedrone bound 
outside of the pocket, was 14.66 kcal·mol-1 (Figure 83A). Flephedrone bound 
inside of the pocket, has an interaction energy of -2.06 kcal·mol-1 (Figure 83B). 
This substantiated that the lowest energy conformations of each of the respective 
drug are indicative of the way they bind to probe 3.17.  
Based upon the minimum energies of the complexes in Figures 82 and 83, 
it can be inferred that mephedrone binds inside the pocket of the probe, while 
flephedrone prefers to bind outside of the pocket. The electron donating 
properties of the methyl group on mephedrone are more conducive to π-π 
interactions. This explains the energetically favorable complex where 
 130 
mephedrone is inside the pocket experiencing π interactions with the benzyl 
moieties on the probe. 
3.6.5 Simulated Street Sample Studies 
Mephedrone is often found in combination with any number of cutting 
agents, the two most common being caffeine and benzocaine.77 It has already 
been shown that caffeine and benzocaine do not bind to the sensor, but to 
ensure mephedrone can be detected in such mixtures a protocol was established 
to freebase mephedrone in the presence of benzocaine and caffeine.  
Mephedrone hydrochloride, benzocaine, and caffeine were dissolved in 
water in equal proportions. The mixture was filtered to remove the undissolved 
cutting agents; as benzocaine is only sparingly soluble in water compared to 
caffeine and mephedrone hydrochloride. The mephedrone freebase was 
liberated with ammonium hydroxide (pH~10) and extracted into diethyl ether. The 
organic layer was washed multiple times with water to ensure there were no 
residual anions present. The organic layer was dried over MgSO4 and 
evaporated to dryness yielding a yellow oil with small amounts of white solid. The 
NMR of the mixture shows that all the compounds are still present, however 
larger proportions of mephedrone are present compared to the caffeine and 
benzocaine. Ion Chromatography indicated that no counter anions were present, 
indicating that all the mephedrone was in the free base form. 
NMR titration of compound 3.17 against the extracted street sample 
mixture shows that mephedrone is still binding in the presence of the caffeine 
and benzocaine.  The chemical shift of N(1)H (0.3 ppm) is less than observed in 
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the titration of pure mephedrone (2.0 ppm). To determine which component of 
the simulated street sample is responsible for the reduced N(1) shift, each 
component was analyzed with mephedrone. Figures 84 and 85 are a 1H-NMR 
analysis of mephedrone, benzocaine and probe 3.17 without caffeine, which was 
present in the simulated street sample mixture. N(1)H signal shift in that mixture 
is 0.1 ppm. A mephedrone and caffeine mixture was tested in the absence of 
benzocaine (Figure 86) and resulted in a N(1) shift of 0.26 ppm. These indicate 
that benzocaine is inhibiting the interaction between probe 3.17 and mephedrone 
because the mephedrone-benzocaine mixture elicited a much smaller shift of the 
N(1)H amine signal than the mephedrone caffeine mixture. This is because 
benzocaine is the most structurally similar adulterant to mephedrone. 
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Figure 84. 1H-NMR titration of simulated street sample in 19.7 mM of compound 3.17 in acetone-d6. 
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Figure 85. 1H-NMR titration expansion of simulated street sample in 19.7 mM of compound 3.17 in acetone-d6. 
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Figure 86. Simulated street titration (mephedrone and benzocaine only) in 19.7 mM of compound 3.17 in acetone-
d6. 
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Figure 87. Simulated street titration (mephedrone and caffeine only) in 19.7 mM of compound 3.17 in acetone-d6. 
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3.6.7 UV-Vis Spectroscopy Studies 
UV-Vis studies on probe 3.17 did not produce significant changes in the 
absorption spectra. In fact, there was a linear decrease in absorption (Figure 88). 
This is likely the result of the formation of the pericyclic cycloaddition product 
discussed in Section 3.6.3. The formation of bonds between the 9 and 10 
positions of two anthracenes interrupts the planarity and conjugation of the 
molecule. This no longer allows anthracene to function as a fluorophore, which 
reduces its absorption. 
 
Figure 88. UV-Vis titration of probe 3.17 plus mephedrone (2.5 х 10-6 M, 
acetone). 
3.6.8 Fluorescence Spectroscopy Studies 
Titration of a 2.5 х 10-6 M solution of free-based flephedrone in acetone 
into 3.17 doesn’t produce a significant change in the fluorescence emission (grey 
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spectra in Figure 89); however, addition of neat free-based flephedrone to a 5 х 
10-6 M solution of 3.17 produces substantial fluorescence quenching (red 
spectrum in Figure 89). Addition of a solution of mephedrone does not produce 
emission changes, either; therefore, neat, free-based mephedrone and 
flephedrone were added in 5 µL aliquots to 5 х 10-6 M solutions of 3.17 in 
acetone to observe the changes in the fluorescence emission. Figure 90 is the 
neat addition of mephedrone, and Figure 91 is the neat titration of flephedrone. 
 
Figure 89. Fluorescence titration of compound 3.17 plus free-based flephedrone 
(5 х 10-6 M, acetone, δex = 410 nm). 
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Figure 90. Fluorescence titration of compound 3.17 plus neat, free-based 
mephedrone (5 х 10-6 M, acetone, δex = 410 nm). 
Addition of flephedrone and mephedrone as acetone solutions does not 
produce fluorescence emission changes. This is because the acetone has 
formed a hydrogen bonding shell around the drug and hinders the formation of 
hydrogen bonds with the sensor (3.17). Neat addition of the free-based oils, 
initially produces an increase in intensity; however, after the addition of 10 µL 
(~300 molar equivalence) of mephedrone (5 µL and ~150 equivalences for 
flephedrone) the fluorescence emission quenches. The quenching is due to 
saturation of the fluorophore with large amounts of the analyte. Another 
explanation is that the quenching could also be the result of the pericyclic 
cycloaddition, which causes anthracene to no longer be a fluorophore. 
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Figure 91. Fluorescence titration of compound 3.17 plus neat, free-based 
flephedrone (5 х 10-6 M, acetone, δex = 410 nm). 
Addition of neat free-based mephedrone or flephedrone produces 
significant changes to the fluorescence emission of probe 3.17 (Figures 90 and 
91). Aliquots were added to an acetone solution of probe 3.17; each aliquot was 
approximately 150 molar equivalences. Addition of the first aliquot produced an 
increase in fluorescence intensity, which was a much larger increase for 
flephedrone than mephedrone. This is supported by the DFT calculations of the 
complexes; flephedrone forms a more stable exciplex with the anthracene 
moiety, due to the electron withdrawing nature of the fluorine group (Figure 83A). 
This produces a much larger fluorescence emission increase, resulting from the 
exciplex. DFT studies indicate mephedrone prefers to bind inside the pocket and 
interact with the benzyl π systems, rather than the anthracene moiety (Figure 
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82A). This is evident in the strength of their exciplex fluorescence signals in 
Figures 90 and 91.  
3.7 Summary 
A selective mephedrone sensor was designed, synthesized, and 
characterized. Its monopodal counterpart was prepared and did not show any 
interaction with mephedrone. Sensor 3.17 features a bisthiourea, dipodal design, 
which allowed for the selective detection of mephedrone over methamphetamine 
through hydrogen bonding interactions between the β-carbonyl on mephedrone 
and the thiourea moieties on probe 3.17.  
1H-NMR studies indicated binding of mephedrone was causing significant 
downfield shifts in the thiourea amine, the C(9)H, and C(10)H 1H-NMR signals. 
Mephedrone induced a shift of 2.0 ppm for the N(1)H signal; this was 
substantially more than any other NPS or adulterant. A 1:1 probe 3.17-
mephedrone host-guest complex mass was also observed via ESI-MS. DFT 
calculations further supported the observations made from the NMR and 
fluorescence work and established different binding geometries for mephedrone 
and flephedrone. These two binding hypotheses are supported by the neat 
fluorescence titrations. Flephedrone has a more dramatic change in fluorescence 
emission than mephedrone. This is because it directly interacts with the 
anthracene signaling unit via π interactions; mephedrone binds in the pocket of 
the sensor, whereby the aromatic ring of the drug is sandwiched between the two 
aromatic moieties on probe 3.17. 
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The development of an in-field chemosensor has not been fully achieved; 
however, significant knowledge about the structural components necessary to 
selectively bind mephedrone has been investigated. The probe does not respond 
to mephedrone salts, the form it is commonly found in on the street, but it does 
selectively bind the free-based form of mephedrone. The bisthiourea design is 
crucial for binding mephedrone; there was no deshielding of the thiourea amine 
protons with the monopodal probe in the presence of mephedrone. This indicates 
that the molecular cleft is necessary in order to facilitate the cooperative binding 
of the drug to the host. 
Chapter V of this document will analyze the probes’ responses to common 
salts of cathinones. Much of the binding characterization has been investigated 
via non-photophysical methodologies (NMR and mass spectrometry); however, 
one significant point to make concerning the fluorescence of the probe is that it 
responds to neat, free-based mephedrone. This is important for in-field detection; 
a response to the addition of neat mephedrone is more suitable for in-field 
detection than forcing drug enforcement officers to make a solution of 
mephedrone. 
3.8 Experimental Methods 
3.8.1 General Experimental Conditions 
The same conditions that have applied to the other studies in this 
document also apply to this study. Refer to Chapter II’s General Experimental 
Methods section for the conditions used in the study. The chapter specific 
conditions are in the subsequent section of this chapter. All experiments involve 
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psychoactive substances were performed by collaborators at the University of 
Hertfordshire in Hatfield, UK, due to their license to handle illicit, psychoactive 
substances. Design, synthesis, and characterization were carried out in the 
Wallace lab. 
3.8.2 NMR Methods 
1H NMR titrations were carried out by preparing a 20.0 mM solution of 
molecular compound 3.17 or 3.18 in acetone-d6 (2.0 mL). A stock solution of the 
free-based drugs was prepared in acetone-d6 (2.0 mL). Aliquots of 2.5 µL (2.5 µL 
= 0.1 equivalence of drug to probe) were added and the 1H-NMR spectra was 
recorded after each addition. Due to the instability of the free-based drugs, new 
1H-NMR signals as the result of impurities appeared as the titrations commenced 
and are marked with asterisks (*). 
3.8.3 Optical Spectroscopy Methods 
For UV/Vis Spectroscopy, a solution of compound 3.17, 2.5 х 10-4 M was 
prepared in HPLC grade acetone. An additional solution containing 0.01 M 
mephedrone freebase was prepared and aliquots of 25 µL (25 µL = 0.25 
equivalence of mephedrone freebase to compound 3.17) were added, spectra 
was recorded after each addition. Neat fluorescence titration involved adding the 
neat mephedrone and flephedrone free base in 5 µL aliquots and the emission 
spectra was recorded after each addition. The excitation wavelength was at 410 
nm. 
For fluorescence emission studies, a solution of compound 3.17, 5 х 10-6 
M was prepared in HPLC grade acetone. An additional solution containing 5 х 10-
 143 
6 M compound 3.17 and 2.5 х 10-4 M mephedrone freebase was prepared and 
aliquots of 10 µL (10 µL = 0.1 equivalence of mephedrone freebase to compound 
3.17) were added, spectra was recorded after each addition. 
3.8.4 Mass Spectrometry Methods 
Samples were prepared in HPLC grade Acetone at 0.5 mg·mL-1. For 
analysis of the complexed sample, 10 equivalents of mephedrone freebase were 
added to a 0.5 mg·mL-1 solution of compound 3.17 in Acetone. One percent 
formic acid was added to all of the samples as an ionizing agent before injection. 
To ensure complex m/z was not an artifact, deuterated water was added to the 
sample to show an increase in the mass due to the exchange of the labile 
protons. Data was acquired in both the positive and negative ion mode. Needle 
voltage was 5000 V, drying gas temperature was 300°C, and nebulizer pressure 
was 24.6 psi. 
3.8.5 Computational Methods 
Conformational search was carried out for single molecules and 
complexes using HyperChem 8.10 and OPLS force field.102 Five lowest energy 
structures/complexes that were different were submitted for PM7 calculations 
using MOPAC2012.103 A lowest energy complexes for each NPS with compound 
3.17 was optimized at the DFT level, and that was followed by generating and 
optimizing alternative complexes for comparison, i.e. to ensure that the minimum 
conformation of both drugs was in fact achieved, the mephedrone and 
flephedrone were studied in their respective binding positions, i.e. mephedrone 
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was positioned to bind to compound 3.17 outside of the binding pocket and vice 
versa. 
3.8.6 Synthetic Methods 
 
 Preparation of 1,8-diaminoanthraquinone (3.20) 
Compound 3.20 was prepared based upon literature conditions.104 1,8-
Dinitroanthraquinone (3.27, 1.2 g, 4.9 mmol) was dissolved in isopropanol (50 
mL) and stirred under nitrogen for 15 minutes. Upon the addition   of sodium 
borohydride (2.3 g, 59 mmol), the reaction was refluxed for 36 hours. The 
reaction mixture was poured into 100 mL of ice water, which caused a green 
precipitate to form. The green solid was filtered, washed with 50 mL of distilled 
water, and yielded a dark, green solid (3.20) (0.83 g, 3.99 mmol, 93%). 1H NMR 
(CDCl3) δ, ppm: 4.21 (s, 4H, NH), 6.96 (d, 2H, ArH), 7.42 (t, 2H, ArH), 7.81 (d, 
2H, ArH), 8.22 (s, 1H, ArH), 8.37 (s, 1H, ArH). 
 
 Preparation of dibenzylthiourea anthracene (3.17) 
3.203.27
3.20
3.25
3.17
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1,8-Diaminoanthracene (3.20, 877 mg, 4.2 mmol) and 
benzylisothiocyanate (3.19, 1.12 mL, 8.4 mml) were dissolved in 100 mL of 
ethanol and refluxed for two hours. The reaction was cooled in ice and filtered. 
The dark solid was washed with approximately 25 mL of water and ethanol each. 
The product was then dried under vacuum; after which, it yielded a dark brown 
solid (3.17, 1.04 g, 2.05 mmol, 40 %). See the 1H-NMR Studies section for 1H 
and 13C NMR assignments; IR (ATR solid) in cm-1: 3377 νN-H (m), 3131 νAr-H, 
2964 νC=C-H, 1612 νC=S (m), 1495 νC=S (s), and 1250 νC=S (s); mp = 213°C. 
Elemental analysis (%) Calculated for C30H26N4S2: C, 71.11; H, 5.17; N, 11.06. 
Recalculated for C30H26N4S2H2O C, 68.67; H, 4.99; N, 10.68, Found: C, 68.93, 
H, 4.89; N, 10.34. 
 
 Preparation of benzylthiourea aniline (3.18) 
Compound 3.18 was prepared based upon literature conditions.105 Aniline 
(3.28, 400 mg, 392 µL, 4.3 mmol) and benzylisothiocyanate (3.19 640 mg, 568 
µL, 4.3 mmol) were dissolved in ethanol (30 mL) and refluxed for two hours. 
Upon the formation of a cream precipitate, the reaction was allowed to cool to 
room temperature and then filtered. The product, a cream colored solid, was 
3.28
3.25
3.18
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dried under vacuum, which yielded 616 mg (59% yield) of compound 3.18. See 
1H-NMR Studies section for 1H and 13C NMR assignments. 
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CHAPTER IV – 2-AMINOINDANE CLASS DRUG SENSOR 
4.1 Background 
Recreational drug usage, specifically entactogenic (ecstasy mimicking) 
drugs, has been on the rise for the past few years in the UK and more recently 
the US.106 A 2009-2010 British Crime Survey reported that approximately 2.7 
million people between the ages of 16 and 24 have used recreational drugs.107 
New recreational drugs are referred to as “legal highs,” because they have been 
chemically altered from their controlled or illegal counterparts to avoid 
government regulations. These new drugs seem to be replacing established 
recreational drugs, such as, benzylpiperazine (BZP, 3.1), ketamine (4.2), and 
3,4-methylenedioxymethamphetamine (MDMA, 4.3) (Figure 92).106,108 Perhaps, 
this new found popularity is due to the ease with which these legal highs can be 
obtained via the internet and synthesized.107  
 
Figure 92. Common recreational drugs. 
One class of legal highs that are of particular interest is based on  
2-aminoindane family. 2-Aminoindane (compound 4.4), the class’s namesake, 
has been discovered to possess bronchodilation and analgesic properties, as 
well as being an amphetamine mimic.109 Sainsbury et al. discusses that the 
compounds 4.4a, 4.4b , 4.4c, and 4.4d are novel drugs that are gaining in 
popularity with recreational users (Figure 93).106 Figure 93 features 2-
4.1 4.2 4.3 
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aminoindane and popular aminoindane analogues. The most renown of the 
aminoindanes is 5,6-methylenedioxy-2-aminoindane (MDAI), known as “sparkle” 
or “woof woof” on the streets.107 When the UK government reclassified the 
cathinone class as a Class B drug, which banned its usage, in April 2010, MDAI 
and the other analogues came into the public spotlight.107,110 To date, 
aminoindanes are legal; however, the UK’s government is currently working on 
legislation to ban them. The legislation provides a rationale for the development 
of an efficient and economical chemosensor to accurately detect the presence of 
these “legal highs.” 
 
Figure 93. Popular aminoindanes. 
4.4 = 2-aminoindane (2-Ai, 4.4a =5-iodo-2-aminoindane (5-IAI), 4.4b =5-methoxy-6-methyl-2-aminoindane (MMAI), 4.4c = 
5,6=methylenedioxy-2-aminoindane (MDAI), 4.4d = 5,6-methylenedioxy-N-methyl-2-aminoindane (MDMAI). 
MDAI was first synthesized by David E. Nichols in 1990 as a serotonin 
release alternative to MDMA (ecstasy).111 Nichols and his team also synthesized 
many other analogues, such as MMAI, which has been proven to be substitutive 
for equal MDMA doses. Upon administering MDAI or other analogues to rodents, 
Nichols et al. did not observe the damage to neurons and neuronal- pathways in 
the brain as is observed just hours after a dose of MDMA.111 This is one of the 
4.4 
4.4a 
4.4b 
4.4c 
4.4d 
 149 
few aspects of the ecstasy analogues’ pharmacodynamics that is relatively well 
known; their pharmacology is relatively unexplored when compared to other 
serotonin releasing agents, like MDMA.112 The question now is how do 
compounds, such as MDMA and the 2-aminoindane analogues, affect the brain? 
There are several theories about the pharmacological mechanism behind 
these 2-aminoindane analogues. Like all entactogenic drugs, the aminoindanes 
disrupt the levels of neurotransmitters in the brain, which generates the “high” felt 
by the user. There are two main classes of pharmacological mechanisms that 
alter neurotransmitters levels: releasing agents (RAs) and reuptake inhibitors 
(RIs).107 It has been shown that both types of mechanisms involve 
neurotransporter proteins contained within the membranes of monoamine 
neurons; these neurotransporters move monoamine neurotransmitters between 
the cytoplasm and the world beyond the cell.112 It was shown that MDMA and its 
analogues interact with these transporters to alter serotonin, dopamine, and 
norepinephrine levels in the brain. 
Releasing agents bind to the neurotransmitters and are transferred into 
the cytoplasm. This inhibits the function of the transporters, causing an elevation 
in the neurotransmitter levels in two different ways.112 The first mode is that an 
RA increases cytoplasmic neurotransmitter concentrations by preventing the 
storage of it in vesicles. RAs also promote a non-exocytotic release of 
neurotransmitters by a carrier mediated exchange mechanism. Reuptake 
inhibitors simply bind to the transport proteins in the cell wall and prohibit the cell 
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from the reuptake of any neurotransmitters outside the cell wall, Figure 94, where 
a selective serotonin reuptake inhibitor (SSRI) is displayed. 
 
Figure 94. Selective Serotonin Release Inhibitor (SSRI) Diagram. 
Reprinted by permission from Macmillan Publishers Ltd: [Journal of Perinatology]: Lattimore, K. A; Donn, S. M.; Kaciroti, 
N.; Kemper, A. R.; Neal, C. R.; Vazquez, D. M. Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and 
Effects on the Fetus and Newborn: A Meta-Analysis. J. Perinatol. 2005, 25 (9), 595–604., Copyright 2005. 
Nichols et al. showed that MDAI and most of the other aminoindane 
analogues possess a primary RI pharmacological mechanism, much like 
MDMA.113 They proved that the short term monoamine changes of MMAI and 
MDAI were very similar to those of MDMA and MDA (3,4-
methylenedioxyamphetamine).111 MMAI significantly decreased the 5-HT (5-
hydroxytryptamine) and 5-HIAA (5-hydroxyindoleacetic acid) levels in the frontal 
cortex and hippocampus, while increasing the levels of DA (Dopamine) in the 
frontal cortex. Unlike MDMA or MDA, MMAI and MDAI do not cause permanent 
decrease in 5-HT or 5-HIAA levels, which leads to the selective degeneration of 
serotonin axons in the raphe nuclei in the brain. Although, the exact mechanism 
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of the degeneration is uncertain, it is hypothesized to be related to the rigidity of 
the indane functionality that is not seen in an amphetamine structure.107,111,113  
Although MMAI, MDAI, and the other analogues appear “safer” for the 
body than MDMA and MDA due to their non-neurotoxic nature, an overdose of 
MDAI has been responsible for the death of a 17 year old girl in 2011; it is 
supposedly the first reported death involving 2-aminoindane analogs.107 The UK 
National Poisons Information Service has reported some unconfirmed cases of 
MDAI usage that were related to renal failure, acute respiratory distress 
syndrome and hepatic failure. MDAI increases the concentration of circulatory 5-
HT, which can increase the risk of Primary Pulmonary Hypertension (PPH). 
Along with these increased risk, MDAI and the other analogues produce 
amphetamine-like hallucinations and psycho-motor stimulations.  
Not only do the aminoindanes pose health risks to users, but other 
compounds utilized to augment the amount of substance also endanger users. 
Approximately 85% of the legal high samples analyzed by Baron et al. did not 
contain “what they said on the tin.”114 Baron et al. confirmed via FTIR and GC-
MS that six of their legal high samples contained large amounts of caffeine, while 
others even contained the controlled substances BZP (benzylpiperazine) and 3-
TFMPP (3-trifluoromethylphenylpiperazine). Online suppliers are not regulated; 
therefore, unsuspecting customers are being misled in ways that could result in 
harm. Only one of the samples contained the drug it advertised, which was 
MDAI. Users are led by unregulated suppliers to believe the labels on “legal high” 
 152 
containers. They are really getting large amounts of other illegal substances with 
small amounts of legal high in the “tin.” 
4.2 Literature Review 
The common feature between the entactogenic street drugs is the primary 
amine functional group. Since this functional group is found in all the drugs, it 
becomes exploitable as a receptor motif in a chemosensor to bind the amine or 
ammonium functional group. For the duration of this chapter, the amine group will 
be substituted deliberately to indicate the protonated ammonium functionality, 
except in cases of reference to the ammonium cation. An amine group can be 
involved in many forms of intermolecular attractions, i.e. London Dispersion 
Forces and dipole-dipole interactions, but the most significant of these attractions 
is hydrogen bonding, which has bond strengths ranging from a weak bond 
energy of 12 kJ(mol)-1 to a strong interaction of covalent nature at 120 kJ(mol)-1.2 
Crown ethers (cavitands) have been extensively utilized to bind amine 
functionalities.6,115–118  
4.2.1 The Binding Unit Discussion 
Crown ethers were serendipitously synthesized by Charles Pederson at 
DuPont in the 1960s.115 Pederson noted that crown ethers have a remarkable 
affinity for a large selection of metals, especially K+ (See Cation Sensors section 
in Ch. I).15 In the ensuing five decades, a plethora of research by George Gokel 
involving the broad spectrum of cations and anions bound by crown ethers has 
produced many new macrocyclic complexes.115,119–121  
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Though crown ethers bind metal ions effectively, this research focuses on 
the structures formed between crown ethers and amine species. Caviplexes or 
cavitates (structures formed between a non-metallic guests and cavitands) 
involving protonated amines and crown ethers have been extensively studied.122 
Solid state, gaseous, and solution binding studies show that [18]crown-6 binds 
three of the four hydrogen atoms (4.5a) on an ammonium cation forming a 
caviplex with pseudo-D3d symmetry; however, this is not the only structure known 
to crown ether amine cavitates (Figure 95). Cram and Trueblood illustrate that 
intermolecular hydrogen bonding can also occur in a ditopic fashion (4.5b) 
between monoprotonated hydrazine and [18]crown-6.123 It has been shown that 
receptor size plays an important role in the stability and structure of the cavitate 
between the crown ether and the amine species just as it does with the spherical 
cations.122  
 
Figure 95. [18]crown-6 binding modes for ammonium (4.5a) and protonated 
hydrazine (4.5b). 
Although, there is no literature examples outlining the specific detection of 
the novel entactogenic drugs via crown ethers, crown ethers have been utilized 
to detect other primary amines, but before discussing the various applications, a 
thorough understanding of the structure and stability will be addressed. 
4.5a 4.5b 
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[18]Crown-6 forms a caviplex, e.g. 4.5a and 4.5b, with ammonium salts. It may 
also bind alkylammonium species. Doxsee et al. observed average bond lengths 
of 2.86 Å between the three oxygen atoms involved in bonding and the three 
hydrogen atoms on ammonium ion in methanol (Log Ka = 4.0 M-1).124,125 
Buschmann et al. calculated the thermodynamic parameters and stability of 
cavitates formed with [18]crown-6 various aromatic and alkyl guests in methanol 
(Table 11).122 It is clear from the data presented that sterically unhindered, 
protonated amine groups form more stable caviplexes. 
  
[18]Crown-6 and various amine stabilities. 
Amine -ΔH (kJ(mol)-1) Log K 
n-C4H9NH2 31.5 2.60 
[n-C4H9NH3]+ 44.3 3.95 
(n-C4H9)3N 2.3 2.58 
[(n-C4H9)3NH]+ 5.5 2.28 
C6H5NH2 1.6 2.52 
[C6H5NH3]+ 41.6 3.85 
C6H5CH2NH2 22.5 2.46 
[C6H5CH2NH3]+ 47.7 4.37 
C6H5CH2NHCH3 1.2 2.47 
[C6H5CH2NH2CH3]+ 3.6 2.43 
 
Motifs, like aromatic rings, have been attached to crown ethers to further 
enhance binding and stability via π- π interactions, and in the subsequent 
example, facilitate crystallization for solid state structure determination. Kryatova 
et al. studied the enthalpically -driven caviplexes between benzo[15]crown-5, 
which only hydrogen bonds to two of the three hydrogen atoms, and both alkyl 
and aromatic amines (Figure 96).6 It was shown that, like [18]crown-6, 
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benzo[15]crown-5 bound R-NH3+ functionalities in a 1:1 stoichiometry (4.6a), but 
binds ammonium species in a 2:1 ratio.124 This is due the sterically hindering 
alkyl or aryl functionalities. Kryatova also took advantage of this enthalpically (-
ΔH = 20.5±2.0 kJ(mol)-1 and Log K = 2.60 for 4.6a in CH3CN) driven cavitate 
formation by utilizing the chelate affect to further stabilize the caviplex (4.6b and 
4.6c).6  
 
Figure 96. Chelate effect illustration with benzo[15]crown-5. 
Another illustration of the utilization of the chelate effect for additional 
stability of a crown ether and amine cavitate is the sandwiching of ammonium 
cations between crown ethers. Doxsee et al. utilized benzo[15]crown-5 to study 
such sandwich caviplexes.124 Since the small cavity (1.7-2.2 Å) of 
benzo[15]crown-5 only binds to two of the hydrogen atoms on the ammonium 
cation, this allows the other two hydrogen atoms to bind to an adjacent 
macrocycle.  
4.6a 
4.6b 
4.6c 
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As illustrated by Table 11, the most favorable binding unit appears to be 
[18]crown-6. It is also far more stable than [15]crown-5, when bound in a 1:1 
cavitate. [18]Crown-6 binds protonated benzyl amine with a -ΔH = 47.7 kJ(mol)-1 
and a Log K = 4.37.122 [15]Crown-5 binds the same guest with a -ΔH = 20.5 
kJ(mol)-1 and Log K = 2.60.6 The differences in these values is associated with 
the size of the crown ether and the fact that [18]crown-6 hydrogen bonds all three 
hydrogen atoms on the protonated guest, which would increase the stability of 
the caviplex. This data would suggest that [18]crown-6 is a more ideal receptor 
candidate for protonated amines. 
4.2.2 Literature Examples of Crown Ethers Binding Small Molecules 
From simple compounds to peptides, crown ethers have been utilized as 
receptors in chemosensors for the detection of various of amine containing 
molecules.1 On the fundamental side, Mehta et al. has developed a coumarin 
substituted azacrown (4.9) ether for the molecular recognition drugs containing 
functionalities of aromatic amines (Figure 97).126 The binding ability of the 
coumarin-based primary aromatic amine sensor was investigated via 
fluorescence and absorbance studies; it exhibited no color change in the 
presence of secondary and tertiary aromatic and aliphatic amines. The sensor 
host in 4.7 was pH dependent due to the coumarin motif; its maximum 
absorbance was in the window of 5.5-7.0. The heightened colorimetric aspect at 
this pH is hypothesized to be due to the electrostatic interaction of the 
deprotonated coumarin with the positive charged nitrogen atom. 
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Figure 97. Fluorescent aniline sensor featuring a coumarin-based fluorophore. 
Mehta et al. first analyzed the receptor response via UV-Vis absorbance in 
the presence of aniline and many of its analogues, i.e. isomers (o-, m-, and p-) of 
toluidine, nitroaniline, anthranilic acid, and p-aminobenzoic acid.126 They 
proposed a structure for the receptor and protonated aniline caviplex (4.7). Only 
after analyzing the receptor with standard aromatic amines did Mehta et al. 
expose the receptor to drugs that contain primary aromatic amines, like 
bromohexine, folic acid, metoclopramide, sulfadiazine, sulfaguanidine, and 
trimethoprim. Mehta et al. synthesized a colorimetric receptor that took 
advantage of hydrogen bonding and electrostatic interactions to selectively 
detect protonated, primary amines.  
One of the most utilized fundamental aspects of crown ether cavitates 
involves stereochemistry; crown ethers can aid in the distinguishing R and S 
enantiomers. Cho et al. developed a colorimetric chiral sensor based on chiral 
crown ether to differentiate between the enantiomers of primary alcohols and 
amines (Figure 98).127 They utilized a diazophenol and dinitrobenzene to 
incorporate a UV-Vis handle on the sensor (4.8). A 3,3’-diphenyl-1,1-binaphthyl 
4.7 
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chiral barrier architecture was employed to aid in producing different binding 
structures for R and S enantiomers.  
 
Figure 98. Colorimetric chiral amine sensor based on a chiral crown ether. 
Of all the primary amines investigated, phenylalaninol produced the most 
intense chromophoric response of all the guests. The other guests were 2-amino-
1-propanol, 1-amino-2-propanol, leucinol, phenylglycinol, 1-aminoindane, and 1-
phenylethylamine. The λmax for the R enantiomer of phenylalaninol was 558 nm, 
while the S enantiomer’s λmax was 602 nm. Although Cho et al. were unable to 
elucidate the structure of the caviplex via molecular modeling calculations or 
NMR studies, they were able to determine via absorbance data that the chiral 
blocking motif did significantly affect the stability of the binding more than it did 
for the other guests, such as phenylglycinol.127 For phenylalaninol, the KR 
(binding constant for R enantiomer) was 3.90 х 102 M-1, while the KS (binding 
constant for S enantiomer) was double (9.80 x 102 M-1). The difference in the 
association constants for each of the 1-aminoindane enantiomers was not as 
drastic as the phenylalaninol isomers (5.74 x 102 M-1 and 4.86 x 102 M-1 for the S 
and R enantiomers, respectively). It was concluded that the significantly varying 
color and stability constants produced in the phenylalaninol and 1-aminoindane 
4.8 
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caviplexes were probably due to chiral barrier and chromophore inducing 
different binding modes for each enantiomer. 
Another fundamental application of crown ethers is the selectivity; they 
can distinguish between 1°, 2°, and 3° amines.116 Jung et al. employed a crown 
ether combined with an α-cyclodextrin moiety to bind the various substituted 
amines and utilized UV-Vis, NMR, and mass spectrometry to elucidate the 
structure of the caviplex (Figure 99). They attribute the stability of the various 
amine structures to efficient hydrogen bonding of the amines to the crown ethers, 
the hydrophobic interaction between the cyclodextrin and the aliphatic tail of the 
amines, and the acidity of the host. These varied interactions for the 1°, 2°, and 
3° amines are attributed to the diverse chromophoric response, which allows 
Jung et al. to distinguish between the amines. 
 
Figure 99. Primary amine crown-ether/cyclodextrin based receptors. 
Crown ethers have been also utilized to detect complex biological 
molecules, like amino acids and peptides. Spath et al. utilized a fluorometric 
based ditopic azacrown ether receptor to selectively detect zwitterionic amino 
acids or small peptides and ϒ-aminobutyric acid (GABA).118 The sensors (probes 
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4.8 and 4.9) contained crown ether moieties to bind the N-terminus of the 
peptide, and nitrogen containing functionalities appended to the crown ether 
were for binding of the C-terminus of the peptide, hence a ditopic sensor (Figure 
100). Incorporated in the crown moiety, specifically [21]crown-7, is the 
fluorometric signaling unit, dimethyl phthalate. 
 
Figure 100. Ditopic sensors for amino acids and small peptides. 
Spath et al. observed the selective binding of GABA by 4.9 via 
fluorescence emission and absorbance spectra variances.118 The same 
molecules even displayed the ability to distinguish between GABA and its 
precursor, glutamic acid. Spath showed via fluorescence and absorbance studies 
that the receptor (4.10) bound the tripeptide in Figure 100. Both the proposed 
caviplexes for the binding of 4.9 and 4.10 are illustrated in Figure 100. 
4.3 Rationale 
The goal of this project is to establish efficient and economic 
chemosensors for the detection of aminoindanes. Previous methods for the 
detection of this class of compounds utilized techniques, such as HPLC and 
Raman spectroscopy.81,128  These methods are sensitive and reliable; however, 
they are not conducive to field testing conditions that are sometimes necessary 
4.9 4.10 
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for drug determination. It is anticipated that a fluorescent change after drug 
recognition will facilitate testing for these chemicals in the field. This research 
seeks to generate a fluorescent host for primary amines containing molecules. 
4.4 Hypothesis 
A probe containing 1-aza-18-crown-6 moieties will function as a 
chemosensor for the protonated amine groups on the aminoindane class of 
drugs. The crown ether will form hydrogen bonds with the protonated amine 
functionality. This has been repeatedly shown in literature.116,118,126 A fluorescent 
signaling unit will improve the sensitivity of the probe. One of the main concerns 
is how will the sensor be selective for 2-aminoindane over other primary amines, 
such as aniline or alkyl amines, i.e. will the 1-aza-18-crown-6 binding unit be able 
to distinguish between various primary amines? 
4.5 Sensor Design 
Inspired by previous work, a chemosensor for aminoindanes was 
synthesized.116,118,127 The chemosensor featured 1- aza-18-crown-6 binding units 
for their complementarity in the hydrogen bond coordination of primary, 
protonated 2-aminoindanes and a rigid acridine fluorophore integrated as part of 
the sensor design. A fluorescent probe design was chosen due to the increased 
sensitivity of fluorescence spectroscopy over other instrumental techniques, like 
UV-Vis and NMR, as demonstrated in the previous literature examples.126,129  
Both a mono aza-crown (a control) and a bis aza-crown designs were both 
proposed in order to characterize the binding of the protonated primary amines to 
the aza-crown ether moieties (Figure 101). It is anticipated that the rigid acridine 
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backbone will interact with the π system of the aminoindanes. This will produce 
changes in the fluorescence spectroscopy as the complex forms. Therefore, 
characterization of the hydrogen bond complex can be accomplished through 
fluorescence spectroscopy, in addition to UV-Vis. 
 
Figure 101. Proposed mono aza-crown and bis aza-crown primary amine 
sensors. 
 
Figure 102. Proposed binding hypothesis for Probes 4.11, 4.12, and 2-
aminoindane. 
4.6 Results and Discussion 
4.6.1 General Synthesis 
Compound 4.12 was synthesized from 4,5-bis(bromomethyl)acridine and 
1-aza-18-crown-6, which were stirred for 48 hours at room temperature and 
refluxed for 48 hours in dry acetonitrile. Upon the addition of acetone, a yellow 
precipitate was formed and allowed to crystallize and filtered. Compound 4.12 
was characterized with multinuclear and multidimensional NMR, ESI-MS, UV-Vis, 
4.11 4.12 
 163 
and fluorescence. 1H-NMR indicated formation of compound 4.12 by the 
disappearance of the amine signal from the 1-aza-18-crown-6 reactant. 
Formation of the product (4.12) was also characterized by the shift of the 
methylene bridges’ signal to 4.61 ppm for 4.12 from 5.42 ppm on the 4,5-
bis(bromomethyl)acridine reagent. Synthesis of probe 4.11 was not attempted 
due to the inability of probe 4.12 to be selective for 2-aminoindane-HCl over 
aniline-HCl.  
4.6.2 Mass Spectrometry Studies 
Probe 4.12 was characterized via ESI-MS. A signal for the masses 730 
mz, 752 m/z, and 862 m/z was observed (Figure 103). The 730 m/z signal 
represents [4.12 + H]+, while the 752 m/z signal is the sodium charged adduct 
[4.12 + Na]+. The 862 m/z signal represents a 4.12-solvent adduct, involving 
three methanol and two water molecules [4.12 + 3MeOH + 2H2O +H]+. CID of the 
730 m/z signal shows the loss of 263 m/z, an aza-crown moiety, with the 
appearance of a 467 m/z signal (Figure 104). A MS/MS of the 467 m/z signal 
results in the loss of a large portion (194 m/z) of the adjacent aza-crown ether, 
leaving a 273 m/z. Further CID was unreliable due to a low signal-to-noise ratio.  
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Figure 103. ESI-MS of 1 mg·mL-1 probe 4.14 in methanol. 
 
Figure 104. CID pathway of probe 4.12. 
730 m/z 
[4.14+H]+ 
752 m/z 
[4.14+ 
Na]+ 
862 m/z 
[4.14+3(MeOH)+2(H2O)+H]+ 
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Analysis of a 2-aminoindane-HCl and probe 4.12 complex was attempted 
via ESI-MS in order to characterize the intermolecular interactions in an 
environment without solvent interference. A mass for the 4.12:2-aminoindane-
HCl adduct was observed. However, the signal was weak, and the mass could 
not be confidently assigned. Even after optimizing the experimental conditions on 
the ESI-MS for the complex mass signal (i.e. lowering the capillary temperature 
and tuning the instrument for that mass), the signal-to-noise ratio was still too low 
to report. 
4.6.3 NMR Studies 
NMR studies allow for the determination of which atoms of the probe are 
involved in the binding event. Changes in the nuclear environments close to the 
receptor site occur during binding and are evident in their changes in chemical 
shift. This can provide key structural information about changes that occur during 
binding. The next few pages feature 1H-NMR titrations between Compound 4.12 
and 2-aminoindane-HCl (2-Ai-HCl), potassium perchlorate, and aniline-HCl. The 
equivalences of analyte to 4.12 are on the right side of the NMR stack plot. Upon 
the addition of analyte, a shift in the 1H-NMR signals as the equivalences of 
analyte increase indicates a change in the chemical environment of the nuclei. 
During the discussion of the changes in chemical shifts, the reader may use 
Figure 105 to reference the 1H-NMR shifts on the chemosensor 4.12. 
 166 
 
Figure 105. 1H-NMR labelling for chemosensor 4.12. 
The formation of hydrogen bonds between the analyte (primary amines or 
potassium) and 4.12 is primarily responsible for the changes in the nuclei in the 
aza-crown ether methylene protons; in fact, the largest chemical shifts changes 
occur with those crown ether proton signals. A 1H-NMR titration between probe 
4.12 and 2-Ai-HCl was completed (Figure 108). Signal 12 shifts upfield from 3.46 
ppm to 3.27 ppm (Δ0.19 ppm), when 10 molar equivalences of 2-aminoindane-
HCl are present (Figure 109). These protons are in proximity to the hydrogen 
bonding acceptor oxygens that bind to the primary amines; hence, they 
experience the most nuclear environmental changes as a consequence of the 
hydrogen bonding.  
The binding of 2-aminoindane-HCl also induces changes in the nuclear 
environments of the acridine protons as well (Figure 110). Signal C(9)H is 
deshielded from 8.94 ppm to 9.08 ppm (Δ0.14 ppm) in the presence of 10 
1,8,3,6 
2,9 10 11 
MeOH H2O 
12 
13-16 
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equivalences of 2-Ai-HCl. There is no conjugation connecting the fluorophore or 
the binding unit, so this is due to the fact that 2-Ai-HCl is interacting with the 
acridine fluorophore. 2-Aminoindane-HCl can interact with the fluorophore via π-
π stacking (Figure 102) or one of the amine protons can hydrogen bond to the 
nitrogen heteroatom in the 10 position of the acridine ring (Figure 106). 
To ensure that the changes in compound 4.12’s proton signals were 
legitimately due to the binding of the protonated amine, it was decided to analyze 
the probe’s response to potassium, a common [18]crown-6 guest. Probe 4.12 
was analyzed in the presence of increasing equivalences of KClO4 (Figure 111). 
The changes in 4.12’s proton shifts mimic the changes in the 2-Ai-HCl titration. 
Signal 12 moved upfield from 3.46 ppm to 3.37 ppm (Δ0.09 ppm) at 10 
equivalences of KClO4 (Figure 112). Signal C(9)H experienced deshielding and 
shifted 0.09 ppm (8.95 ppm to 9.04 ppm) after the addition of 10 equivalences of 
KClO4 (Figure 113).  
These signals are significantly less than the shifts observed in the 2-Ai-
HCl titration. The smaller change in the aza-crown signals (Δ0.09 ppm vs. Δ 0.19 
ppm) is due to the electronegativity difference between potassium and nitrogen. 
Potassium is much less electronegative than nitrogen, meaning the coordination 
of potassium won’t induce as large a change in the nuclear environments as the 
hydrogen bonding of a protonated amine. The smaller change in the aromatic 
acridine signals (Δ0.09 ppm vs. Δ 0.14 ppm) is due to the fact that potassium 
cannot interact with the acridine fluorophore, like the 2-aminoindane-HCl analyte, 
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which can hydrogen bond to the nitrogen heteroatom on the acridine (Figure 106) 
or interact with the π system of the acridine backbone (Figure 102). 
 
Figure 106. Proposed binding hypothesis between 4.12 and 2-aminoindane 
featuring a hydrogen bonding interaction between the acridine and the guest. 
To further investigate the binding and spectroscopic response of probe 
4.12, aniline-HCl was added (Figures 114 and 115). When compared to the 2-
aminoindane-HCl titration, larger shifts in the NMR signals were observed for the 
aromatic, acridine protons, while the aza-crown methylene protons did not shift 
as much. Signal C(12)H moved upfield from 3.46 ppm to 3.44 ppm (Δ0.02 ppm) 
in the presence of 10 equivalences of aniline-HCl (Figure 114), while signal 9 
(the 9 position of acridine) experiences a Δ0.42 ppm (8.95 ppm to 9.37 ppm) at 
10 equivalences of aniline-HCl (Figure 115). In addition to larger changes in 
aromatic shifts, the aniline proton signals underwent changes in their chemical 
shifts, as well (Figure 115). This was not observed for the 2-aminoindane-HCl 
(Figure 110) proton signals during its 1H-NMR titration.  
The differences in chemical shift changes results from the differences in 
the structures of 2-Ai-HCl and aniline-HCl. The amine functionality on aniline is 
directly attached to the aromatic ring, and its lone pair is in resonance with the 
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ring. This is not the case for 2-aminoindane (Figure 107); its amine is separated 
from the aromatic ring by an aliphatic ring system. This is reflected in their pKa 
values; at 25°C aniline-H+ has a pKa = 4.6 in dilute aqueous conditions, while 1-
aminoindane-H+ has a pKa = 9.2 (2-aminoindane was not available).130  The 
lower pKa of aniline-HCl makes the N-H bond more polar, making aniline-HCl a 
better hydrogen bond donor than 2-Ai-HCl. A possible reason why there are 
larger changes in chemical shifts for aniline-HCl compared to 2-Ai-HCl. Aniline-
HCl binds to probe 4.12 better than 2-Ai-HCl. The shifts in the aniline-HCl 
protons results from the fact that the amine is directly associated with the 
aromatic protons on aniline, so the hydrogen bonding event affects the nuclear 
environment of the aromatic aniline protons. The 2-Ai-HCl aromatic protons are 
not affected by the hydrogen bonding event, as evident in their chemical shifts 
remaining constant during the 1H-NMR titration. 
 
Figure 107. 2-Aminoindane-HCl (left) and aniline-HCl (right). 
The differences in proton signal changes are supported in the 1H-NMR 
binding constants. Binding constants for each analyte was calculated with 
HypNMR 2008.62 Probe 4.12 exhibited a 1:1 Ka = 1148 ± 1 M-1 for aniline-HCl. 
The binding constant had a Ka = 457 ± 1 for a 1:1 M-1 binding stoichiometry of 2-
aminoindane-HCl. This indicates that the probe has a higher affinity for aniline 
and, perhaps, other aromatic amines. 
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Figure 108. 1H-NMR titration of compound 4.12 (10 mM) and 2-aminoindane-HCl in MeOD. 
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Figure 109. 1H-NMR titration of compound 4.12 (10 mM) and 2-aminoindane-HCl in MeOD (aza-crown region). 
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Figure 110. 1H-NMR titration of compound 4.12 (10 mM) and 2-aminoindane-HCl in MeOD (aromatic expansion). 
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Figure 111. 1H-NMR titration of compound 4.12 (10 mM) and KClO4 in MeOD. 
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Figure 112. 1H-NMR titration of compound 4.12 (10 mM) and KClO4 in MeOD (aza-crown region). 
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Figure 113. 1H-NMR titration of compound 4.12 (10 mM) and KClO4 in MeOD (aromatic expansion). 
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Figure 114. 1H-NMR titration of compound 4.12 (10mM) and aniline-HCl in MeOD (aza-crown region). 
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Figure 115. 1H-NMR titration of compound 4.12 (10 mM) and aniline-HCl in MeOD (aromatic expansion). 
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4.6.4 Optical Spectroscopy 
Titration of a 1 х 10-3 M solution of 2-aminoindane-HCl in methanol into 
4.12 (1 х 10-5 M) was analyzed via UV-Vis and fluorescence spectroscopy. 
Unfortunately, there is little change that occurs in the UV-Vis or fluorescence 
spectroscopy (Figure 116 and Figure 117, respectively).  In the UV-Vis titration 
(Figure 116), there is no change, with the exception of the linear increase of the 
band at 272 nm, in the absorption spectra. Likewise, the fluorescence emission 
spectrum does not exhibit much change (Figure 117). There is an initial quench 
of the fluorescence emission, but there is essentially no change in the spectra 
upon the addition of the subsequent equivalences of 2-Ai-HCl (Figures 116 and 
117). 
No changes in the optical spectra of 4.12 indicate that 2-Ai-HCl does not 
interact with the fluorescent signaling unit. This contradicts the data from the 1H-
NMR studies. However, the concentrations at which the optical spectroscopy and 
1H-NMR studies were conducted differ by several orders of magnitude. The 
optical spectroscopy was conducted at 1 х 10-5 M, while the 1H-NMR studies 
were completed at 1 х 10-2 M. The relatively dilute solution of 4.12  in the optical 
studies lowered the probability of interactions between the fluorescent acridine 
and 2-Ai-HCl; therefore, there is essentially no change in the optical spectra of 
4.12 in the presence of 2-Ai-HCl. 
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Figure 116. UV-Vis titration of 10 µM compound 4.12 and 2-aminoindane-HCl in 
MeOH. 
 
Figure 117. Fluorescence titration of 10 µM compound 4.12 and 2-aminoindane-
HCl in MeOH. 
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4.7 Summary 
A bisaza-crown primary amine sensor has been synthesized and 
characterized for its binding ability to 2-aminoindane-HCl, a ‘legal high’, KClO4, 
and aniline-HCl via mass spectrometry, 1H-NMR, and optical spectroscopy. 
Although the mass spectrometry studies did indicate a signal for the 4.14:2-Ai-
HCl adduct, the signal was not abundant enough to report. The 1H-NMR studies 
indicated binding through changes in chemical shifts. However, there were no 
significant changes in the optical spectra upon the addition of 2-aminoindane-
HCl.  
In the 1H-NMR studies, the most significant changes in the chemical shifts 
occurred with the aza-crown protons in the titration of KClO4. In the 1H-NMR 
titration of the small molecules (2-Ai-HCl and aniline-HCl), the aromatic acridine 
protons underwent changes in chemical shifts. This is because the small 
molecules are interacting with the acridine signaling unit, either through hydrogen 
bonding with the nitrogen heteroatom, π-π stacking, or both.  
The unfortunate aspect of this sensor design is that it is not selective for 
the intended analyte, 2-aminoindane-HCl. The changes in the 1H-NMR chemical 
shifts for probe 4.12 were greater in the presence of aniline-HCl than 2-
aminoindane-HCl, indicating probe 4.12’s higher affinity for aniline. The current 
receptor’s design did bind 2-aminoindane, but it was not selective for that 
particular analyte. In order to boost selectivity, probe 4.12 needs to be altered 
take advantage of additional intermolecular forces. The chemosensor needs to 
not only target the primary amine motifs in the aminoindanes, but it should have 
 181 
motifs that can interact with their π system. An asymmetric probe with better 
preorganization of the π systems than the current receptor, would allow the 
newer probe to interact with the aminoindanes’ aromatic motifs. Intermolecular 
interactions in addition the hydrogen bonding of the amine functionality will help 
promote binding via concerted effort with multiple intermolecular interactions 
occurring. This will improve the selectivity of the probe for aminoindanes. 
4.8 Experimental Methods 
4.8.1 General Experimental Conditions 
The same conditions that have applied to the other studies in this 
document also apply to this study. Refer to Chapter II’s General Experimental 
Methods section for the conditions used in the study. The chapter specific 
conditions are in the subsequent sections of this chapter. 
4.8.2 Mass Spectrometry Methods 
Mass spectrometry experiments were performed on a Thermo LXQ ESI-
MS with an ion trap mass separator. A solution of compound 4.12 was made at 1 
mg·mL-1 in LC/MS grade methanol. After a blank was recorded, the compound(s) 
was injected into the instrument and the mass spectrums were recorded. Mass 
spectrums of the chemosensor and the complex are reported in positive ion 
mode. 
4.8.3 NMR Methods 
1H-NMR titrations of TBA anions and chemosensors 4.12 were performed 
by preparing a 10 mM solution of the chemosensors in MeOD (1.0 mL). A stock 
solution of the 2-Ai HCl (0.20 M) salt was prepared in MeOD (1.0 mL). Aliquots of 
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2.5 µL (5.0 µL = 0.2 equivalence of 2-Ai-HCl to 4.12) of 2-Ai HCl salt were added, 
resulting in increases in equivalences of 2-Ai salt to chemosensor, and the 1H-
NMR spectra was recorded after each addition. Binding constants were 
determined by HypNMR software.62 
4.8.4 Optical Spectroscopy Methods 
For UV-Vis and fluorescence emission studies, a solution of compound 
4.12, 1.0 х 10-5 M was prepared in methanol. For fluorescence studies, 
chemosensor 4.12 was excited at 338 nm and the emission was recorded from 
348-700 nm. An additional solution containing 1.0 х 10-3 M of 2-Ai HCl salt was 
prepared and aliquots of 4 µL (40 µL = 1.0 equivalent of TBA salt to compound 
4.12) were added. UV-Vis and emission spectra were recorded after each 
addition. 
4.8.5 Synthetic Methods 
 
 Synthesis of 4,5-bis(bromomethyl)acridine (4.13) 
Compound 4.13 was prepared from based upon conditions found in 
literature.131 Acridine (1.031 g, 5.75 mmol) and bromomethyl methyl ether (1.3 
mL, 1.9 g, 15.3 mmol) were added to a round bottom flask with 12 mL of 
concentrated H2SO4. The solution was stirred for 20 hours at 50°C. The reaction 
was allowed to cool to room temperature, and ice was added directly to the 
reaction and stirred for an hour. A yellow solid precipitated from solution upon the 
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addition of ice. The yellow solid was separated via vacuum filtration, then it was 
dissolved in chloroform. After drying the chloroform solution with MgSO4, the 
solvent was removed with rotary evaporation, and the resulting yellow solid was 
recrystallized from diethyl ether to afford 4.13 (257 mg, 0.7 mmol, 12% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.80 (s, 1H), 8.01 (d, J = 8.5 Hz, 2H), 7.95 (d, J = 6.7 
Hz, 2H), 7.58 – 7.48 (m, 2H), 5.44 (s, 4H). IR (ATR solid) in cm-1: 3055 νAr-H, 
2972 νC-C-H. 
 
 Synthesis of Chemosensor 4.12 
Compound 4.12 was prepared based upon literature conditions of similar 
molecules.132 4,5-Bis(bromomethyl)acridine (4.13, 101.1 mg, 0.28 mmol),  
1-aza-18-crown-6 (145.7 mg, 0.55 mmol), and Cs2CO3 (180.2 mg, 0.55 mmol) 
were dissolved in 10 mL of dry acetonitrile and stirred at room temperature for 48 
hours. Then, the reaction was heated to 50°C for 48 hours. After cooling, the 
cream colored solid, which was Cs2CO3, was filtered off. The filtrate was 
concentrated under vacuum, and the product (4.12) was precipitated with 
acetone (112.0 mg, 0.15 mmol, 28 %). 1H NMR (400 MHz, MeOD) δ 8.95 (s, 1H), 
8.02 (m, 4H), 7.61 (t, 2H), 4.61 (s, 4H), 3.70 (dd, J = 5.9, 2.3 Hz, 8H), 3.64 (dd, J 
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= 10.2, 4.2 Hz, 16H), 3.58 (dd, J = 5.5, 3.0 Hz, 8H), 3.46 (dd, J = 5.4, 3.0 Hz, 
8H), 2.97 (s, 8H). IR (ATR solid) in cm-1: 3365 νN-H (m), 2876 νC-C-H (m) 1246 νC-O 
(s); mp = 96°C.  
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CHAPTER V – BISTHIOUREA DERIVED ANION SENSORS 
5.1 Background 
Chapter V is based upon the anion binding abilities of the probes 
synthesized and characterized in Chapter III. Thiourea moieties are well known 
to bind anions via hydrogen bonding interactions, and cathinone ‘legal highs’ 
street samples commonly exist as chloride or bromide salts.69,90,133 Therefore, the 
binding interactions between the molecular probe and the anion is crucial in our 
understanding towards the selectivity. In other words, we want to analyze 
whether our probe is selective for the drug or the anion. 
Thiourea groups are common binding units employed in anion 
chemosensors.134 They are better hydrogen bond donors than urea groups, due 
to the sulfur atom being less electronegative than oxygen.1 This allows more 
electron density to reside on the nitrogen atoms, which makes the N-H bond 
more polar. Thiourea moieties are beneficial for anion sensing since hydrogen 
bonding is a common intermolecular interaction utilized to bind anions. The 
subsequent paragraphs will feature examples of anion sensors similar to the 
probes in Chapter III. 
There have been a plethora of monopodal thiourea based anion sensors 
in the literature.135 Three related examples that utilized photophysical detection 
methods will be subsequently discussed.136–138 Udhayakumari et al. designed a 
colorimetric, anthracene coupled thiourea fluoride sensor (Compound 5.1, Figure 
118).138 Other anions, such as Cl-, Br-, CH3CO2-, H2PO4-, HSO4-, OH-, and CN-, 
did bind, but those anions did not produce the color change observed with 
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fluoride (Ka = 3.2  104), which is a the result of deprotonation instead of 
hydrogen bonding. Compound 5.1 also possessed a binding affinity for copper(II) 
(Ka = 8.0  105). The interesting aspect of compound 5.1 is its dual detection of 
fluoride and copper(II). The binding of fluoride is evident via a colorimetric 
response (color change), while copper(II)’s binding produces a quenching effect 
on the fluorescence emission. 
 
Figure 118. Monopodal thiourea anion sensor examples. 
(Compound 5.2a: R1 = H, Compound 5.2b: R1 = NO2); (Compound 5.3a: R2 = OCH3,R3 =4-NO2; Compound 5.3b: R2 = 
F,R3 =4-NO2;Compound 5.3c: R2 = F,R3 =2,6-F2). 
Compounds 5.2a-5.3c demonstrated colorimetric responses to the fluoride 
and acetate anions.136,137 Compounds 5.2a and 5.2b showed the formation of a 
new absorbance band at 275 nm up on the incremental addition of fluoride or 
acetate; during fluorescence studies, quenching of the fluorescence emission 
was observed, especially in the case of compound 5.2b.137 The quenching can 
be explained by the PET mechanism; upon addition of fluoride or acetate, 
electron-transfer between the electron-rich, thiourea binding unit and the 
5.1 
5.2a-b 
5.3a-c 
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azophenyl fluorophore became energetically feasible. The PET mechanism was 
enhanced. Further 1H-NMR studies on compounds 5.2a and 5.2b showed that 
deprotonation was a huge portion of the receptors’ interactions with fluoride and 
acetate.  
Compounds 5.3a-c also were reported to selectively bind fluoride and 
acetate.136 Addition of those two anions produced a new absorbance band at 391 
nm; UV-Vis detection limits for fluoride and acetate were 5  10-6 M and 2  10-5 
M, respectively, for compound 5.3a. 1H-NMR studies indicated the deprotonation 
was occurring; this was by the appearance of a signal at approximately 16 ppm, 
which is assigned to the formation of HF2-. An interesting aspect from this work 
was that compounds 5.3a and 5.3b were capable of naked-eye fluoride and 
acetate detection in an aqueous environment with less than 15% water content. 
Kim et al. developed a bisurea, anthracene derivatives that functioned as 
a fluorescent probe for anions (Figure 119).133 In order to establish proper anion 
selectivity, they investigated their probes’ (5.4a-c) binding abilities via 
fluorescence for a host of structurally varied tetrabutylammonium salts, including 
C6H8O42- (adipate), C5H6O42- (glutarate), C4H4O42- (succinate), C3H2O42- 
(malonate), P2O74- (pyrophosphate), H2PO4-, CH3CO2-, HSO4-, F-, Cl-, Br-, and I-. 
Compound 5.4a showed a 1:1 binding stoichiometry for dicarboxylates with 
binding constants of 1.2 х 104, 9.1 х 104, 2.1 х 104, 6.9 х 103 and 3.1 х 103 M-1 for 
adipate, glutarate, succinate and malonate, respectively. In a 9:1 acetonitrile-
DMSO solvent system for fluorescence studies, compounds 5.4b and 5.4c 
exhibited 1:1 association constants (Ka) of  1.3 х 104 M-1 and 2.3 х 10-5 M-1 for 
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pyrophosphate, respectively, while compound 5.4a was more selective, 
exhibiting a 101,300 M-1 1:1 association constant for pyrophosphate. Calculated 
structures of the hydrogen bond complexes illustrated the anions inside the 
binding pocket hydrogen bonds formed between the pyrophosphate or 
dicarboxylate species and the urea/thiourea amines 
 
Figure 119. Fluorescent anion sensors based on bisurea anthracene derivatives. 
(Compound 5.4a: X = O, R = H; Compound 5.4b: X = S, R = H; Compound 5.4c: X = S, R = CF3). 
Hossain et al. synthesized a dipodal thiourea based system that had an 
affinity for fluoride and dihydrogen phosphate (Compound 5.5, Figure 120). 
Solution binding studies were investigated using 1H-NMR and UV-Vis 
spectroscopy. Hossain et al. were able to observe shifts in the N-H signals on 
their probe in the presence of anions in DMSO-d6; fluoride induced a large 
change in the N-H chemical shift (3.43 ppm). The fluoride ion had the highest 
binding constant of the halide series (Log K1:1 = 3.69); however, the dihydrogen 
phosphate ion had the greatest binding constant of all the oxoanions (Log K1:1 = 
3.79). The perchlorate and nitrate showed no significant 1H-NMR shifts. A 
colorimetric change was observed in the titration of fluoride, dihydrogen 
5.4a-c 
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phosphate, and acetate. UV-Vis titrations showed this color change through a 
bathochromic shift and the appearance of a new band at 475 nm. 
 
Figure 120. Dipodal thiourea-based sensor for anions. 
Another example of a bisurea phosphate sensor is an electrode 
immobilized probe developed by Aoki et al. (Figure 121).139 They were able to 
show that the binding of dihydrogen phosphate occurred on the thiol 
functionalized surface of a gold electrode by observing the signal of an 
electroactive marker, a [Fe(CN)6]4- redox reaction. They showed that the binding 
of dihydrogen phosphate electrostatically hindered the redox reaction of 0.5 mM 
ferrocyanide in a 0.1 M HEPES buffer solution (Figure 121). In addition to 
dihydrogen phosphate, Aoki et al. also examined the effect of various anions 
(SO42-, AcO-, NO3-, and Cl-) on the electron transfer reaction of ferrocyanide. 
Ultimately, their bisurea immobilized probe was selective for dihydrogen 
phosphate, which was the only anion that electrostatically inhibited the 
ferrocyanide redox reaction (shown by the curved arrows in Figure 121).  
5.5 
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Figure 121. Schematic of the ion-channel sensor for dihydrogen phosphate base 
on a gold electrode immobilized bis-thiourea. 
Reprinted from Aoki, H.; Hasegawa, K.; Tohda, K.; Umezawa, Y. Voltammetric Detection of Inorganic Phosphate Using 
Ion-Channel Sensing with Self-Assembled Monolayers of a Hydrogen Bond-Forming Receptor. Biosens. Bioelectron. 
2003, 18 (2–3), 261–267. Copyright 2003, with permission from Elsevier. 
5.2 Rationale 
Thiourea moieties have been incorporated in many chemosensors to bind 
anions via hydrogen bonding interactions.139,140 The use of a bisthiourea moiety, 
which has been incorporated on an anthracene backbone has already been 
discussed in Chapter III. Since all cathinones street samples exist in the form of 
chloride and bromide salts, we turned our attention to the anion recognition 
properties of the already synthesized cathinone probes. 
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5.3 Hypothesis 
A bisthiourea chemosensor will bind anions via hydrogen bonding 
interactions. Monitoring hydrogen bonding binding events can occur by NMR, 
fluorescence, and mass spectrometry. The NMR experiments helps in our 
understanding of the chemical environment of the protons bound to the anions. 
Due to its photophysical properties, the rigid anthracene backbone can act as 
both a signaling unit and the organic linker for the two arms of the sensor. Mass 
spectrometry studies allow us characterize the “pure” probe-anion interaction, 
due to the lack of solvent. This is crucial since anions have a higher energy of 
solvation, and chemosensors have to compete with solvent in order to bind 
anions. 
The questions that arise surrounding these molecular probes are typical 
questions that one would ask of any novel chemosensor. Can they be selective 
for spherical halides above larger oxyanions due to their binding pocket size? 
Will the probes, with their large aromatic functionalities, be sufficiently soluble in 
a polar solvent to facilitate the study of anion binding? Will probe 3.18, with its 
monopodal nature, bind anions through a self-assembly process? These are 
some questions that were contemplated in the initial stages of the project.  
5.4 Results and Discussion 
5.4.1 General Synthesis 
The syntheses and characterizations of both compound 3.17 and 3.18 
were previously discussed in Chapter III. Compound 5.6 was synthesized from 
naphthyl isothiocyanate and 1,8-diaminoanthracene by refluxing in ethanol. A 
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dark brown precipitate was filtered after cooling the reactions in ice. Compound 
5.6 was characterized with multinuclear and multidimensional NMR, ESI-MS, UV-
vis, and fluorescence. 1H-NMR indicated formation of compound 5.6 by the 
appearance of the two distinct amine proton signals in the downfield, aromatic 
region at 9.90 and 8.32 ppm.  
 
Figure 122. Proposed thiourea based anion probes. 
5.4.2 Mass Spectrometry Studies 
Chemosensor 5.6 was characterized via ESI-MS (-ve mode) in 50/50 
toluene/methanol with no charging agent present. Residual chloride anions from 
the mass spectrometer capillaries were sufficient to charge 5.6 (m/z = 606) and 
resulted in a stronger signal in negative ion mode. [5.6 + Cl]- was the parent ion 
peak of the spectrum for 5.6 (Figure 123). A MS/MS of this signal results in the 
loss of HCl to form the 605 m/z ion, which represents [5.6]-. Upon CID of 605 m/z 
signal, the loss of naphthylmethylamine occurs, which produces an 
isothiocyanate adduct of probe 5.6, as illustrated by Figure 123. This further 
supports that 5.6 was, in fact, synthesized. One MS/MS iteration of the chloride 
charged adduct produces a mass signal that is analogous to the deprotonated 
version of 5.6. 
3.18 
3.17 5.6 
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Figure 123. CID fragmentation pattern of 5.6 in 50/50 toluene/methanol with no 
charging agent. 
Probe 3.17’s characterization via ESI-MS is detailed in Chapter III. Here, 
the analysis of 3.17-bromide adduct is presented, as the example. Bromide was 
chosen for characterization of the anion complex due to the fact that 3.17-
chloride adduct was evident in the characterization of the probe, itself. In other 
words, another anion was chosen to support that signals generated were due to 
the formation of hydrogen bond complexes other than the chloride ones present 
in the analysis of probe 3.17. The host-guest complex was analyzed in negative 
mode in acetonitrile. A 587 m/z signal, assigned to a 3.17-81Br complex mass, is 
the parent ion peak (Figure 124), while a 585 m/z signal was assigned to the 
3.17-79Br complex, which was 96% abundant and further bolstered the 
hypothesis of a bromine complex. A MS/MS of the 585 m/z mass indicates the 
-157 m/z 
641 [5.6 + Cl]- 605 [5.6]- 448 
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loss of HBr, which is shown by the appearance of a 505 m/z peak that is 
representative of a deprotonated 3.17. This indicates the formation of a 3.17-Br 
adduct because the first MS/MS iteration is the loss of HBr. 
 
Figure 124. ESI-MS CID Flow of a 1.0 molar equivalent of 3.17-Br complex in 
acetonitrile. 
ESI-MS was utilized to characterize probes 3.17, 5.6, and a 3.17-Br 
complex. The characterization of 3.17 by mass spectrometry was previously 
discussed in Chapter III. In this chapter, 5.6 was charged by chloride and after a 
MS/MS resulting in the loss of HCl, the deprotonated version of 5.6 was evident 
from the 605 m/z signal. The probe 3.17-Br hydrogen bond complex (585 m/z) 
was also seen. The CID of this signal results in the loss of HBr, which reveals the 
deprotonated version of 3.17 (505 m/z). A probe 5.6-Br complex was analyzed 
using ESI-MS, but the signal intensity was not strong enough to report. 
587 [3.17 + Br]- 505 [3.17]- 
398 401 
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5.4.3 NMR Studies 
Characterization of binding via NMR allows for the determination of which 
nuclei are involved in the binding and provides key data about structural changes 
that occur during binding. The next few sections feature 1H-NMR titrations 
between Compound 3.17 and 3.18 and various tetrabutylammonium salts. The 
equivalences of anion to 3.17 or 3.18 are on the right side of the NMR stack plot. 
Upon the addition of anions, a downfield shift in the 1H-NMR signals as the 
equivalences of anions increase indicates a change in the chemical environment 
of the nucleus because the nucleus is being de-shielded. The formation of 
hydrogen bonds between the anions and 3.17 or 3.18 is primarily de-shielding 
the nuclei in proximity to the binding site; for example, the largest downfield shifts 
occur with the thiourea amine proton signals. These protons are directly involved 
in the hydrogen bonding coordination of the anions.  
The chemical shifts for compounds 3.17 and 3.18 have been previously 
assigned in Chapter III. Please refer to Figure 125 for 3.17 and 3.18 1H-NMR 
assignments. A number of 1H-NMR titrations was conducted with the probes to 
test their binding affinities in the presence of various tetrabutylammonium salts. 
This section will discuss the results concerning the 1H-NMR characterization of 
compounds 3.17, 3.18, and 5.6 and their TBA anion binding abilities. 
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Figure 125. Numbering systems used for the NMR assignments for molecular 
compound 3.17 and 3.18. 
All the 1H-NMR signals N(1)H, N(2)H, and C(9)H experience a downfield 
shift due to the formation of hydrogen bonds between the thiourea amines and 
the anions. These chemical shifts occur upon the additions of various geometries 
of anions, such as chloride, nitrate, and acetate (Figures 131, 132, and 133, 
respectively). It was suggested that the anions would bind in a 1:1 stoichiometry 
(Figure 126). The N(1)H and N(2)H signals in the TBAC2H3O2 titration (Figure 
133) diverge into two signals at 0.4 molar equivalences, but only the N(2)H 
remains two signals at equivalences above 0.4. This is because the acetate may 
only hydrogen bond with N(2)H (Figure 126). The N(1)H and N(2)H signals 
disappear in the H2PO4- and F- titrations because H2PO4- and F- are strong 
conjugate bases and deprotonate the thiourea amines at higher equivalences 
(Figure 135). 
The chemical signals associated with C(10)H, C(4)H, and C(5)H actually 
undergo upfield shifts in the presence of the three mentioned anions (chloride, 
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nitrate, and acetate). This is because the electron density is being removed from 
the thiourea side of the anthracene moiety. It generates a more polarized 
electronic structure of anthracene and results in more electron density resided on 
the side of the C(4)H, C(5)H, and C(10)H positions. Similar chemical shift 
observations were made during the 1H-NMR titrations of TBABr, TBAI, and 
TBAHSO4. 
 
Figure 126. Binding hypothesis of probe 3.17 and various TBA anions. 
To ensure that the chemical shifts were due to genuine hydrogen bond 
coordination, it was decided to analyze the probe’s response to “weakly 
coordinating” anions or anions that do not form strong hydrogen bonds, like BF4- 
or PF6-. A representative 1H-NMR titration showing little to no chemical shifts 
after the addition of TBABF4 is shown in Figure 134; addition of TBAPF6 exhibited 
little or no chemical shift either. This was an expected response; BF4- or PF6- form 
weak hydrogen bonds. Therefore, they should not bind to the probe, which would 
result in little or no chemical shifts.  
Calculation of binding constants from the NMR data indicated that the 
probes preferred a 2:1 binding stoichiometry, instead of the hypothesized 1:1 
stoichiometry(Figure 127). This is anticipated to be due to the high 
concentrations (20 mM) required by NMR spectroscopy; more host was available 
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at 20 mM, so a 2:1 geometry was preferred for the hydrogen bond complexes. 
The binding constant actually decreases down the halide series, due to their 
increase in size. The oxyanions all have relatively similar binding constants; the 
probe has an affinity for chloride over all the tested anions. 
 
Figure 127. 2:1 Binding hypothesis with 3.17 and anions. 
  
Probe 3.17 1H-NMR binding constants with various TBA anions 
Probe 3.17 Log K2:1 
TBACl >10  
TBABr 6.9 ± 0.03  
TBAI 4.0 ± 0.07 
TBAHSO4 6.7 ± 0.17 
TBANO3 4.8 ± 0.08 
TBAC2H3O2 7.2 ± 0.08 
TBAH2PO4 6.0 ± 0.04 
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Figure 128. Binding isotherms from 1H-NMR of the N(1)H signal with increasing 
concentration of various TBA anion salts in acetone-d6. 
Probe 3.18 indicated binding of chloride via the deshielding of its N(1)H 
and N(2)H thiourea amine proton signals through hydrogen bonding (Figure 129). 
It also exhibited the similar deshielding with TBACl and TBAC2H3O2 as indicated 
by the binding constants in Table 13. Binding constants also indicate that it 
prefers a 2:1 binding stoichiometry much like 3.17. This means that chemosensor 
3.18 is binding anions in a self-assembly manner, which is what was 
hypothesized prior to any binding studies.  
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Figure 129. Binding hypothesis of probe 3.18 and chloride. 
  
Probe 3.18 1H-NMR binding constants with various TBA anions 
Probe 3.18 Log K2:1 
TBACl 8.3 ± 0.02  
TBABr 7.1 ± 0.09  
TBAC2H3O2 8.8 ± 0.02 
 
 
Figure 130. HypNMR 2016 fitted data for 3.17 and TBABr. 
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Figure 131. 1H-NMR titration of 20 mM probe 3.17 and TBACl in acetone-d6  
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Figure 132. 1H-NMR titration of 20 mM probe 3.17 and TBA(NO3) in acetone-d6.  
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Figure 133. 1H-NMR titration of 20 mM probe 3.17 and TBA(C2H3O2) in acetone-d6.  
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Figure 134. 1H-NMR titration of 20 mM probe 3.17 and TBABF4 in acetone-d6.  
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Figure 135. 1H-NMR titration of 20 mM probe 3.17 and TBAH2PO4 in acetone-d6  
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Figure 136. 1H-NMR titration of probe 3.18 and TBACl in acetone-d6 
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5.4.4 2D-NMR Studies 
Two dimensional ROESY NMR techniques allow for key structural 
analysis of the probe and the hydrogen bond complex. Probe 3.17 (Figure 138) 
and a 3.17-Cl complex (Figure 139) were analyzed via 2D-ROESY (Rotational 
Overhauser Effect Spectroscopy) NMR to determine if certain protons brought 
into proximity (5 Å or less) due to the hydrogen bonding event. The proton 
correlations (within 5 Å of each other) in Probe 3.17 and a 3.17-Cl complex are 
displayed in Figure 137. 
 
Figure 137. 2D ROESY correlations between 3.17 (A) and a 3.17-Cl complex (B). 
There are four correlations present in the ROESY spectrum of compound 
3.17.These correlations are assigned in Figure 136 and are also labeled in each 
ROESY spectra in Figures 138 and 139. Correlations a, b, and c are seen in both 
compound 3.17 and the 3.17-Cl complex. Correlation d appears in compound 
3.17 between signal C(10)H and signals C(4)H and C(5)H, which are vicinal 
protons in the C(10), C(4), and C(5) positions, respectively. In the 2D ROESY 
a a 
b 
b 
c c 
d 
d 
e 
B A
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spectrum of the 3.17-Cl complex the same correlation is missing; therefore, 
correlation d is assigned to another vicinal proton correlation between the C(3)H 
and C(6)H position and the C(2)H and C(7)H position protons. These correlations 
are all between protons that are within the 5 Å distance necessary for rOe 
magnetization transfer. However, a new correlation (e) is fundamental for 
supporting the existence of the Cl- complex. Correlations a, b, c, and d are all 
sequestered to the rigid anthracene linker or occur within one arm of the sensor. 
Correlation e is not present in the 2D ROESY of the ligand (probe 3.17) alone, 
but is found to be a significant correlation in the ROESY of the 3.17-Cl complex. 
The hydrogen bonding event of chloride stimulates this magnetization transfer. 
The correlation is between the two thiourea amine signals (N(1)H and N(2)H). 
The binding of the chloride anion via hydrogen bonding locks the amine protons 
into place (Figure 137B); this prevents the free rotation of those protons that 
occurred in the ligand ROESY. Once “locked” into place, magnetization can 
transfer through-space more easily. In Figure 137B, the correlation is drawn to 
the N(2)H amine signal on the same arm of probe and to the N(2)H amine signal 
on the opposite arm. It is difficult to establish exactly which N(2)H amine proton is 
responsible for the correlation, but the binding of the chloride via the amines 
produces this significant correlation, indicating the formation of a the anion 
hydrogen bond complex. 
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Figure 138. 2D ROESY of Probe 3.17 in acetone (COSY symmetrized).  
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Figure 139. 2D ROESY of 1.2 eq TBACl/Probe3.17 complex in acetone (COSY symmetrized). 
a b 
c 
d 
e 
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5.4.5 NMR Studies of Probe 5.6 
The NMR data and numbering scheme for compound 5.6 is shown in 
Figure 140 and Table 14, respectively. Upon the addition of chloride to 
chemosensor, probe 5.6 induces chemical shifts as are previously outlined for 
those experienced by probe 3.17 (Figure 141). The thiourea amine protons 
(N(1)H and N(2)H) and the proton on the C(9)H position of the anthracene 
(Signal 9) all experience progressive deshielding in the presence of increasing 
molar equivalences of TBACl. Initially, the N(1)H begins at 9.90 ppm and shifts to 
10.3 ppm at five molar equivalences of TBACl  (Δδ = 0.4 ppm in DMSO) . Probe 
3.17’s N(1)H signal experienced a Δδ = 1.52 ppm between 0 and 5 equivalences 
of TBACl in acetone (Figure 141). These changes in chemical shift are not 
directly comparable due to the use of different solvents; chemosensor 5.6 most 
likely experience less chemical shift due to DMSO’s competitive nature, i.e. 
competing hydrogen bonding. Probe 5.6 is competing with the solvated sphere 
surrounding the anion. With that said, probe 5.6 still exhibited a Log K2:1 = 3.07 ± 
0.01. 
 
Figure 140. Numbering systems used for the NMR assignments for molecular 
compound 5.6. 
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1H NMR and 13C NMR chemical shifts from compound 5.6 (* = disappears on 
D2O shake) 
Probe 5.6 
1H-NMR 
(DMSO-d6, ppm, J Hz) 
13C-NMR 
(DMSO-d6, ppm) 
1 N/A 135.5 
2 7.85 (d, J = 7.0 Hz) 117.2 
3 7.57 (m) 127.0 
4 8.13 (d, J = 7.7 Hz) 125.7 
4a N/A 131.3 
5 8.13 (d, J = 7.7 Hz) 125.7 
6 7.57 (m) 127.0 
7 7.85 (d, J = 7.0 Hz) 117.2 
8 N/A 135.5 
8a N/A 125.9 
9 8.83 (s) 123.8 
9a N/A 125.9 
10 8.68 (s) 124.7 
10a N/A 131.3 
11/11’ N/A 183.0 
12/12’ 5.25 (d, J = 4.1 Hz) 46.5 
13/13’ N/A 134.5 
14/14’ 7.57 (m) 130.1 
15/15’ 7.57 (m) 128.0 
16/16’ 7.57 (m) 127.6 
16a/16a’ N/A 133.7 
17/17’ 7.96 (d, J = 7.2 Hz) 129.0 
18/18’ 7.57 (m) 126.3 
19/19’ 7.57 (m) 126.8 
20/20’ 8.02 (d, J = 8.4 Hz) 126.0 
20a/20a’ N/A 132.6 
N(1)H* 9.90 (s)*  
N(2)H* 8.32 (s)*  
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Figure 141. 1H-NMR titration of 20mM probe 5.6 and TBACl in DMSO-d6. 
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5.4.6 Fluorescence Studies 
The optical properties of compound 3.17 and 5.6 were investigated. 
Titrations of a 2.5 х 10-5 M solution of various TBA halide salts (5 х 10-3 M) in 
acetone into 3.17 produced a linear quench in the fluorescence emission (Figure 
142 is a TBACl example). The Stern-Volmer quenching constant (Ksv) is 0.24 
L·mol-1(Figure 143). Chemosensor 5.6 exhibited a very different response than 
3.17 in the presence of anions. The fluorescence emission increased in the 
presence of anions (Figure 144).   
 
Figure 142. Fluorescence emission titration of 2.5 х 10-5 M probe 3.17 and TBACl 
in acetone (λex = 389 nm). 
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Figure 143. Stern-Volmer plot of 3.17 and TBACl 
Molecular probe 5.6 differs from 3.17 with the naphthyl motif in place of 
the benzyl moiety. The binding of the anion in the cavity brings the two arms 
within proximity. The naphthyl moiety can form a proximity-based excited dimer 
or excimer, which is characterized by a broad emission band near 500 nm. This 
broad emission band is observed in the emission spectra of chemosensor 5.6 
(Figure 144). Increasing equivalences of anions resulted in an increase in the 
excimer emission band, which proved the excimer hypothesis that anion binding 
events cause the naphthyl moieties to be brought into proximity to each other 
(Figure 1445.  
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Figure 144. Fluorescence emission titration of 1 х 10-7 M probe 5.6 and TBACl in 
DMSO (ex. = 284 nm). 
 
Figure 145. Probe 5.6:Cl- binding hypothesis. 
An extensive anion study was carried out with probe 5.6 to determine its 
fluorescence emission response to the anion stimulus. All the tested TBA anions 
(Cl-, Br-, I-, NO3-, HSO4-, C2H3O2-, and H2PO4-) exhibited the same emission 
increase response, with varied intensity, as chloride. A binding constant was 
determined for each anion (Table 15). The halides all exhibit similar binding 
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constants (Log K1:1 = 6.67, 6.16, and 7.04 for Cl-, Br-, and I-, respectively). The 
highest binding constants were nitrate and acetate (Log K1:1 = 9.47 and 7.41, 
respectively).  This trend in the binding constants somewhat matches the binding 
isotherm trend from the 1H-NMR studies in Figure 128. In those binding 
isotherms of the N(1)H signal, dihydrogen phosphate and acetate had the largest 
Δδ chemical shifts. Besides solvent, the most significant difference between the 
binding constants calculated from 3.17, 3.18, and 5.6 is the binding 
stoichiometry.  
The 3.17 and 3.18 NMR association constants were 2:1, but the 
fluorescence constants for 5.6 were 1:1. This is due to the substantial difference 
in the concentrations in which these were measured. The NMR binding constants 
were completed at 20 mM, while the association constants in Table 15 were 
measured at 1 х 10-7 M. The high concentration of the NMR studies made so 
much more of the host available for 2:1 binding. The lower concentration of the 
fluorescence studies was more conducive to a 1:1 stoichiometry. 
  
Fluorescence binding constants of 5.6 and various TBA anion salts in DMSO 
Probe 5.6 Log K1:1 (DMSO) 
TBACl 6.67 ± 0.01 
TBABr 6.16 ± 0.002 
TBAI 7.04 ± 0.01 
TBANO3 9.47 ± 0.06 
TBAHSO4 6.56 ± 0.003 
TBAC2H3O2 7.41 ± 0.01 
TBAH2PO4 6.69 ± 0.002 
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Due to the chloride binding abilities of probe 3.17 in 1H-NMR studies, the 
fact that it exhibited no fluorescence emission enhancement upon the addition of 
TBA salts, and due to its structural similarity, probe 5.6 was selected to 
determine a limit of detection for anions. Chemosensors 3.17’s  and 5.6’s binding 
pocket is structurally the same; therefore, the limits of detection should be 
similar. Utilizing the sensitivity of the fluorescence technique, a limit of detection 
for 5.6 was determined in DMSO (Figure 146). At a probe concentration of 1 х 
10-9 M, the detection limit was 29.5 nM (3.3 ppb) for TBACl via a linear 
regression (Figure 146). A comparable limit of detection should be observed for 
3.17, due to its structural similarity.  
 
Figure 146. Linear regression limit of detection for 5.6 and Cl-. 
LOD = 29.5 nM 
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5.5 Summary 
Utilizing the molecular probes from the mephedrone detection chapter, 
characterization of the anion binding abilities bisthiourea designs was achieved. 
A 3.17-bromide adduct mass signal was observed in ESI-MS. In addition, probe 
3.17 exhibited binding affinities toward many tetrabutylammonium salts (chloride, 
bromide, iodide, dihydrogen phosphate, acetate, and bisulfate) in 1H-NMR 
studies. Probe 3.18, the monopodal version of 3.17, exhibited binding abilities, 
which were characterized via the deshielding of its thiourea amine proton signals. 
Probe 5.6 exhibited the same deshielding effects of its 1H-NMR signals that were 
in proximity to the binding event. 
In terms of optical spectroscopy, probe 3.17 showed a linear quench in 
fluorescence upon the addition tetrabutylammonium salts, while chemosensor 
5.6 had a fluorescence emission increase in the presence of various TBA anions. 
This increase was the result of the formation of an excimer that was stimulated 
by the hydrogen bonding of the anion in the pocket. This brought the 
naphthalene fluorophores into close proximity allowing for the formation of the 
excimer. This is evident by the broad, featureless emission band seen at 500 nm 
in 5.6’s fluorescence spectra.  
The characterization of these probe’s anion binding abilities was crucial to 
the determining if each probe could be utilized in the detection of cathinone salts, 
which is the form in which cathinones exist in street samples. Each probe 
possessed binding abilities for a broad array of anion geometries. This proves 
difficult in the quest to develop a selective sensor for cathinone salts. The probe’s 
 220 
indicated an almost identical change in chemical shift for anions, like chloride (Δ 
1.65 ppm), and the neutral molecule, mephedrone (Δ 2.07 ppm). Still, this study 
was beneficial in characterizing the anion binding of anthracene linked, 
bisthiourea moieties. Thiourea anion binding abilities are well studied, but this 
project investigates the ability of our host molecules to distinguish between the 
intended target and anions. 
5.6 Experimental Methods 
5.6.1 General Experimental Conditions 
The same conditions that have applied to the other studies in this 
document also apply to this study. Refer to Chapter II’s General Experimental 
Methods section for the conditions used in the study. The chapter specific 
conditions are in the subsequent section of this chapter. 
5.6.2 Mass Spectrometry Methods 
Mass spectrometry experiments were performed on a Thermo LXQ ESI-
MS with an ion trap mass separator. A solution of compound 3.17, 3.18, and 5.6 
was made at 1 mg·mL-1 in LC/MS grade acetone for 3.17 and 50/50 
toluene/methanol for 5.6. After a blank was recorded, the compound(s) was 
injected into the instrument and the mass spectrums were recorded. Mass 
spectrums of the chemosensor and the complex are reported in positive ion 
mode. 
5.6.3 NMR Methods 
1H-NMR titrations of TBA anions and chemosensors 3.17, 3.18, and 5.6 
were performed by preparing a 20 mM solution of the chemosensors in acetone-
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d6 (1.0 mL) for 3.17 and 3.18 and DMSO-d6 for 5.6. A stock solution of the TBA 
(0.394 M) salts was prepared in acetone-d6 or DMSO-d6 (1.0 mL). Aliquots of 2.5 
µL (2.5 µL = 0.1 equivalence of TBA salt to chemosensor) of TBA salt were 
added, resulting in increases in equivalences of TBA salt to chemosensor, and 
the 1H-NMR spectra was recorded after each addition. Binding constants were 
determined by HypNMR software.62  
5.6.4 Fluorescence Spectroscopy Methods 
For fluorescence emission studies, a solution of compound 3.17, 2.5 х 10-5 
M was prepared in acetone. Chemosensor 3.17 was excited at 389 nm and the 
emission was recorded from 400-740 nm. In order to account for dilution during 
titrations, an additional solution containing 2.5 х 10-5 M compound 3.17 and 5 х 
10-3 M of TBA salts was prepared and aliquots of 10 µL (10 µL = 1.0 equivalent 
of TBA salt to compound 3.17) were added. Emission spectra were recorded 
after each addition. Fluorescence emission binding studies for chemosensor 5.6 
were carried out at 1 х 10-5 M concentration in DMSO. The excitation wavelength 
was at 284 nm, and fluorescence emission was recorded from 304-560 nm. 
5.6.5 Synthetic Methods 
 
 Synthesis of 1-(isothiocyanatomethyl)naphthalene (5.13) 
Compound 5.13 was prepared based upon conditions found in 
literature.141 Triethylamine (3.54 mL, 25.4 mmol) and 1-aminomethylnaphthalene 
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(5.12, 955 mg, 6.1 mmol) were added to a round bottom flask with 15 mL of THF. 
The solution was cooled in ice to 0°C and CS2 (770 µL, 975 mg, 12.8 mmol) was 
added dropwise, and the reaction was allowed to warm to room temperature and 
stirred overnight. The reaction was again cooled to 0°C, and tosyl chloride (TsCl, 
1.4 g, 7.3 mmol) was added, and the reaction was stirred a further 3 hours at 
room temperature. Workup of the reaction involved adding 1M HCl (10 mL) and 
diethyl ether (10 mL) to the reaction and stirring for half an hour. Extraction the 
organic layer was completed with diethyl ether, which was dried with MgSO4. The 
solvent was removed using rotary evaporation and 1-
(isothiocyanatomethyl)naphthalene was obtained as a colorless oil (5.13, 606.8 
mg, 3.0 mmol, 50% yield). 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 1H), 
7.73 (t, J = 6.9 Hz, 2H), 7.46 (m, 2H), 7.33 (m, 2H), 4.89 (s, 2H). IR (ATR oil) in 
cm-1: 3175 νAr-H, 2975 νC-C-H, 1977 νN=C=S. 
 
 Synthesis of Chemosensor 5.6 
1,8-Diaminoanthracene (3.26, 38.5 mg, 0.2 mmol) and 1-
(isothiocyanatomethyl)naphthalene (5.13, 107 mg, 0.54 mmol) were dissolved in 
10 mL of ethanol and refluxed for two hours. The reaction was cooled in ice and 
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filtered. The dark solid was washed with approximately 10 mL of water and 
ethanol each. The product was then dried under vacuum; after which, it yielded a 
dark brown solid (5.6, 80.3 mg, 2.05 mmol, 80 %). See the NMR Studies section 
for 1H and 13C NMR assignments; IR (ATR solid) in cm-1: 3377 νN-H (m), 3144 νAr-
H, 2968 νC=C-H, 1615 νC=S (m), 1505 νC=S (s), and 1259 νC=S (s); mp = 201°C. 
Elemental Analysis (%) Calculated for C39H30N4S2: C, 75.34; H, 4.99; N, 9.24.  
Recalc. C39H30N4S2·0.5(C3H6O) 1(C2H6O): C, 73.21; H, 5.77; N, 8.23. Found: C, 
72.4, H, 4.68; N, 8.84. 
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CHAPTER VI – GENERAL CONCLUSIONS 
Supramolecular chemistry has led to pioneering applied research in the 
development of chemosensors. The research presented in this dissertation was a 
broad endeavor involving supramolecular chemistry and chemosensor and is 
part of a broad study that investigates the design and synthesis of chemosensors 
for toxic analytes Separate chemosensors were developed for a cation, neutral 
molecule, charged molecule, and anions and all involved hydrogen bonding. A 
bistriazole-derived redox active Zn2+ ion sensor had to overcome an 
intramolecular hydrogen bond to coordinate Zn2+ ions, a bisthiourea molecular 
‘tweezer’ for the binding of mephedrone and anions, and a bisaza-crown with a 
rigid acridine backbone as a host for 2-aminoindane were all designed and 
synthesized to utilize hydrogen bonding to binding the guest molecules.  
The bistriazole derived Zn2+ ion receptor was inspired by previous Wallace 
group work discussed in Figure 11, which had a pyrene signaling unit. It was 
anticipated the redox active ferrocene signaling unit would improve the solubility 
of the probe. Probe 2.15 bound Zn2+ ions in a 1:1 fashion, and had a larger 
affinity for ZnCl2 (Log K1:1 = 4.1 ± 0.02) over other Zn2+ salts (Log K1:1 = 2.2 ± 
0.01 for Zn(ClO4)2). This is due to the simultaneous cation/anion binding with the 
Zn2+ ion coordinated by the probe and the Cl- anions hydrogen bonding to the 
amide proton. Two dimensional NMR studies indicated formation of the complex 
with the appearance of two new ROESY correlations, which indicated that the 
ferrocene protons were now within 5 Å of the adjacent arm’s triazole proton. This 
is further supported by the DFT calculations, which indicate that Zn2+ binds inside 
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the binding pocket of the dipodal system. Upon addition of Zn2+ ions, the redox 
potential of the ferrocene units increases due to the withdrawal of electron 
density from the ferrocene motifs by the complex formation. Therefore, more 
energy is required for the redox reaction. This project showed that by using a 
known receptor motif with a different signaling unit the guest can still be detected 
even with a different instrumental technique. 
The bisthiourea motifs were used as hydrogen bond donors for the binding 
of mephedrone, a novel psychoactive substance. The thiourea motifs were 
anticipated to bind in a bifurcated fashion to the β-carbonyl of the mephedrone 
and promote selectivity over methamphetamine. 1H-NMR studies did indicate that 
binding was occurring with mephedrone in the free-base form. Unfortunately, 
thermodynamic binding constants were unable to be determined due to a 
pericyclic cycloaddition reaction occurring between adjacent anthracene moieties 
at the high concentrations (20 mM) used in NMR studies. However, 
methamphetamine did not induce as much changes in chemical shift as 
mephedrone. A NMR titration of simulated street sample, containing 
mephedrone, lidocaine, benzocaine, and acetaminophen, displayed the probe’s 
ability to distinguish between mephedrone and common cutting agents.  
ESI-MS studies indicated mass signals were observed for a 1:1 
mephedrone:probe 3.17 complex. Fluorescence studies showed that upon the 
addition of neat mephedrone in the free-base form produced an increase in 
fluorescence. The addition of neat flephedrone (free-base) produced an even 
greater increase. This was corroborated with DFT studies that indicated 
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flephedrone hydrogen bonds to the thiourea moieties and interacts with the π 
system of the anthracene fluorophore, while mephedrone only interacts with the 
π system of the benzyl moieties on probe 3.17.  
The bisaza-crown-derived molecular probe was utilized to function as a 
chemosensor for protonated 2-aminoindane, another novel psychoactive 
substance. 1H-NMR titrations indicated that compound 4.12 formed complexes 
with aniline-HCl, 2-aminoindane-HCl, and KClO4. Association constant 
calculations for 1:1 stoichiometries showed that 4.12 had an affinity for aniline-
HCl (Ka = 1148 ± 1 M-1) over 2-aminoindane (Ka = 457 ± 1 M-1). This is due to the 
aromatic nature of the amine group on aniline; it promotes hydrogen bonding. 
Optical spectroscopic studies did change much upon addition of 2-aminoindane. 
Unfortunately, this sensor was not selective for the intended target.  
The bisthiourea motifs (probe 3.17) were also analyzed for their anion 
binding abilities as well. Compound 3.17 showed an affinity for the Cl- anion (Log 
K2:1 > 10), while other anions ranged from Log K2:1 = 4.0 ± 0.07 for I- to Log K2:1 = 
7.2 ± 0.08 for C2H3O2-. Probe 3.18, the monopodal version of 3.17, had similar 
association constants and no affinity for a particular anion. This is due to its self-
assembled nature; it can accommodate a variety of anion sizes and geometries. 
Fluorescence studies of 3.17 shows that addition of anions produces a 
quenching in the fluorescence emission. Replacing the benzyl group on 3.17 with 
a naphthyl moiety (probe 5.6) causes the fluorescence emission to increase in 
the presence of anions. This is because the hydrogen bond coordination of the 
anions brings the two naphthyl moieties into close proximity, which facilitates the 
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formation of an excimer. Association constants for 5.6 indicate a 1:1 binding 
stoichiometry. This is in contrast with the 2:1 observed in the NMR studies. The 
fluorescence studies were carried out a 0.1 µM vs. the 20 mM concentration for 
the NMR studies. At a lower concentration, there is fewer host molecules around, 
so a 1:1 stoichiometry is the preferred binding mode.  
This dissertation has outlined the design and synthesis of varied 
chemosensor for a host of targets (Zn2+, mephedrone, 2-aminoindane, and 
various anions). These chemosensors have employed many supramolecular 
concepts, such as selectivity and complementarity, in an effort to selectively bind 
the target guests. Some were somewhat successful in being selective; probe 
2.15 exhibited a higher association constant for Zn2+ than for Cd2+ or Al3+. 
However, receptor 4.12 was not selective; it had a higher affinity for aniline-HCl 
over 2-aminoindane-HCl. These studies conducted on the structural motifs found 
in the chemosensors outlined in this work can be further utilized in the future to 
improve upon the selectivity of the intended targets. Studies into structural motifs 
for selective molecular probes for these targets will allow for research into field 
applications for these types of chemosensors, which will ultimately make the 
world a better place.
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